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RÉSUMÉ 
L’émergence des micro-dispositifs implantables est une voie prometteuse pour le traitement de 
troubles neurologiques. Ces systèmes biomédicaux ont été exploités comme traitements non-
conventionnels sur des patients chez qui les remèdes habituels sont inefficaces. Les récents 
progrès qui ont été faits sur les interfaces neuronales directes ont permis aux chercheurs 
d’analyser l’activité EEG intracérébrale (icEEG) en temps réel pour des fins de traitements.  
Cette thèse présente un dispositif implantable à base de microsystèmes pouvant capter 
efficacement des signaux neuronaux, détecter des crises d’épilepsie et y apporter un traitement 
afin de l’arrêter. Les contributions principales présentées ici ont été rapportées dans cinq articles 
scientifiques, publiés ou acceptés pour publication dans les revues IEEE, et plusieurs autres tels 
que «Low Power Electronics» et «Emerging Technologies in Computing». Le microsystème 
proposé inclus un circuit intégré (CI) à faible consommation énergétique permettant la détection 
de crises d’épilepsie en temps réel. Cet CI comporte une pré-amplification initiale et un détecteur 
de crises d’épilepsie. Le pré-amplificateur est constitué d’une nouvelle topologie de stabilisateur 
d’hacheur réduisant le bruit et la puissance dissipée. Les CI fabriqués ont été testés sur des 
enregistrements d’icEEG provenant de sept patients épileptiques réfractaires au traitement 
antiépileptique. Le délai moyen de la détection d’une crise est de 13,5 secondes, soit avant le 
début des manifestations cliniques évidentes. La consommation totale d’énergie mesurée de cette 
puce est de 51 µW. 
Un neurostimulateur à boucle fermée (NSBF), quant à lui, détecte automatiquement les crises 
en se basant sur les signaux icEEG captés par des électrodes intracrâniennes et permet une 
rétroaction par une stimulation électrique au même endroit afin d’interrompre ces crises. La puce 
de détection de crises et le stimulateur électrique à base sur FPGA ont été assemblés à des 
électrodes afin de compléter la prothèse proposée. Ce NSBF a été validé en utilisant des 
enregistrements d’icEEG de dix patients souffrant d’épilepsie réfractaire. Les résultats révèlent 
une performance excellente pour la détection précoce de crises et pour l’auto-déclenchement 
subséquent d’une stimulation électrique. La consommation énergétique totale du NSBF est de 16 
mW. Une autre alternative à la stimulation électrique est l’injection locale de médicaments, un 
traitement prometteur de l’épilepsie. Un système local de livraison de médicament basé sur un 
nouveau détecteur asynchrone des crises est présenté. Ce dernier système dépendant des calculs 
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de données réduit jusqu’à 49% la consommation énergétique en comparaison avec le 
neurostimulateur synchrone précédemment présenté. Le détecteur a été validé à partir 
d’enregistrements icEEG de sept patients ayant déjà subi des examens intracrâniens pour une 
chirurgie d’épilepsie. Le déclenchement du système de livraison de médicaments a été testé et 
une dose prédéfinie de médicament est libérée environ 16 secondes après le début des crises 
électrographiques.  
Dans le but d’améliorer les performances du dispositif implantable, de nouvelles électrodes 
sous-durales seront présentées. Elles offrent une meilleure qualité d’enregistrement des icEEG et 
permettent de délimiter la zone épileptogène durant l’évaluation pré-chirurgicale. De plus, le 
nouveau réseau d’électrodes a une nouvelle forme et permet de minimiser certaines 
complications (i.e. infection, œdème et hémorragie au niveau du cerveau) habituellement 
rencontrées avec l’utilisation des électrodes sous-durales actuelles. Ces nouvelles électrodes ont 
été testées in vitro dans une solution saline et in vivo pendant une période de trois semaines. Le 
rapport signal sur bruit a été amélioré de 6 dB en comparaison avec des électrodes commerciales 
actuellement disponibles. 
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ABSTRACT 
Emerging implantable microdevices hold great promise for the treatment of patients with 
neurological conditions. These biomedical systems have been exploited as unconventional 
treatment for the conventionally untreatable patients. Recent progress in brain-machine-interface 
activities has led the researchers to analyze the intracerebral EEG (icEEG) recording in real-time 
and deliver subsequent treatments.  
We present in this thesis a long-term safe and reliable low-power microsystem-based implantable 
device to perform efficient neural signal recording, seizure detection and subsequent treatment 
for epilepsy. The main contributions presented in this thesis are reported in five journal 
manuscripts, published or accepted for publication in IEEE Journals, and many others such as 
Low Power Electronics, and Emerging Technologies in Computing. The proposed microsystem 
includes a low-power integrated circuit (IC) intended for real-time epileptic seizure detection. 
This IC integrates a front-end preamplifier and epileptic seizure detector. The preamplifier is 
based on a new chopper stabilizer topology that reduces noise and power dissipation. The 
fabricated IC was tested using icEEG recordings from seven patients with drug-resistant epilepsy. 
The average seizure detection delay was 13.5 sec, well before the onset of clinical manifestations. 
The measured total power consumption of this chip is 51 µW. 
A closed-loop neurostimulator (CLNS) is next introduced, which is dedicated to automatically 
detect seizure based on icEEG recordings from intracranial electrode contacts and provide an 
electrical stimulation feedback to the same contacts in order to disrupt these seizures. The seizure 
detector chip and a dedicated FPGA-based electrical stimulator were assembled together with 
common recording electrodes to complete the proposed prosthesis. This CLNS was validated 
offline using recording from ten patients with refractory epilepsy, and showed excellent 
performance for early detection of seizures and subsequent self-triggering electrical stimulation. 
Total power consumption of the CLNS is 16 mW.  Alternatively, focal drug injection is the 
promising treatment for epilepsy. A responsive focal drug delivery system based on a new 
asynchronous seizure detector is also presented. The later system with data-dependent 
computation reduces up to 49% power consumption compared to the previous synchronous 
neurostimulator. The detector was validated using icEEG recordings of 7 patients who have 
previously undergone intracranial investigations for epilepsy surgery. The triggering of the drug 
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delivery system was tested and a predefined seizure suppression dose was delivered ~16 sec after 
electrographical seizure onsets. 
In order to improve performances of the whole implantable device, a novel subdural electrode is 
presented for better icEEG recording quality and delineation of the epileptogenic zone during the 
presurgical evaluation. Moreover, the new subdural grid electrode has a new shape and several 
attributes to address some of the problems (e.g. brain infection, swelling and hemorrhage) 
encountered with currently used subdural electrodes.  These electrodes are tested in vitro saline 
solution and in vivo experiments for 3 weeks, and signal-to-noise ratio is improved up to 6 dB 
compared to using commercial electrodes. 
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INTRODUCTION 
Epilepsy is a neurological disorder affecting 1.3% of Canadians and up to 1% of the world 
population. Each year, an average of 15,500 Canadians learns that they have epilepsy. Epilepsy is 
a common chronic neurological disorder characterized by a predisposition to unprovoked recurrent 
seizures. A seizure is the manifestation of an abnormal, hypersynchronous discharge of a 
population of cortical neurons. Several causes may disturb the normal pattern of brain activity and 
trigger an epileptic seizure, such as head injury, brain infection, developmental malformations, 
brain tumors, cerebrovascular disease, vascular malformations, genetic disorders, and 
hippocampal sclerosis. Antiepileptic drugs are the mainstay of treatment, but many patients have 
systemic and central nervous system side effects and a third of them are refractory. Because most 
drug-resistant epileptics suffer from focal epilepsy, these patients may benefit from epilepsy 
surgery. Many studies have shown that resection of the epileptogenic zone may lead to seizure 
freedom (ENGEL, 2009). Success of the surgery is dependent on the accurate localization and 
complete resection of the epileptogenic zone. Unfortunately, not all refractory patients with focal 
epilepsy benefit from resective surgery; some have an epileptogenic zone overlying eloquent areas 
(language, primary motor or visual areas) that cannot be resected without permanent sequelae, 
while others have multifocal epilepsy (SPENCER, 2009). Therefore, the poor neurological 
outcome of these cases combined with the lack of efficacy and adverse effects of antiepileptic 
drugs provide sufficient justification to have an alternative treatment to supplement conventional 
treatments. The details motivation behind the neurostimulator therapies and the improved 
presurgical procedure for the treatment of epilepsy are discussed below.   
Motivation 
Over the last quarter century, the vast progression in neurotechnology has allowed the Food 
and Drug Administration (FDA) to approve stimulators for the treatment of neurological 
disorders, such as multichannel cochlear implant for hearing loss, deep brain simulation for 
Parkinson diseases, and vagus nerve simulation (VNS) for epilepsy. Commercially available VNS 
provides scheduled stimulation (open-loop) to the left vagus nerve to reduce seizure frequency by 
a yet unclear mechanism. However, seizure freedom is rare, and only 30 – 40% of patients show a 
significant decrease in seizure frequency (SCHACHTER, 2009). More recently, there has been 
growing interest in the development of responsive therapeutic devices to abort seizures at their 
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onset. The responsive device (detection and treatment) identifies seizures at their onset and 
triggers focal treatment to the epileptogenic zone to abort the seizure, whether by electrical 
stimulation, cooling, or drug release. To do so, an efficient seizure detection algorithm is required 
for accurate seizure onset detection without false alarms, and which can be implemented in a 
custom integrated circuit.  
Several mathematical models have been developed to detect electrographic seizures onset. 
Intracerebral EEG-based models have shown much better performance than scalp EEG-based 
models, as lesser artifacts are encountered with the former. Several others studies have shown 
better seizure detection performances than random predictor. These models were developed using 
desktop computers for off-time data processing. These types of algorithms cannot be employed in 
a low-power implantable microchip. However, a power-efficient epileptic seizure detection 
algorithm can be integrated in novel therapeutic devices for epilepsy that the system could run on 
a button cell battery for more than 8 years. Currently, only a few clinically applicable seizure 
detectors exist (e.g. Responsive Neurostimulation System, NeuroPace Inc., and Seizure Advisory 
System, NeuroVista Corporation). Apart from the seizure detection performance, the other 
concerns are safety, low-power techniques, miniaturized devices and determination of optimal 
stimulation parameters. The several proof-of-concept experiments were introduced for the 
treatment of epilepsy, among them the surgical treatment, focal electrical stimulation, and direct 
drug delivery. 
Surgical treatment of epilepsy  
Patients with refractory epilepsy may benefit from epilepsy surgery if the epileptogenic zone 
(EZ) can be identified and resected without harm. Due to the limited spatial or temporal resolution 
of currently available non-invasive localization techniques, accurate delineation of the EZ may 
sometimes be arduous, particularly with nonlesional refractory epilepsy (SPENCER, 2009). As 
such, invasive EEG recordings may be necessary prior to resective surgery. An intracerebral EEG 
(icEEG) study consists of implanting intracerebral subdural strip, grid or depth electrodes to 
sample suspected areas of epileptogenicity. Intracranial electrodes will overcome the sensitivity 
limitations of extracranial (scalp) electrodes because they are closer to generators of epileptiform 
activity. Whereas a large cortical surface is required to generate a recordable signal by extracranial 
electrodes, intracranial electrodes can pick up potential changes occurring over only a few 
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millimeters of cortex. When seizures occur, the icEEG signal is analyzed to identify the EZ for 
subsequent resection.  But there are some risks associated with icEEG recordings using available 
commercial intracranial electrodes, such as brain infection, cerebral edema and failure to 
adequately localize the EZ from inadequate brain sampling 
Focal electrical stimulation 
In a pilot trial, Osorio et al. (2005) demonstrated the feasibility and short-term safety of 
automated high-frequency electrical stimulation in blocking seizures using an external prototype 
composed of an electrocorticographic acquisition system, a desktop computer, and a stimulator 
(Grass S12). Another external responsive neurostimulator (eRNS) has been shown to terminate 
electrographic seizures as well (KOSSOFF, 2004). Apart from seizure detection performance, the 
other concerns are the safety of chronic electrical stimulation and the determination of optimal 
stimulation parameters. It is generally agreed that limiting the maximum charge density to 30 
µC/cm2 per phase can avoid tissue damage (AGNEW, 1990); however, no cell damage in human 
cortex has been found for 50 to 60 µC/cm2 per phase stimulation (GORDON, 1990; RISINGER, 
1995).  
Direct drug delivery 
The currently available orally administrated antiepileptic drugs are associated with variable 
systemic side effects (adverse effects in liver, bone marrow, and central nervous system). Focal 
drug delivery directly onto the epileptogenic zone could enhance the efficacy of drugs while 
limiting side effects to a minimum. Experiments in the past showed that focal diazepam infusion 
using a programmable pump in response to automated seizure detection could suppress the 
seizure (STEIN, 2000; DAVID, 2004). Other drugs such as DP-valproic acid (FISHER, 2002), 
gabapentin (OOMMENA, 2007), and adenosine (ANSCHEL, 2004) have been used but with less 
success. Much work lies ahead prior to clinical application in optimal drug selection, the delivery 
system, automated seizure detection, the refilling procedure, etc. To date, technological barriers 
limit the exploration of direct drug delivery for the long-term treatment of focal epilepsy. 
Thesis Works 
The new technologies give us the opportunity to solve drawbacks of the available treatments 
and extend the traditional neurostimulation therapies and resective surgical treatment procedures 
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for better treatments of epilepsy. In this thesis, our objectives are to propose new technologies for 
implantable device therapies and presurgical evaluation for epilepsy. We introduce long-term, 
safe and reliable low-power microsystems-based implantable devices to perform efficient neural 
signal recording, seizure detection and subsequent treatment. We have accomplished three 
specific objectives in the implantable device therapies: (i) Designed and implemented a low-
power neural preamplifier and real-time seizure onset detection algorithm in a microchip using 
advanced integration technology; (ii) Designed a low-power closed-loop electrical stimulators 
and constructed a responsive neuromodulator by assembling the detector chip and stimulator 
together; and (iii) Modeled and implementated of an implantable responsive focal drug delivery 
system as an alternative promising treatment. For the epilepsy presurgical evaluation, we have 
introduced novel intracranial electrodes and a wireless icEEG recording system in order to 
improve EZ localization and reduce morbidity.  
Contributions  
The main contributions of this thesis have been reported in several peer-reviewed scientific 
journals and international conferences. These contributions are: 
1. Design, simulation, implementation, and validation of novel power-efficient epileptic seizure 
detection algorithms for refractory epilepsy patients (SALAM, 2009(a), (b); SALAM, 2010 
(a), (b); SAFI-HARB, 2011(b)). 
2. Design, fabrication and testing of new preamplifiers and novel low-power implantable 
epileptic seizure-onset detectors. The systems were implemented using 0.18µm CMOS 
technology and discrete components in miniaturized printed circuit boards (PCBs). The 
implemented devices were validated using icEEG recordings of several refractory epilepsy 
patients (SALAM, 2011(a), (c); SAFI-HARB, 2011(b)). 
3. Modeling, implementation and validation of new implantable closed-loop epilepsy prosthesis. 
The system was assembled with an embedded microchip (0.18µm CMOS technology) and 
field-programmable gate array (FPGA) in miniature PCBs, and tested using icEEG recordings 
of ten refractory epilepsy patients (SALAM, 2010(c), SALAM, 2012(a); SALAM, 2012(c)). 
4. Design, implementation and testing of an implantable asynchronous responsive drug delivery 
system for Treatment of Epilepsy. The system was assembled with commercial discrete 
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components in miniature PCBs and validated using icEEG recording of refractory epilepsy 
patients (SALAM, 2011(a); SALAM, 2012(b)).  
5. Design and fabrication of new subdural porous and notched mini grid electrodes for wireless 
icEEG recordings. The electrodes were validated in vivo icEEG recording experiments and 
demonstrated comparative studies with the commercial electrodes (SALAM, 2011(b); 
SALAM, 2012(c)).  
Thesis organization 
This thesis is divided into 8 chapters. The first chapter of this thesis describes a comprehensive 
literature review on the alternative treatment for epilepsy. Chapters 2 through 6 address the 
design, implementation and validation of the new implantable device. The last chapters 
summarize the entire thesis, and draw attention to the contribution of this research and the 
recommended future works. The following is the brief chapter-wise summary of this thesis. 
Chapter 1 reviews the fundamental concepts of implantable device therapies and presurgical 
evaluation for the treatment of epilepsy. This chapter begins with basic theories, design issues 
and design criteria of the implantable device. We discuss about subdural electrodes, preamplifiers 
front-end, seizure detectors and stimulators in the prospect of state-of-the-art, and highlight 
factors limiting performance in implantable device therapies for epilepsy. 
Chapter 2 investigates electrographic seizure onset detection criteria and noises affect for 
limiting performance in the responsive neuromodulation therapies. A modified chopper stabilized 
preamplification method and a new power efficient seizure onset detection algorithm are 
proposed for the responsive neuromodulation therapy. The ultra low-power detector is 
implemented and validated using icEEG recordings from seven refractory epileptic patients.              
Chapter 3 describes electrical stimulation therapy, a new low-power circuit design, 
implementation and testing of a new closed-loop electrical stimulator. The proposed FPGA 
embedded neurostimulator is triggered by the seizure onset detector chip for disrupting an 
upcoming seizure. Experimental results demonstrated safety and reliability for the automated 
triggering of the bipolar electrical stimulator. 
Chapter 4 demonstrates modeling, implementation and validation of a new closed-loop 
electrical stimulator (second prototype). The new electrical stimulator has lower power 
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consumption, wider range of parameter variation, better precision, and larger memory. 
Experimental results show spatial voltage distribution in brain due to the current stimulation and 
suggest optimum electrical stimulation parameters for the suspected epileptic focus.    
Based on the design and implementation trend in the previous chapters, which aims at closed-
loop electrical stimulator; chapter 5 presents an asynchronous closed-loop drug delivery system. 
A new power saving strategy is employed to design this direct drug delivery device. This chapter 
also describes a new preamplifier, an asynchronous seizure onset detector, a drug delivery 
system, and a hybrid subdural electrode. The experimental results demonstrate efficiency of the 
device and wide range of drug dosing capacity at seizure onset. 
Chapter 6 describes novel subdural electrodes to improve icEEG recording quality as well as 
localization of the epileptogenic zone with less morbidity. The new subdural mini grid electrode 
has new a shape and several attributes to overcome some of the currently encountered problems 
with intracranial recordings. This chapter also demonstrates the design of the novel electrodes, 
method of fabrication, architecture of a wireless EEG recording system, and in vitro and in vivo 
experimental results. 
Finally, a discussion chapter is presented in Chapter 7 followed by a conclusion and 
recommendation for future works in chapter 8. 
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CHAPTER 1  MICROELECTRONIC SYSTEM FOR 
TREATMENT OF EPILEPSY 
In the last decade, implantable microelectronic systems have been exploited as unconventional 
treatment for the conventionally untreatable patients. Several microelectronic devices have been 
commercialized for treatment of heart disease, Parkinson’s disease, Epilepsy, and deaf. Recent 
progress in brain-machine-interface (BMI) has led to the idea of using the medical devices to 
analyze the intracerebral EEG (icEEG) recorded data in real-time in order to provide subsequent 
treatments. The combination of the online icEEG analysis and responsive treatment approaches 
ensure consistent link in between neuronal pathways for normal brain activities and break the 
pathway for the abnormalities. Thus, microelectronic therapeutic devices offer new attractive 
treatment option for the neurological disorders. However, many challenges are involved in 
designing the implantable microelectronic devices. The design issues and factors limiting 
performances of microelectronic therapeutic devices are discussed in the chapter. This review 
work published in “Journal of Healthcare Engineering” is reproduced in following pages. 
1.1 LOW-POWER IMPLANTABLE DEVICE FOR ONSET 
DETECTION AND SUBSEQUENT TREATMENT OF EPILEPTIC 
SEIZURES: A REVIEW 
Muhammad Tariqus Salam1, Mohamad Sawan1, and Dang Khoa Nguyen2 
1Polystim Neurotechnologies Laboratory, École Polytechnique de Montréal, Québec 
2Neurology service, Notre-Dame Hospital (Centre Hospitalier de l'Université de Montréal) 
Abstract - Over the past few years, there has been growing interest in neuro-responsive 
intracerebral local treatments of seizures, such as focal drug delivery, focal cooling, or electrical 
stimulation. This mode of treatment requires an effective intracerebral electroencephalographic 
acquisition system, seizure detector, brain stimulator, and wireless system that consume ultra-low 
power. This review focuses on alternative brain stimulation treatments for medically intractable 
epilepsy patients. We mainly discuss clinical studies of long-term responsive stimulation and 
suggest safer optimized therapeutic options for epilepsy. Finally, we conclude our study with the 
proposed low-power, implantable fully integrated device that automatically detects low-voltage 
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fast activity ictal onsets and triggers focal treatment to disrupt seizure progression. The detection 
performance was verified using intracerebral electroencephalographic recordings from two 
patients with epilepsy. Further experimental validation of this prototype is underway. 
 
1.2 MICROELECTRONIC SYSTEM DESIGN CRITERIA FOR 
CHRONIC BRAIN IMPLANTS 
Microelectronic systems are generally implanted on the skull under the skin and interface 
directly with the recording/stimulation sites for the treatment of epilepsy. Thus, the system size 
needs to be small, lightweight and invisible after surgical implantation.  The microelectronic 
implants are safety-critical in nature; high reliability is an essential system attribute. Moreover, 
the implants must operate under stringent low-power constraints for minimal heat dissipation in 
surrounding tissues and to avoid frequent surgical battery replacement. Energy harvesting is 
essential to recharge the implanted battery from an external power source. The rechargeable 
implantable battery needs short-circuit protection mechanism and constant current discharge state 
for longer time. The implant must ideally function for 8 – 10 years without having to replace the 
battery. The electronic components of an implant must be sealed with biocompatible casing 
which is implanted in a viable places for energy harvesting, data communication, and battery 
replacement without a major surgery. Apart from the long lasting implantation facts, the other 
concerns are proper device functionalities, accurate icEEG monitoring, personalized treatment 
parameters, and external tuning. The key challenges of a BMI are the icEEG monitoring for true 
electrographic seizure activity in real-time and the trigger of focal treatment at seizure onset. 
Thus, noise reduction or isolation from the icEEG recordings is essential for device performance. 
Moreover, the abnormal icEEG detection criteria and focal treatment parameters may vary from 
patient to patient, and these criteria and parameters for a patient may change over the time. 
Therefore, a remote tunability is required in the device for adjusting detection criteria and 
increase/decrease intensity of the treatment.   
1.3 ICEEG RECORDING METHOD  
The icEEG records the activity of thousands of neurons in the region across the ∼5 mm 
diameter of an intracranial electrode contact. A frequency analyzer can decompose the icEEG 
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Figure 1-1: Seizure signal analysis: (a) is icEEG recording Vin from the epileptogenic zone 
during a seizure and (b) is |SF| of Vin. 
recording and extract brain state information (e.g. normal and abnormal). Recent studies using 
higher sampling rates (1000 – 2000Hz) have showed high-frequency oscillations in preictal 
activities (JACOBS, 2010). Until we obtain a better understanding of the significance of these 
high-frequency oscillations with regards to epileptogenesis, most clinical epileptologists still rely 
on the analysis of a limited frequency range in the low-frequency bandwidth (10 – 40Hz) of 
icEEG recording (OSORIO, 2009(b)). In order to acquire the brain state information of a patient, a 
data acquisition system with low gain-bandwidth product and low noise are required. Commercial 
instrumentation has poor noise performance for the low-spectral neural signal amplification. 
Therefore, microelectronic circuit design problems increase due to the various noises located in 
the low frequency band that degrade the input icEEG recordings. As a result, the icEEG recording 
may translate erroneous brain state information.  
Partial seizure generally begins in the EZ, spreading to adjacent regions. However, 
electrographic seizure onsets may vary in terms of onset morphology, discharge frequency, 
focality, and spread pattern. The most common seizure onset pattern in a partial epilepsy patient 
is characterized by a low-voltage high-frequency discharge. Figure 1-1(a) shows icEEG 
recording from the EZ (Vin) using a 200 Hz sampling frequency with the sudden appearance of 
this typical low-voltage fast activity at seizure onset. Figure 1-1(b) illustrates the spectrogram 
analysis of Vin. Magnitude of short-time Fourier transformation |SF| reveals low frequency 
activity (< 3 Hz) before seizure onset and high frequency activity (> 10 Hz) at seizure onset and 
during the seizure. The frequency at seizure onset may vary from patient to patient but generally 
stands between 10 – 40 Hz in epileptic human icEEG recordings (OSORIO, 2009(b); SALAM, 
2011(a)). 
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Figure 1-2: Various noise sources affect icEEG recording Vin. 
 
1.4 NOISE FIGURES 
 Unlike scalp EEG recordings, icEEG recordings are relatively devoid of motion and muscle 
artifacts. However, several other noises may degrade the icEEG recording and subsequent 
automated evaluation in microelectronic implant may lead to erroneous brain state translation. 
Figure 1-2 illustrates the noises influence in the input icEEG recording Vin. In this situation, the 
subdural electrodes placed directly on the brain tissue and the electrode-tissues interface create a 
capacitive double layer that generates dc offset (VOS) in the millivolts range. But, the front-end 
amplifier has a low dynamic input range due to the microvolt input neuronal signal and VOS 
saturates the amplifier. Therefore, VOS needs to be suppressed adequately so that Vin can dominate 
over VOS in front-end amplification. Moreover, flicker noise VnF contributes a major amount of 
noise in the low frequency band due to fundamental physics properties of instrumentation. 
Thermal noise VnT dominates in higher frequency (above the flicker corner frequency) due to 
internal resistance of instrumentation and wire resistance. Finally, 60 Hz noise Vn60 is a large 
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source of noise generated from the AC power supply; this noise may completely degrade the Vin.  
1.5 INTRACRANIAL ELECTRODE CONTACT 
Noises generated from electrodes, electrode-tissues interface, and from instruments may 
modulate the neural signal and degrade the signal-to-noise ratio (SNR). The custom integrated 
amplifiers could reduce instrument noise effect for the low-spectral neural signal amplification, 
but optimum SNR values can be obtained by modifying intracranial electrode contacts (SALAM, 
2011(b)). Microelectrode (MRE) arrays are widely used in neurological research to improve 
spatial resolution in icEEG recording (CHEN, 2011). But MRE arrays have high resistivity in 
electrode-tissues interface which may impede icEEG neural recording (CHEN, 2011). 
Macroelectrodes (e.g. subdural (SDE) and depth electrodes (DPE)) have been used for the last 
sixty years in epilepsy presurgical evaluation. Dimensions of a SDE and a DPE are well suited to 
delineate the EZ. Due to their larger electrode-tissues interface, these electrodes have different 
electrical characteristics (compared to microelectrodes) including lower electrode impedance. 
Platinum (Pt) and stainless steel materials are commercially used in SDE and DPE, with Pt 
having better biocompatibility properties. Gold (Au) has been used in subdural electrodes (REN, 
2010) but no significant improvement on icEEG recording has been reported. The details 
drawbacks of the available intracranial electrode contacts are described in chapter 6.  
1.6 NEURAL SIGNAL AMPLIFIER 
Over the past few decades, many neural signal amplifiers have been developed to overcome 
several challenges (e.g. low-power, low-noise, and minimal chip area). Many integrated amplifiers 
have been proposed, but very few designs meet the requirements for epilepsy device therapies or 
presurgical evaluation. The intracranial electrodes potential mismatch creates input dc offset 
(SALAM, 2011(a)). There are two schemes for the dc offset suppression. The first scheme is 
capacitive feedback of an operational transconductance amplifier (OTA) (HARRISON, 2003). 
MOS-bipolar pseudo-resistor elements in parallel with the capacitive feedback were used to 
provide a very low high-pass cutoff frequency as well as a fast settling time (ZARIFI, 2008). The 
capacitive feedback scheme removes the dc offset, but it may increase input referred noise 
(GOSSELIN, 2007(c)). 
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The second scheme is based on closed loop control of dc level (GOSSELIN, 2007(c); 
GOSSELIN, 2010(a)). This scheme is made of active components that are placed in the feedback 
path of an instrumentation amplifier. It can reduce low-spectrum noise and provide high input 
impedance. Further high-pass and low-pass filters are needed to suppress significant amount of 
noise. CMOS technology is widely used for bioamplifier due to the low-power dissipation, but this 
technology has relatively poor noise performance and the amplifier requires low input-referred 
noise (GOSSELIN, 2007(c); GOSSELIN, 2010(a), (b); GOSSELIN, 2009). Chopper 
preamplifiers have been constructed using CMOS technology and reported performance have been 
satisfactory (GOSSELIN, 2007(c); MASAYA, 2010; JAWED, 2009). The chopper preamplifier 
is based on modulation, amplification, demodulation, and filtering. The restrictions on the power 
consumption and size of an implantable device limit increasing the biasing current of the 
amplifier. Therefore, design trade-offs between the biasing current and noise are required to 
optimize the performance of a device. For the seizure detection application, the neural signal 
amplifier needs low frequency bandwidth (10 – 40 Hz). However, many amplifiers are made for 
neural spike detection and the amplifiers bandwidth starts from 100 Hz (GOSSELIN, 2007(c)); 
GOSSELIN, 2009). But the main challenge in seizure detection application is to record neural 
signal from the lower frequency band where noises are prominent. 
1.7 LOW-POWER SEIZURE DETECTOR 
In recent years, there has been growing interest in developing seizure detection algorithm. 
Several mathematical models have been proposed for this task, such as support vectors (MEIER, 
2008), artificial neural networks (GHOSH-DASTIDAR, 2008), wavelet transformation (ZANDI, 
2009), wavelet decomposition (SAAB, 2005), nonlinear time series analysis (LEHNERTZ, 1995), 
and mean nonlinear decision function (TITO, 2009). IcEEG-based models (MEIER, 2008; 
GHOSH-DASTIDAR, 2008; LEHNERTZ, 1995; TITO, 2009) perform much better than scalp 
EEG-based models (ZANDI, 2009; SAAB, 2005) owing to motion/muscle artifacts on scalp EEG 
recordings. Table 1.1 briefly summarizes different detection algorithms. These mathematical 
models have been implemented in high-speed computer for short-term EEG/icEEG monitoring 
applications. These models cannot be employed in an implantable device due to heavy 
mathematical computation involved and high-power dissipation. So far, few seizure detection 
algorithms have been proposed for low-power implantable microelectronic devices.  
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The detection algorithm presented in (RAGHUNATHAN, 2009) is based on classifying icEEG 
data into events, which are defined by two threshold voltages in icEEG recording. An ictal event 
is translated by high-frequency discharges. Recent studies have showed that high-frequency 
discharges can be very brief (few seconds), remain very focal (without spread), do not evolve in 
time or frequency, and are clinically silent (electrical seizures) (SALAM, 2010(a); SALAM 
2009(b)). This device may result in false positive detection due to the high-frequency discharge 
Table 1.1: Summary of seizure detection algorithms 
Reference Method Description Applicat
ion 
MCSHARRY, 2002 Multi-modal 
probability 
evaluation 
Time evolution of the probability 
density function. 
SESD 
SHOEB, 2004 Wavelet and 
neural network 
Wavelet decomposition constructs 
feature vector and the support-vector 
machine classification algorithm that 
determine seizure onset. 
SESD 
SUFFCZYNSKI, 
2006 
Bistable 
mathematical 
model 
Predict time of seizure occurrences 
using a Poisson process and a random 
walk process. 
IEBSD 
MOXON, 2001 Correlation Similarity between a reference and 
dynamically recorded signal. 
IEBSD 
IASEMIDIS, 2003(a) Nonlinear, 
Lyapunov 
exponent 
Convergence and divergence of short-
term maximum Lyapunov exponents 
(STLmax) among critical electrode 
sites. 
IEBSD 
IASEMIDIS, 2003(b) Phase changes Measure average angular frequency and 
optimize the techniques. 
IEBSD 
MORMANN, 2000 Coherence  Statistical measurement of phase 
synchronization of signals. 
IEBSD 
TETZLAFF, 2006 Features 
extraction  
Automated technique for the detection 
of a preseizure state. 
IEBSD 
ARNHOLD, 1999 Signals 
synchronization 
Detect weak interdependences of signal. IEBSD 
NAGARAJ, 2006 Synchronization Cross-correlationship used to find 
dissimilarity of signals between 
interictal periods and epileptic seizures. 
IEBSD 
SUKHI, 2005 Bayes’ theorem Spectral feature extraction, Bayes’ 
theorem and spatiotemporal analysis. 
IEBSD 
SESD: Scalp EEG recording and software in desktop computer. 
IEBSD: Intracranial electrodes, band pass filter and software in desktop computer. 
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detection. The support vector seizure detection algorithm (VERMA, 2010) has good flexibility but 
based on only spectral content of icEEG recording. Moreover it requires a large number of support 
vectors to define the complex decision boundary between a patient’s seizure and non-seizure 
activity. This explains its high-power consumption and cost. Similarly, another detector (PATEL, 
2009) based on linear discriminant analysis classifiers requires higher complexity of the digital 
signal processor to improve sensitivity and specificity. In order to avoid redundancy, further 
discussions on the low-power seizure detectors are described in chapters 2, 3, 4, and 5. 
1.8 IMPLANTABLE DEVICES FOR THE TREATMENT OF 
EPILEPSY 
Few implantable devices for the treatment of epilepsy have been commercialized. The only 
FDA-approved implantable device for the treatment of epilepsy is the vagal nerve stimulator 
(VNS). The VNS is an open-loop (non-responsive) system comprising an implantable stimuli 
generator, two leads incorporating two bipolar electrodes, and an external pulse programming 
system for the stimuli generator (Table 1.2). The stimuli generator of the VNS is inserted through 
an incision in the left axilla and implanted under the skin in the left chest below the clavicle 
under general anesthesia. The lead is tunneled to the neck, and the two helical bipolar stimulating 
electrodes are placed around the left vagus nerve. After the operation, the VNS can be turned on 
by a computer and programming wand. The most common settings for the stimulator are a 
frequency of 20 – 30 Hz, a pulse width of 250 – 500 µsec, time on of 30 sec, and time off of 3 – 5 
min. The advantages of VNS include (a) no need to exactly delineate the epileptogenic zone, (b) 
no craniotomy, (c) a lower rate of surgical complications, and (d) mild and infrequent side effects 
due to stimulation (hoarseness, cough). The main disadvantage is that, while 30 – 40% of cases 
show a reduction in seizure frequency of more than 50%, only about 3% of them attain seizure 
freedom (RYCHLICKI, 2006; SETHI, 2008).  
Deep Brain Stimulation (DBS) featuring, for example, 1-10 V, 90 µsec pulse width, 100 – 165 
Hz frequency for the treatment of Parkinson’s disease has been shown to be safe and effective as 
evidenced by FDA approval (BLAD, 2007). A 1 min on and 5 min off stimulation paradigm was 
used during an investigational DBS trial for epilepsy. DBS has also been investigated for the 
treatment of drug-refractory epilepsy by providing scheduled stimulation (open-loop) via depth 
electrodes to various sites such as the hippocampus, thalamus, cerebellum, caudate nucleus, 
15 
 
Table 1.2: Comparison of two commercially available neurostimulators for the treatment of 
epilepsy. 
 
centromedian thalamus, anterior thalamic nucleus, and neocortical seizure foci (LEGA, 2009; 
ZHONG, 2011; CHABARDES, 2002; HANDFORTH, 2006; HODAIE, 2002). Recently, a large 
and multicenter trial (SANTE: Stimulation of the Anterior Nucleus of the Thalamus for Epilepsy) 
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was conducted and subsequently with encouraging results, making anterior thalamic nucleus the 
most well-established target for DBS in the treatment of epilepsy to date (ZHONG, 2011). The 
mechanism through which DBS affects seizure frequency is yet unknown, the results so far have 
been modest in the same line as the VNS (FISHER, 2011). 
Most of the reported experiments have shown abortion of seizure activity by electrical 
stimulation, but there is indication that low-frequency stimulation (lower than 10 Hz delivered to 
either posterior hypothalamus or thalamus) may induce a seizure (OSORIO, 2001). It may very 
well be that proper stimulation parameters need to be individualized during the presurgical 
intracerebral EEG study for maximum efficacy prior to the implantation of a closed-loop 
responsive stimulation device. Many stimulation parameters have shown promising performance. 
For example, Osorio et al. (2005) used a biphasic, charge-balanced square pulse (100 µsec/phase 
width, 100 – 500 Hz frequency) for 1 sec. If the stimulation failed to terminate the seizure, the 
next seizure detection begins within 1 minute.  A maximum of five stimulations are allowed to 
terminate a seizure. More recently, the cranially implanted Responsive Neurostimulator (RNS, 
closed-loop) system has been proposed for the treatment of refractory epilepsy (MORRELL, 
2011). It consists of a programmable, battery-powered microprocessor-controlled device (the 
RNS neurostimulator) implanted in the cranium, which delivers a short train of electrical pulses 
to the epileptogenic zone through intracranial electrodes (depth and cortical strip leads) when a 
seizure onset is detected. An external programmer, laptop computer, wand, and telemetry 
interface enable communication with the implanted RNS neurostimulator, allowing the physician 
to modify the parameters of detection and stimulation of RNS through wireless communication. 
This investigational responsive device is still under clinical trial (MORRELL, 2011; 
SCHACHTER, 2009; THEODORE, 2004; MORRELL, 2002).  Table 1.2 compares the RNS 
features with those of the VNS.  
1.9 CONCLUSION 
Drug-resistant epileptic patients may be candidates for non-pharmacological therapies, such as 
epilepsy surgery and implantable medical device therapies. Unfortunately, currently available 
commercial intracranial electrodes used to delineate the EZ for surgery or implantable devices for 
non-operable patients have some limitations. A number of strategies hold promise for improving 
their effectiveness. Closed-loop implantable responsive systems for the focal treatment of 
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refractory partial epilepsy are promising therapeutic avenues that show potential for effective 
treatment with minimal side effects. Novel approaches in direct electrical stimulation, drug 
delivery, and new subdural electrode design could offer a chance for long-term seizure remission 
or even cure. 
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CHAPTER 2  CMOS BASED EPILEPTIC SEIZURE DETECTOR 
This chapter concerns implementation of a low-power epileptic seizure detector for the 
treatment of epilepsy. The design and experimental results of the fabricated seizure detector chip 
are demonstrated using icEEG recordings from seven refractory epilepsy patients. This seizure 
detector has low-power consumption, accurate seizure detection, tuneable neural signal amplifier, 
sophisticated noise reduction techniques, excellent seizure detection sensitivity, higher 
specificity, and short seizure detection delay. This work published in “IEEE Transactions on 
Biomedical Circuits and Systems” is reproduced in following pages. 
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Abstract – A novel implantable low-power integrated circuit is proposed for real-time 
epileptic seizure detection. The presented chip is part of an epilepsy prosthesis device that 
triggers focal treatment to disrupt seizure progression. The proposed chip integrates a front-end 
preamplifier, voltage level detectors, digital demodulators and a high-frequency detector. The 
preamplifier uses a new chopper stabilizer topology that reduces instrumentation low frequency 
and ripple noises by modulating the signal in the analog domain and demodulating it in the digital 
domain. Moreover, each voltage level detector consists of an ultra low-power comparator with 
adjustable threshold voltage. The digitally integrated high-frequency detector is tunable to 
recognize the high-frequency activities for the unique detection of seizure patterns specific to 
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each patient. The digitally-controlled circuits perform accurate seizure detection.  A mathematical 
model of the proposed seizure detection algorithm was validated in Matlab and circuits were 
implemented in a 2 mm2 chip using CMOS 0.18-µm process. The proposed detector was tested 
using intracerebral electroencephalography (icEEG) recordings from seven patients with drug-
resistant epilepsy. The seizure signals were assessed by the proposed detector and the average 
seizure detection delay was 13.5 sec, well before the onset of clinical manifestations. The 
measured total power consumption of the detector is 51 µW.  
2.2 INTRODUCTION  
Epilepsy is a common medical condition characterized by a predisposition to unprovoked 
recurrent seizures. A seizure is the manifestation of an abnormal, hypersynchronous discharge of 
a population of cortical neurons (SPENCER, 2009). Approximately 30% of patients, the majority 
of which suffer from partial (focal) seizures with or without secondary generalization, are 
refractory to anticonvulsants. Not all refractory patients are good epilepsy surgery candidates due 
to an extensive area of epileptogenic zone (EZ), multifocal, inability to localize the EZ, and an EZ 
overlying eloquent areas (language, primary motor or visual areas) that cannot be resected without 
permanent sequelae (SPENCER, 2009). As a result, the uncontrolled seizures bring a devastating 
impact on their quality of life.  
Proof-of-concept experiments conducted in animals and humans with epilepsy have 
demonstrated that focal electrical, thermal, or pharmacological manipulations of the EZ can 
suppress seizure activity (SCHACHTER, 2009; SALAM, 2010(a); FISHER, 2010; OSORIO, 
2005).Over the last few years, there has been growing interest in the development of implantable 
devices as an adjunctive treatment for patients with refractory partial epilepsy. So far, the vagus 
nerve stimulator (VNS) is the only Food and Drug Administration (FDA) approved medical 
device for the treatment of epilepsy. This scheduled (open-loop) stimulation device provides a 
reduction in seizure frequency; however, the overall effectiveness is modest (SCHACHTER, 
2009; SALAM, 2010(a)). A cranially implanted responsive neurostimulator that triggers  
stimulation only upon detection of a seizure holds the promise of better seizure control, lower 
systemic, peripheral and central nervous system side effects, as well as lower battery consumption 
(SCHACHTER, 2009; SALAM, 2010(a); OSORIO, 2005; OSORIO; 2009(a); OSORIO, 
2009(b)). Preliminary results on a new responsive device for the treatment of epilepsy (RNS 
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system, Neuropace Inc.) have been promising (SCHACHTER, 2009). Several issues remain to be 
addressed, such as the necessity of a reliable seizure detection system that is sensitive enough to 
detect seizures early on but also specific enough to prevent unwarranted triggering of focal 
intervention. 
The initial steps required for the development of any responsive focal therapy device for 
epilepsy are the recording of intracerebral electroencephalography (icEEG) followed by the 
automated detection of seizures. IcEEG recordings are generally performed using subdural strip 
and/or depth electrode contacts. The recorded icEEG represents synchronous firing of many 
neurons throughout a region across the diameter of an electrode contact. It is generally 
characterized by a low-amplitude signal (microvolts) and low-frequency bandwidth. Due to the 
microvolt-level range, the neural signal must be amplified very carefully before further analysis 
(e.g. detection, digitization). CMOS technology has relatively poor noise performance and the 
low-amplitude amplification requires a CMOS amplifier with low input-referred noise (SALAM; 
2009(a); SALAM; 2009(a); SALAM; 2010(b); GOSSELIN; 2010(a); GOSSELIN; 2010(b); 
GOSSELIN; 20o9; GOSSELIN; 2007; GOSSELIN; 2004). However, the restrictions on the power 
consumption and size of an implantable device limit increasing the biasing current. Therefore, 
design trade-offs between the biasing current and noise are required to optimize the performance 
of a device. 
The challenges of seizure detection are variability in epileptic seizure onset pattern, signal 
amplitude and spectral content. Over the past few decades, many seizure detection and prediction 
algorithms have been proposed (BERDAKH; 2009; ZANDI, 2009; NAGARAJ, 2006; SUKHI, 
2005; YADAV, 2009). However, these algorithms are carried out offline using high-performance 
computers. These types of algorithms cannot be employed in a low-power implantable microchip. 
More recently, a few implantable integrated seizure detectors have been proposed (SALAM; 
2009(a); SALAM; 2009(a); SALAM; 2010(b); RAGHUNATHAN, 2009; VERMA, 2010; 
PATEL, 2009; BHAVARAJU, 2006; AZIZ, 2006; AZIZ 2007). Earlier design of our seizure 
detectors (SALAM; 2009(a); SALAM; 2009(a); SALAM; 2010(b)) are based on several detection 
criteria in different amplitude levels, details will be explained in section II and IV. The detection 
algorithm presented in (RAGHUNATHAN, 2009) is based on classifying icEEG data into events, 
and the events are related to a threshold voltage in the icEEG during high frequency discharges at 
seizure state. Because the detector (RAGHUNATHAN, 2009) relies only on two threshold 
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voltages (positive and negative), there is a high risk for false positive detections. The support 
vector seizure detection machine (VERMA, 2010) needs a high number of support vectors in order 
to define the complex decision boundary between a patient’s seizure and non-seizure activity, 
explaining its high power consumption and cost. Similarly, the detector based on linear 
discriminant analysis classifier requires higher complexity in digital signal processor (DSP) and 
application-specific integrated circuit (ASIC) implementation to improve sensitivity and 
specificity (PATEL, 2009). 
In this paper, we present a low-power implantable CMOS integrated seizure onset detector 
(SOD) for patients with medically intractable epilepsy. The detector is part of an epilepsy 
prosthesis that triggers focal treatment to disrupt seizure progression. This SOD includes 
implanted electrodes, a data acquisition system, as well as analog and digital signal processors in 
order to acquire and process real-time icEEG. The proposed SOD chip uses the specific seizure 
onset features of a patient in order to detect their progressive increase of low-voltage fast-activity 
ictal pattern. The system is designed to have tunable parameters, which would allow for trade-off 
between sensitivity (SXT), false detection (FD) and detection delay (DTD). The tunability of the 
SOD provides higher accuracy on seizure detection. The adjustable gain of an amplifier can 
emphasize the amplitude level of interest, and variable threshold voltages of the voltage level 
detectors (VLD) delimit the detected signal locations and extract the information of frequency as 
well as progressive increase in amplitude. The SOD chip was tested offline on seven patients with 
refractory epilepsy. The measured results have shown that the SOD maximizes the SXT and 
minimizes the FD, which would trade-off for longer the DTD, but prior to first clinical 
manifestations of the patients. The detection is expected to be reliable in an implantable device 
without risking false detections of physiological rhythms (e.g. sleep spindles). 
 The epileptic seizure detection algorithm is described in Section II and the global system in 
Section III. The proposed circuits and their implementations are the subject of Section IV. 
Experimental results are presented in Section V, and Conclusions are summarized in the last 
Section of this paper.  
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Figure 2-1: IcEEG recordings of two patients with refractory focal epilepsy and signal analyses: 
(a) Start of seizure activity characterized by low-amplitude fast activity, (b) Frequency analysis 
(FSZ) of (a), (c) Mean absolute amplitude (VMA) analysis of (a), (d) Seizure activity of second 
patient with an initial brief electrical seizures (BES) followed by an electroclinical seizure, (e) FSZ 
of (d), and (f) VMA of (d). 
2.3 EPILEPTIC SEIZURE DETECTION ALGORITHM 
Partial seizures originate primarily within discretely localized or more widely distributed 
networks limited to one cerebral hemisphere. They may subsequently generalize as the epileptic 
discharge spreads contralaterally. Seizure onsets may vary from patient to patient in terms of onset 
morphology, discharge frequency, focality, and spread pattern. Electrographically, several patterns 
can be seen at seizure onset such as low-voltage and high-voltage fast activities or rhythmic 
spiking (SPENCER, 2009).  Figure 2-1(a) shows the sudden appearance of the typical low-voltage 
fast activity recorded from two intracerebral contacts positioned over the EZ, increasing in 
frequency (Figure 2-1(b)), and amplitude (Figure 2-1(c)). The icEEG is analyzed over the seizure 
onset (Figure 2-1(a)-(c)) and the SOD detects the high frequency discharge in icEEG, which may 
suggest an upcoming electroclinical seizure. However, as seen in many icEEG recordings, some of 
these high frequency discharges (e.g. Figure 2-1(d)) can be very brief (few seconds), remain very 
focal (without spread), do not evolve in time or frequency, and are clinically silent (electrical 
seizures). For most patients, it is probably not necessary to target them as ‘seizures’ warranting 
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focal treatment, they can simply be ignored.  For this reason, the seizure onset detection criteria 
are preferably set as a high frequency activity (Figure 2-1(b) and (e)) showing progressive increase 
in amplitude (Figure 2-1(c) and (f)). This should avoid false detections of interictal spikes and 
polyspikes, movement artifacts, physiological rhythms (e.g. sleep spindles), and brief 
asymptomatic high frequency voltage activities or very brief electrical seizures which would 
erroneously trigger unwarranted focal treatment.  
The proposed seizure detector is specialized to detect very specific type of seizure characterized 
by their progressive increase of low voltage fast activity. In this algorithm, the input signal (Vin in 
Figure 2-2 (a)) is modulated into high frequency (Fs = 1/Ts) so that the instrumentation’s low 
frequency noise does not affect the signal. Moreover, this modulation (Eq. (2.1)) converts negative 
signal amplitudes to positive amplitudes (Figure 2-2 (b)). Thus, positive hyper-excited threshold 
voltages (Vi,HET1,2) of a voltage level detectors (VLD) are sufficient to detect the high frequency of 
Vin. The discrete modulated signal (Vmod) confined to a time frame (Tf) passes through N number of 
VLDs to detect the specific features (Eq. (2.2)) characterized by progressive increase in amplitude 
and high-frequency variation. Figure 2-2(c) shows the output of a VLD Vcomi when it detects fast 
activities following Eq. (2.2).  
∑
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Figure 2-2: Seizure detection algorithm:  (a) Input signal Vin, (b) Modulated signal of Vin, (c) 
Output of VLDs Vcomi, and (d) Digital demodulation VDi. 
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where i =1, 2, 3, ….., N.  Vi,HET1,2 and Tf are tuned to the specific seizure onset frequency (FZ) 
of a patient so that no false alarms happen during seizure detection. Due to the modulation, VLDs 
detect a burst of pulses and unwanted high-frequency samples (Figure 2-2(c)). The following Eq. 
(2.3) shows the elimination of false positive detections for the unwanted high- frequency samples.   
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where PW is the pulse width of Vcomi(n). The detected burst pulses are converted to a single 
pulse by Eq. (2.4). 
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The signal frequency (FSZi) is defined by the total number of identified pulses VDi confined to Tf 
as follow. 
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Thus, seizure onset will be declared based on following conditions (Eq. (2.6)). 
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The SXT of the algorithm is enhanced, and several decision boundaries are introduced to reduce 
the number of FDs for the patient’s specific seizure onset pattern. Signal analysis of this algorithm 
demonstrates that the early modulation and proper rectification of icEEG can identify the seizure 
onset efficiently.  
2.4 PROPOSED SYSTEM 
The proposed implantable SOD provides continuous long-term monitoring of icEEG from the 
EZ. Figure 2-3(a) illustrates the implant configuration of the SOD and the functional block 
diagram of Figure 2-3(b) presents its architecture. The device will be implanted within the skull 
and interfaced directly with the recording site using standard subdural/depth electrodes 
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Figure 2-3: The proposed integrated SOD: (a) Implant configuration which shows the devices 
and two sets of electrodes; the sensing subdural electrodes and depth electrodes, and (b) Block 
diagram of the proposed SOD chip. 
 (diameter/size: 5mm and interelectrode spacing: 10 mm). This SOD consists of a preamplifier, 
voltage level detectors (VLD), digital demodulators (DD) and a high-frequency detector (HFD). In 
this SOD, several variable parameters (VREF, Vi,HET1,2 and TF) are introduced to facilitate higher 
accuracy in real-time seizure onset detection. VREF controls the amplification of neural signals, 
Vi,HET1,2 are used to adjust the threshold voltages of VLDs, and TF in HFD sets the tunability of the 
frequency detection. Figure 2-3(b) shows that most of the signal processing in the SOD is 
accomplished in the digital domain because of the relatively poor noise performance of CMOS 
technology. The preamplifier initially modulates the neural signal in Fs and amplifies the input 
amplitude level of interest. Subsequently, the VLDs convert the amplified signal VBuf to a digital 
signal Vcomi. Once the signal is digitalized, there is little further possibility to add noises in this 
signal. Then the Vcomi is demodulated to the original digital signal VDi. Finally, the HFD 
determines the seizure onset frequency from processed signals and declares a seizure detection 
(VSO) without false alarm. 
2.5 CIRCUIT IMPLEMENTATION  
As illustrated in Figure 2-3, the SOD consists of four main functional blocks. Details are given 
below. 
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2.5.1 Preamplification 
A dedicated chopper preamplification method was introduced in our previous work (SALAM, 
2009(a)). Figure 2- 4 shows the block diagram of the preamplifier and the frequency analysis of 
signals in different nodes. This figure demonstrates that the preamplifier input signal is modulated 
by a signal with frequency Fs, and the flicker noise Vk and dc-offset voltage noise Vos of the 
amplifier are attenuated by the high-pass filter, while the finite bandwidth of the amplifier and 
buffer band limits the thermal noise Vnt. The proposed preamplifier is advantageous over the 
conventional chopper preamplifier for the detection of epileptic seizures.  
The comparison of the preamplifiers is shown in Table 2.1. Figure 2-5(a) illustrates the 
preamplifier construction, which comprises an operational transconductance amplifier (OTA) 
(Figure 2- 5(b)), high-pass filter, and a buffer. These circuits give a band-pass frequency response, 
which is produced by the preamplifier (Figure 2-5(a)) and the band-pass filter that has a maximum 
 
Figure 2-4: Preamplification front-end: (a) Band-pass filter comprising an OTA, a high-pass 
filter and a buffer, (b) Circuit of the OTA used in preamplifier. 
 
Figure 2-5: The dedicated chopper stabilizer circuit and corresponding frequency analysis of 
signals in different nodes. 
 
27 
 
Table 2.1: Comparison of the conventional and the proposed chopper preamplifier. 
The preamplifier [15]  The proposed preamplifier  
A demodulator adds ripple noise.  No demodulator  
A low-pass filter with sharp cutoff 
frequency consumes extra power.  
No low-pass filter is used.  
Thermal noise is attenuated by the low-
pass filter.  
Thermal noise is attenuated by the band 
limited amplifier.  
Flicker noise is shifted to high frequency 
and attenuated by the low-pass filter.  
Flicker noise is attenuated by high-pass 
filter (a capacitor and 2 PMOS transistors). 
Design complexity is high.  Design complexity is low.  
Moderate input referred noise.  Lower input referred noise  
Medium power consumption (24µW).  Lower power consumption (6µW)  
 
of 80 dB midband gain and 17 kHz (2 kHz to 19 kHz) bandwidth with 6 µVrms input-referred 
noise. Moreover, the OTA has variable gain that can emphasize a specific amplitude range of the 
neural signal. 
2.5.2 Voltage Level Detector 
A VLD consists of comparators, logic gates, DFF and a buffer (Figure 2-6(a) an (b)). A low-
power comparator has been reported in (Tangel, 2004) that includes two cascaded CMOS 
inverters, with the threshold voltage set by the aspect ratios of the transistors. The main 
disadvantage of this comparator is the fixed threshold voltage in an integrated device. However, a 
modified version of the comparator (Figure 2-6(c)) provides variable threshold voltages Vi,HET1,2.  
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                                   (2.7)  
where Vtp and Vtn are the threshold voltage of the NMOS and PMOS devices, respectively; 
VSGp1 is the source to gate voltage of Mcp1 transistor; and Kn = (W/L)n µn Cox and Kp = (W/L)p µp 
Cox.  Eq. (7) shows that VSGp1 is the only variable parameter that can adjust the value of VHETi in 
an integrated circuit. The variation of VSGP1 is proportional to the bias voltage Vi,bVD1,2. The other 
advantages of the modified comparator are (i) negligible static power consumption, (ii) no 
hysteresis effect, and (iii) relatively small transistor area.   
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Figure 2-7: The digital demodulator (DD): (a) Circuit, (b) Burst of pulses detected by VLD, (c) 
Voltage Veb across the RC circuit, and (d) Output VDi. 
In order to construct a VLD, two modified comparators are used. Figure 2-6(a) shows several 
VLDs; the bias voltages Vi,bVD1 and Vi,bVD2 set the variable lower (Vi,HET1) and upper (Vi,HET2) 
threshold voltages, respectively. The DFF circuit removes unnecessary high-frequency samples. 
2.5.3 Digital Demodulator 
A digital demodulator (DD) includes a RC circuit and a VLD (Figure 2-7(a)) that converts a 
burst of pulses to a single pulse. During a seizure, the VLD (Figure 2-6) detects the abnormalities 
in signals and generates several bursts of pulses (VSEi) due to modulation in the preamplification 
stage. In the DD, each of these input pulses VSEi (Figure 2-7(b)) charges the capacitor (Ceb) 
quickly, but the discharging time (Teb) of Ceb is longer than the duration (TE) between two 
consequent pulses of clock (Figure 2-7(c)). Thus, the Ceb cannot be discharged completely 
Mcn1
Mcp3
Mcn2
Mcp4
Vdd
Mcp1
Mcp2
VN,bVD2
-
V
S
G
p
 +
(c)
VN,bVD1
.
.
.
VSEN
VBuf
Mater 
slave 
DFF
VLD1
Comparator
Comparator
VN,bVD2
Clock
VLDN
(b)
VLD2
VLD3
VLDN
V1,bVD1,2
V2,bVD1,2
V3,bVD1,2
VN,bVD1,2
Clock
VBuf
VSE1
VSE2
VSE3
VSEN
(a)
VBuf
 
Figure 2-6: Construction of VLDs: (a) Block diagram of VLDs, (b) Schematic of a VLD, and 
(c) Circuit of a comparator. 
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Figure 2-8: Microphotograph of the fabricated SOD chip. 
 
 
during a burst of pulses. However, a VLD connected to a RC circuit detects the end of a burst, 
where the Ceb discharges completely through a diode connection of Meb1 transistor and 
generates a pulse VDi (Figure 2-7(d)). 
2.5.4 High-Frequency Detector 
The high-frequency detector (HFD) (Figure 2-7(b)) has two main building blocks: a time 
frame selector (TFS) and three frequency detectors (FDs). The TFS is based on a 14-bit counter 
that generates two different time frames Tf13 (= 213/Fs) and Tf14 (= 214/Fs) in 13th and 14th bit, 
respectively. The FD counts the number of pulses received from the DD (VDi) and resets all FDs at 
the end of every Tf. Finally, the logic gates analyze the outputs of FD and declare an upcoming 
seizure (VSO). 
2.6 EXPERIMENTAL RESULTS 
The SOD was fabricated in a CMOS 0.18-µm process and occupies 2 mm x 1 mm of silicon 
area. A photograph of the fabricated chip is shown in Figure 2-8. 
 
2.6.1 Integrated Circuit Measured Performance 
The test bench measurements were performed on five samples of the fabricated chip and 
presented consistency in results. The test bench supply voltage was set to 1.8 V and the 
measurements shown in Table 2-2 are based on averages over the set of test chips. The observed 
measured variation over the test chips was within ±5%. 
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Table 2.2: Measured features for the fabricated SOD 
Block Parameter Value 
Preamplifier 
Midband gain 66 dB 
High-pass cutoff frequency 100 Hz 
Low-pass cutoff frequency 6500 Hz 
Bandwidth 6.1 kHz 
VLD 
Highest threshold voltage 496 mV 
Lowest threshold voltage 6 mV 
Threshold incremental step 30 mV 
HFD 
Detectable seizure 
frequency 
Min  5 Hz 
Max 15 Hz 
Time frame Tf 
Min 0.5 sec 
Max 163 sec 
SOD 
Supply voltage 1.8 V 
Supply current 28 µA 
Area (in 0.18µm- CMOS) 2 mm2 
 
Figure 2-9: Measured results: (a) Variable gain of the preamplification front-end with changing 
of VREF. (b) Gain response of the front-end preamplifier; (c) Comparator threshold levels; (d) 
Time frame (Tf ) generation. 
 
The measured input-output characteristics (Figure 2-9(a)) of the front-end preamplifier show that 
the variable gain of the preamplifier can emphasize a specific amplitude range of the neural signal. 
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The preamplifier gain frequency response is shown in Figure 2-9(b). The maximum achieved 
measured gain of 66 dB was obtained over a 3 kHz to 5 kHz frequency, and the cutoff frequencies 
were measured at 100 Hz and 6.5 kHz. The output voltage VBuf range is 50 mV to 450 mV while 
the VLD detects the desired amplitude of VBuf with 30 mV incremental/decremental steps very 
precisely.  Figure 2-9(c) shows the dc sweeping of the modified comparator with different 
threshold voltages Vi,HET1,2. Table 2.2 shows the lowest and highest threshold voltages VHETa = 6 
mV and VHETn = 495 mV, respectively. Figure 2-9(d) shows the variable time frames Tf13 and Tf14 
generated using different clock frequencies. The generated Tf varied from 1.3 to 8 sec.   
2.6.2 Patient selection methodology 
This study was conducted at Notre-Dame Hospital, Centre Hospitalier de l'Université de 
Montréal (CHUM). The proposed detector was validated using intracerebral recordings from 
seven patients with refractory epilepsy who underwent an intracranial study to better delineate the 
epileptogenic zone. Previously these patients had undergone a comprehensive presurgical 
evaluation, such as video-scalp EEG, a brain magnetic resonance study (MRI), an ictal single-
photon emission computed tomography (SPECT), a positron emission tomography (PET), a 
magnetoencephalographic (MEG) study, and an EEG-functional MRI (EEG-fMRI). These 
complementary non-invasive studies failed to adequately localize the epileptogenic zone and 
invasive intracranial electrode studies were required to delineate with more precision the EZ. In 
these studies, intracranial electrodes were implanted of through a craniotomy or burr holes under 
general anaesthesia. Later, patients were transferred to the epilepsy monitoring unit for 
continuous video-EEG telemetry to record seizures. The patients, who had seizure onsets 
characterized by progressive increase of low-voltage fast-activity in icEEG recordings, were 
good candidates for the proposed detection validation. 
2.6.3 Method of Case Studies 
Seven patients (age: 15 to 49) with intractable nonlesional partial epilepsy who were candidates 
for epilepsy surgery underwent an intracranial study to better delineate the EZs (Table 2.3). A 
combination of depth and subdural (strip and/or grid) electrodes were implanted over suspected 
areas of epileptogenicity (e.g. hippocampus, insula, medial frontal gyrus, orbital frontal cortex 
etc.) through a craniotomy window or burr holes. Following the implantation of intracranial 
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Table 2.3: Case studies of seven patients with partial epilepsy and Matlab Analysis. 
Case 
No. 
Age/ 
sex 
Origin Seizures characterized by 
Matlab simulation results 
V1,HETi (µV) V2,HETi(µV) FSZ 
(Hz) 
TDet 
(sec) i=1 i=2 i=1 i=2 
1 24/M Right 
hippocampus 
Warmth and dizziness, 
confusion ± GTCa. 
100 160 200 260 12 12 
2 49/F Left 
hippocampus 
Déjà vu, visual flash, and 
confusion ± GTCa. 
 
50 100 100 160 8 7 
3 41/M Right 
amygdala/ 
hippocampus 
Viscerosensory symptoms, 
and confusion 
50 70 100 120 10 10 
4 36/M Left lateral 
temporal 
neocortex  
Arrest of speech and 
inability to comprehend 
 ± GTCa 
100 160 200 260 10 24 
5 32/M Left 
hippocampus 
Left somatosensory 
symptoms, dizziness, 
flushing, déjà vu, 
confusion ± GTCa 
50 70 100 120 5 12 
6 15/M Right lingual 
gyrus  
Visual flash, déjà vu, 
nausea, confusion, 
 ± GTCa. 
50 100 100 150 4 25 
7 44/M Left premotor 
cortex 
Right cephalic deviation, 
confusion, ± GTCa. 
50 70 100 120 10 7 
      aGTC : generalized tonic-clonic seizure 
 
electrodes, the patient underwent long-term video-EEG recording in the epilepsy monitoring unit 
(Notre-Dame Hospital, Montréal). The use of intracerebral recordings from epileptic patients 
undergoing an invasive study for the validation of our system was approved by the Notre-Dame 
Hospital ethics committee. Recorded seizures were carefully analyzed to identify the EZ. The EZ, 
seizure characteristics, and seizure detection results of the 7 patients in this study are listed in 
Table 2.3. Commercially available equipment was used to record the icEEG signal during a 
seizure from two contacts located in the EZ. The seizure signals of cases 1, 2, 3, 5 and 6 were 
recorded using depth electrodes and the signals of cases 4 and 7 were recorded using subdural 
strip electrodes. These signals were fed into the proposed seizure detection algorithm (Matlab 
software) and SOD chips. The proposed detector can handle up to two contacts subdural 
electrodes or depth electrodes. Seizure detections were tested on various seizures from seven 
patients (average of 5 seizures of each patient) due to the heterogeneity in signal amplitude and 
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frequencies observed at ictal onset. Parameters of the detector were tuned for each patient based 
on time frequency and time amplitude analysis of a seizure signal and 3 or 4 brief electrical 
seizures. The detection performances in terms of DTD (TDet) of both Matlab analysis and the 
fabricated chip results are presented in the next section.   
2.6.4 Validation of the Seizure Detection Algorithm  
The proposed seizure detection algorithm is evaluated by applying the recorded icEEG from 
seven patients. The performance of the algorithm is shown in Table 2.3. Case 1 is a 24 year-old 
male with drug-resistant partial epilepsy since age 18 years. During the intracranial study, several 
seizures were recorded, all originating from the right medial temporal lobe (hippocampus) and 
spreading to the lateral temporal neocortex and the insula (Figure 2-10(a)). The seizure signal is 
analyzed in time and frequency domains (inset of Figure 2-10(a)) in order to set the Vi,HET1, Vi,HET2 
and FSZ. The frequency domain demonstrates that the seizures were electrically characterized by 
an initial low-voltage tonic alpha activity (12 Hz) evolving into rhythmic spiking while amplitude 
in the time domain increased progressively. Table 2.3 shows that the seizure was detected TDet 
=12 sec after ictal onset. In case 2, seizures similarly started from the left hippocampus with an 
initial low-voltage fast activity pattern, before spreading to the left occipital region. The signal 
analysis (Figure 2-10(b)) shows that the increase of signal frequency and progressive amplitude 
were found at TDet =7 sec.  Case 3 shows a higher signal frequency (20 Hz) at seizure onset 
(Figure 2-10(c)) that started to decrease with the progressive increase of its amplitude. The seizure 
of case 3 was detected at TDet =10 sec. 
Case 4 had seizures which electrically started as a diffuse slow wave followed by 
desynchronization and regional low-voltage high-frequency activity over several temporal 
neocortical contacts (Figure 2-11(a)).  The algorithm ignored the brief electrical seizure (as 
specified by the clinician) and detected the electroclinical seizure after 24 sec. The seizure onset of 
case 5 was initially characterized by fast-activity without increasing of amplitude (Figure 2-11(b)). 
The signal frequency then suddenly drops for 2 sec followed by a higher frequency signal and 
progressive increase in amplitude which are detected (TDet =12 sec). Figure 2-11(c) shows icEEG 
recordings from case 6 of two brief electrical seizures (ES) followed by an electroclinical seizure 
that started with low-voltage fast activity quickly increasing in amplitude and decreasing in 
frequency. Finally, the seizure onset of case 7 was characterized by rapid increase of frequency  
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Figure 2-10: Seizure onset detections where icEEGs were recorded from different locations in 
patients, the zoom inset shows signal analysis and detection: Vin is icEEG of seizure recorded 
using two contacts from the EZ, FSZ is frequency analysis of Vin, VMA is mean absolute amplitude 
analysis of Vin, VD1 – VD2 are high frequency detections, and VSO is seizure onset detection: (a) 
Case 1, (b) Case 2, and (c) Case 3. 
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Figure 2-11: IcEEG analysis and seizure onset detection using Matlab. The icEEG (Vin) of a 
seizure recorded using two contacts from the EZ, frequency analysis FSZ, mean absolute amplitude 
analysis VMA, the high frequency detections VD1 – VD2, and VSO is seizure onset detection: (a) Case 
4, (b) Case 5, (c) Case 6, and (d) Case 7. 
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Table 2.4: The tuneable parameters’ values of the SOD chips and average detection delays. 
Case No. 
VREF 
(mV) 
V1,HETi 
(µV) 
V2,HETi(µV) Tf 
(sec) 
TDet 
(sec) 
i=1 i=2 i=1 i=2 
1 272 300 320 340 360 2 6 
2 275 90 110 120 140 2 12 
3 278 100 130 200 230 2.7 15 
4 272 300 320 340 360 2 15 
5 278 100 130 200 230 2 12 
6 275 90 110 120 140 2 20 
7 278 100 130 200 230 2 15 
 
and progressive amplitude increase of the signal (Figure 2-11(d)). Overall, the proposed algorithm 
maximizes the sensitivity and specificity of the detection, with a slightly longer detection delay as 
a trade off. In these experiments, the seizures of seven patients were detected on an average of 
13.8 sec (min: 7 sec and max: 25 sec) prior to first clinical manifestations.   
2.6.5 Validation of the SOD Chip 
Following the validation of the seizure detection algorithm in Matlab, the integrated circuit of 
the SOD was tested using the same seizure recordings from the seven patients mentioned above. 
The icEEG recordings were modulated, amplified, and analyzed in frequency and time domain in 
order to set the threshold voltages of two VLDs (Table 2.4). The seizure detection on icEEG 
recordings (Vin) of 3 patients is shown in Figure 2-12. Outputs of the VLDs (VD1 and VD2) were fed 
into a HFD to extract the frequency information (the zoom inset of Figure 2-12). The HFD had 
three 3-bit counters and a variable TF generator that detected the seizure onset at an early stage of a 
seizure. The SOD ignored all the preictal activities (as set by the clinician) and detected the 
electroclinical seizures of the seven patients ~13.5 sec after onset, well before onset of clinical 
manifestations (∼12 sec prior). Table IV shows the tunable parameters values and the average 
seizure detection delays of the SOD chips for all cases.  
 The proposed system is compared with recently published seizure detectors based on events 
(ESD) (RAGHUNATHAN, 2009), nonlinear Energy (NLESD) (PATEL, 2009), and spectral 
energy (SESD) (VERMA, 2010) in Table 2.4. The detectors presented in (RAGHUNATHAN, 
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Figure 2-12: Measured seizure onset detection by the SOD chip, where Vin is the icEEG of 
seizure from EZ, VD1 – VD2 are high frequency detections in the icEEG, and VSO is seizure onset 
detection: (a) Case 1, (b) Case 2, and (c) Case 3. 
 2009) and (PATEL, 2009) do not have a neural signal amplifier, and corresponding results are 
based on circuits simulation. The seizure detector from (VERMA, 2010) was fully integrated in 
CMOS 0.18-µm technology, but seizure detection results shown are based on software simulation 
platform using scalp EEG and no experimental results on seizure detection were reported. The 
proposed detector in this paper is a fully integrated device and the experimental results were based 
on icEEG recordings from different locations in the human brain. Furthermore, the power 
consumption of the proposed detector is 7 times lower than one presented in (RAGHUNATHAN, 
2009). The DTD is varied depending on the patient’s specific ictal onset pattern. Although the 
average DTD of the proposed SOD is 5 sec higher than the detector described in 
(RAGHUNATHAN, 2009), the SXT and specificity of the proposed SOD are maximized 100% to 
prevent unwarranted stimulation; however SXT of ESD (RAGHUNATHAN, 2009), SESD 
(VERMA, 2010), and NLESD (PATEL, 2009) are 95.3%, 94.35%, and 93%, respectively. The 
DTD and SXT of other seizure detectors (BHAVARAJU, 2006; AZIZ, 2006; AZIZ, 2007) are 
unknown. 
38 
 
Table 2.5: Comparison with latest competitive results. 
Reference RAGHUNATHAN, 2009 PATEL, 2009 
VERMA, 
2010 This work 
Electrodes Depth Subdural and 
depth 
Ag/AgCl Subdural and depth 
Location Hippocampus Frontal, 
temporal, and 
parietal lobe 
Scalp Lateral temporal, 
mesial temporal 
(amygdala/ 
hippocampus), 
frontal lobe 
Amplifier 
Process 
Data acquisition 
system (TDT 
system Inc) 
interfaced to a 
desktop 
computer 
Neurofile NT 
digital video 
EEG system 
CMOS 
0.18-µm 
CMOS 0.18-µm 
PC N/A N/A 72 µW 
(measured) 
50 µW (measured) 
Detector 
Process 
Simulation on 
MIT 180 nm SOI 
process 
C5510 DSP 
processor 
TSMC 0.13-µm 
CMOS 
CMOS 
0.18-µm 
CMOS 0.18-µm 
PC 350 nW 
(simulation) 
DSP: 80 µW 
(simulation) 
CMOS: 2.7 µW 
48.1  µW 
(measured) 
44.85 nW (measured) 
 
Further a comparative analysis on seizure detection performance is demonstrated using the 
same icEEG recordings of seven patients with several detection methods, such as ESD 
(RAGHUNATHAN, 2009), SESD (VERMA, 2010), and NLESD (PATEL, 2009). Detection 
parameters of these methods were tuned for each patient according to (RAGHUNATHAN, 2009; 
VERMA, 2010; PATEL, 2009). These detection methods were validated in Matlab and 
comparative results of the detection methods using the same data is shown in Figure 2-13. The 
result shows that the ESD, NLESD and SESD methods have lower SXT because the methods 
sometimes detected brief high frequency bursts as seizures, but did not detect the seizure onset 
characterized by low-voltage fast activity. If the detection parameters of ESD, NLESD and SESD 
methods were adjusted to low-voltage fast activity seizure onset, the methods detected low 
amplitude physiological rhythms and other similar activity. Therefore, the proposed algorithm is 
based on the time frequency and time amplitude analysis, and avoids false detections of interictal 
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Figure 2-13: Comparative results of analyzing the same icEEG recordings with several 
detection methods (based on 7 patients). 
spikes and polyspikes, movement artifacts, physiological rhythms (e.g. sleep spindles), and brief 
asymptomatic high frequency voltage activities or very brief electrical seizures. Average DTD of 
the proposed SOD is higher than the ones given by the other methods, but well before onset of 
clinical manifestations. Moreover, the external low-frequency instrumental noise may cause false 
detection. Thus the proposed algorithm is more focus on noise reduction; however the detection 
algorithm of RNS system (SCHACHTER, 2009) is intended for data reduction. Furthermore, the 
detection criteria of RNS system are based on high frequency tracking of amplitude variations in 
icEEG recording, but the proposed algorithm detects progressive increase of high-frequency signal 
in icEEG. In addition, total power dissipation and DTD of the RNS system are unknown.  
2.7  CONCLUSION 
We have described the design and implementation of a new implantable SOD chip responsive to 
ictal low-voltage fast activity patterns, focusing on low power and on noise reduction of involved 
circuits. Experimental results, reported from seven patients with drug-resistant partial epilepsy, 
demonstrate that the early modulation and proper rectification of icEEG can identify the 
progressive increase in amplitude and high frequency of signal efficiently. The fabricated SOD 
chip modulates icEEG recordings, amplifies the desired amplitude level of signal, extracts fast 
activity information using VLDs, demodulates the signal to extract the original frequency using 
RC circuit and detects the seizure by evaluating the frequency of fast activities and the progressive 
increase in amplitude.  
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CHAPTER 3  A RESPONSIVE ELECTRICAL STIMULATOR 
As mentioned in chapter 1, responsive neurostimulation therapy is a promising alternative for 
the treatment of epilepsy; we were working towards building a low-power neurostimulator. 
Chapter 2 has shown the design, fabrication and validation of a seizure detector for a 
neurostimulator and in this chapter, we present a low-power circuit technique for a responsive 
electrical stimulator that detects seizure onsets and triggers an electrical stimulation to suppress 
an upcoming seizure. The simulation and experimental results of the implantable device were 
demonstrated using icEEG recordings from seven patients with medically refractory epilepsy. 
This paper will soon appear in “Journal of Low Power Electronics - American Scientific 
Publishers”. This paper is reproduced as follow.  
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Abstract — In this paper, we present low-power circuit techniques for implementing a closed-
loop neurostimulator (CLNS) as an alternative treatment for medically refractory epilepsy. The 
proposed circuit has low-power dissipation with better detection sensitivity compared to the 
recently proposed circuit techniques for epileptic seizure detector. We demonstrate low-power 
circuit techniques for implementation of an implantable CLNS, individual functional testing, and 
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validation of the seizure detector on real intracerebral EEG (icEEG) recordings and testing of 
self-triggering electrical stimulation. The CLNS comprises a low-power icEEG acquisition front-
end, epileptic seizure detector, and a widely programmable current stimulator. Moreover, the 
tuneable parameters of the detector and stimulator are designed to adjust wirelessly. The 
detection algorithm was validated with Matlab tools and the detection circuits were implemented 
in 2 mm2 chip area using CMOS 0.18-µm process. The current-mode stimulator was assembled 
on two circular (Ø 20mm) shape blocks in a printed circuit board (PCB). The proposed CLNS 
was tested using icEEG recordings from seven patients with medically refractory epilepsy. The 
icEEG recordings were assessed by the proposed CLNS (offline) and the predefined seizure 
suppression biphasic electrical stimulations were triggered ~14.4 sec after electrographical 
seizure onsets. 
Keywords — Low-power, Implantable device, Seizure detector, Electrical stimulator, CMOS, 
FPGA. 
 
3.2 INTRODUCTION 
The growing demand for low power dissipation has been driven by implantable battery-
powered therapeutic systems that demand ever-increasing functionality and battery life. The 
implantable medical devices have been widely used to restore neurological disorders including 
Parkinson’s disease, epilepsy, urinary bladder dysfunctions, and restoration of vision. Epilepsy is 
the second most common neurological disorder, affecting ~50 million people worldwide. 
Antiepileptic drugs are the mainstay of epilepsy treatment. Though close to two- thirds of patients 
are controlled by oral medications, many report side effects and the rest continue to suffer from 
disabling seizures (SALAM, 2010(a); SCHACHTER, 2009). Epilepsy surgery may be an option 
in the presence of a well delineated epileptogenic zone (EZ) located in an area that can be resected 
without harm (SALAM, 2010(a); JEROME, 2009, SPENCER, 2009). For those with a poorly 
defined epileptic focus, multifocal epilepsy, an EZ located in a highly functional/non-resectable 
area or those with persisting seizures despite attempted resective surgery, additional therapeutic 
options are needed.  
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Proof-of-concept experiments conducted in animals and humans have demonstrated the safety 
of successful chronic electrical stimulation for the treatment of epilepsy (KOSSOFF, 2004; 
SKARPAAS, 2009; NIRO, 2007). At first, the Vagus nerve stimulator was introduced for 
adjunctive treatment of patients with partial seizures with or without secondary generalization or 
generalized seizures that are refractory to antiepileptic medications (approved in 1997 by FDA) 
(REESE, 2009; SETHI, 2008). Efficacy of this scheduled (open-loop) stimulation device is, 
however, limited to a 3% rate of seizure-freedom and a 30-40% responder rate (i.e. showing more 
than 50% reduction in seizure frequency) (REESE, 2009; SETHI, 2008; RYCHLICKI, 2006). A 
more recent approach has been to look at closed-loop stimulation triggered upon detection of an 
electrographic seizure onset (REESE, 2009; SETHI, 2008). The RNS system (Neuropace Inc.) is a 
cranially implanted responsive neurostimulator designed to detect seizure activity in the brain and 
to deliver predefined electrical stimulation to suppress seizures before any seizure symptoms 
appear (SKARPAAS, 2009). A recent pivotal randomized double-blind sham stimulation 
controlled trial assessing the efficacy and safety of the RNS system showed moderate reduction in 
seizure frequency in patients with refractory partial onset epilepsy originating from one or two 
locations in the brain (SKARPAAS, 2009). Closed-loop stimulation (KOSSOFF, 2004; 
SKARPAAS, 2009; OSORIO, 2005; OSORIO, 2009) has some potential advantages over the 
open-loop method (REESE, 2009; SETHI, 2008; RYCHLICKI, 2006; FISHER, 2010): (i) lower 
number of treatments; (ii) fewer stimulation-related adverse events, (iii) high efficiency due to 
rapid access; and (iv) ability to review recordings to monitor seizure frequency. Any closed-loop 
system relies upon accurate seizure onset detection (without false alarms).  
In the last decade, many mathematical models have been developed for seizure detection 
based on wavelet (BERDAKH, 2009), entropy-based approach (ZANDI, 2009), spectral feature 
extraction (Sukhi, 2005), and spectral instability (AKSENOVA, 2007). These models were 
developed using desktop computers for off-time data processing and cannot be employed in a 
low-power implantable microchip due to the heavy computation. However, several seizure 
detection algorithms have been proposed for low-power implantable device and hardware 
implementations have been shown feasible using CMOS 0.18-µm (SALAM, 2009(b), VERMA, 
2010; SALAM, 2010(c); SALAM, 2010(f)), MIT 180 nm SOI (RAGHUNATHAN, 2010), and 
CMOS 0.13-µm (PATEL, 2009) process. These types of implementation in custom integrated 
circuits are sensitive enough to detect seizures early on but also specific enough to prevent 
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Table 3.1: Biphasic stimulation parameters 
Stimulation Location Stimulation parameters Frequency On Off 
OLNS (FISHER, 2010) ATN 145 Hz 1 min 5 min 
CLNS (OSORIO, 2005) EZ 100-500 Hz 1 sec 1 min 
ATN 100-200 Hz 2.5 sec 1 min 
OLS:  Open loop neurostimulation, CLNS: Closed-loop neurostimulation,  
ATN:  Anterior thalamic nucleus, and EZ:  Epileptogenic zones 
 
 
unwarrantedly triggered focal intervention. Therefore, the seizure detectors need complicated 
functionalities which result in higher power consumption. Power management is an important 
issue for medical devices. Although rechargeable wireless batteries may partially solve the 
problem, it is important to improve the implantable devices with new features/system design to 
minimize power dissipation while optimizing their performance. 
Apart from the seizure detection performance, the other concerns are safety of chronic 
electrical stimulation and the determination of optimal stimulation parameters. Table 3.1 shows 
the parameters used in pilot trials. Osorio, demonstrated the feasibility and short-term safety of 
automated high-frequency electrical stimulation (100 – 500 Hz) in blocking seizures using an 
external prototype (OSORIO, 2005). Moreover, many promising advances have been made in the 
understanding of electrical stimulation parameters and locations of stimulation (KOSSOFF, 2004; 
SKARPAAS, 2009; REESE, 2009; FISHER, 2010). Several low-power miniaturization 
implantable electrical stimulators have been reported for Urinary bladder dysfunctions 
(MOUNAIM, 2007; MOUNAIM, 2011; SAWAN, 2008) and restoration of vision 
(COULOMBE, 2007; SAWAN, 2005; NADEAU, 2006). However, several issues remain to be 
addressed for the electrical brain stimulation treatment for epilepsy, such as maximum charge 
density, stimulation mode, current distribution, shunting of injected current, impedance of 
cerebral tissue, and the region affected by stimulation.   
In this paper, we present low-power circuit techniques for implementing responsive 
neurostimulator for the treatment of refractory partial onset epilepsy. This prosthetic device 
analyzes the intracerebral EEG (icEEG) recording, detects electrographic seizures at their onset, 
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and triggers focal electrical stimulation to the EZ (or a chosen target such as the anterior thalamic 
nucleus) to abort the seizure. The device comprises intracranial electrode contacts, the icEEG 
acquisition front-end, a seizure detector, and an electrical stimulator. The proposed seizure 
detection algorithm has enhanced sensitivity of detection for the patient-specific seizure pattern, 
while minimize power dissipation. Moreover, the algorithm reduces instrumentational low-
frequency noises by manipulating the icEEG recording into high frequency and demodulating the 
signal to the original frequency band in the digital domain. The widely programmable electrical 
stimulator is suitable for the treatment of refractory epilepsy. The performance of the proposed 
CLNS is verified using icEEG recordings from seven patients with refractory partial epilepsy. The 
measured results of CLNS demonstrate the reliability of the system in an implantable device for 
neurostimulation therapies.  
3.3 METHOD OF TREATMENT 
The proposed CLNS is designed to deliver high frequency electrical stimulation (100 – 500 Hz) 
directly to the EZ at seizure onset prior to clinical manifestation. The CLNS is dedicated to the 
treatment of refractory partial epilepsy. The CLNS will be implanted within the skull and 
interfaced directly with the recording/stimulation sites (Figure 3-1(a)). The CLNS comprises 
subdural or depth electrodes, a seizure detector (SD) and an electrical stimulator (ES). Figure 3-1 
 
Figure 3-1: Overview of method of treatment: (a) proposed CLNS interfaces directly to the part 
of brain through subdural electrodes; (b) flow chart of CLNS; and (c) graphic representation of 
automatic triggering neurostimulation, where Vin is icEEG of seizure from epileptogenic zone, 
VSOD is seizure onset detection, and ISTIM is bipolar biphasic electrical stimulation. 
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(b) illustrates the functional block diagram and flowchart of the CLNS. The corresponding graphic 
representation in Figure 3-1(c) demonstrates the real-time icEEG recording (Vin) acquisition, 
seizure detection (VSOD) at their onset, and triggering of direct electrical stimulation (ISTIM) for T1 
period to the EZ to abort the seizure, while another seizure detection begins after T2, if the seizure 
does not terminate. The SD and ES have different tuneable parameters designed to detect patient-
specific seizure onset patterns and provide individualized effective bipolar biphasic stimulation to 
the brain tissue in order to disrupt seizures. The SD requires low-power, continuous, long-term 
icEEG monitoring to identify seizures online before the appearance of disabling clinical 
manifestations (e.g. altered consciousness, tonic or clonic movements). On the other hand, ES 
remains in sleep mode, unless SD triggers it to active (stimulation) mode. 
After the implant procedure, patients need to have follow-up visits with the clinician to 
program the CLNS. The clinician uses external controller to program the CLNS. This 
programming session sets the optimal detection and stimulation parameters to best manage 
patient’s seizures while minimizing side effects. Battery life of CLNS can vary depending upon 
the programmed stimulation parameters (e.g. amplitude, frequency, pulse width) and number of 
seizure detection. However, this battery can be recharged wirelessly through the skin; moreover, it 
will be automatically recharged during the programming session. The frequency of these follow-
ups depends on the medical background of the patients and the individual circumstances. 
3.3.1 Low-power accurate seizure detector design 
The proposed seizure detector performs real-time icEEG analysis, of which output triggers a 
burst of electrical stimulation. This epileptic seizure detector is designed for lower power 
dissipation and instrumentational low-frequency noises isolation (e.g. flicker noise, dc offset 
voltage, and thermal noise) and also other sources of noise (e.g. 60 Hz noise). Mathematical 
model of the proposed seizure detector was introduced in our previous work (SALAM, 2008(b)) 
and here, we present a brief description of the model, and advantages and disadvantages of the 
model for real-time neurostimulation applications.  
In this mathematical model, high sampling frequency modulates the input signal amplitude and 
passes through amplitude detectors with different threshold voltages to detect the specific features 
characterized by progressive amplitude increase. The detected amplitudes confined in a time frame 
pass through frequency analyzers for time-frequency analysis. Therefore, the algorithm determines 
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the high frequency as well as progressive increases in amplitude and declares an upcoming 
seizure. 
The input icEEG is modulated into high frequency (Fs) for two reasons: (i) instrumentation 
low-frequency noise does not affect the seizure detection performance and (ii) the amplitude 
modulation converts negative signal amplitudes to positive amplitudes, thus, amplitude detectors 
are required only in positive comparators for time-amplitude analysis. Signal processing and 
demodulation are done in digital domain to reduce power dissipation and avoid addition ripple 
noise generated from a classical chopper preamplifier (GOSSELIN, 2004).  Finally, an upcoming 
seizure is declared without influence of internal and external noises, if the filters and detection 
settings are adjusted correctly; otherwise high frequency sampling noise degrades the detection 
performance. 
Apart from the noise effects in the seizure detection, there are others biological impacts that 
may degrade seizure detection performance. Clinically, seizures may be electrical (especially if 
they occur in non-eloquent cortex and remain very focal) or electroclinical (when the ictal 
discharge involves/propagates to a symptomatic zone). Seizure symptoms are obviously dependent 
on what area of the brain is involved and may range from subtle sensations to overt convulsions. 
Electrographically, there are several seizure onset patterns which can be seen in icEEG recording, 
such as low-voltage fast-activity, high-voltage fast-activity or rhythmic spiking (SPENCER, 
2009). The proposed algorithm is designed to detect electroclinical seizures starting with low-
voltage fast-activity, the most frequently encountered ictal pattern.  
The ictal discharges generally contain high frequency components; however, not all high 
frequency discharges are seizures, as some are physiological rhythms. Therefore, the high 
frequency filtering from icEEG is not a sufficient criterion for detecting an epileptic seizure onset. 
Thus, the proposed detection algorithm incorporates both time-frequency and time-amplitude 
analysis of icEEG recordings. Figure 3-2 (a)-(c) show time-frequency FSZ and time-amplitude VMA 
(mean absolute) analysis of different icEEG recordings of a patient to demonstrate the seizure 
detection criteria. 
The signal analysis of normal icEEG recordings Vin shows no abnormalities in FSZ and VMA 
(Figure 3-2(a)). A brief electrical seizure (BES) in Vin (Figure 3-2(b)) has high frequency contents 
in FSZ, but it does not have progressive amplitude increase in VMA and stay for a short period (e.g. 
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4/5 sec). However, the signal analysis of Vin at seizure onset (Figure 3-2(c)) demonstrates a 
sudden increase in FSZ and progressive amplitude increase in VMA (Figure 3-2(c)) leading to 
clinical manifestations. Therefore, the seizure detector proposes two detection criteria: patient-
specific high frequency activity and progressive amplitude increase. Because the initial ictal 
electrical pattern may vary from patient to patient according to the underlying substrate, the type 
of intracerebral electrodes used, and their locations with respect to the EZ, the seizure detector has 
several adjustable parameters for optimizing sensitivity and specificity. Further details of the 
parameters are described in section 3.3.  
3.3.2 Stimulation parameters 
Chronic cortical electrical stimulation for the treatment of neurological conditions has been 
shown to be feasible, safe, tolerable and efficacious in humans (KOSSOFF, 2004; SKARPAAS, 
2009; NIRO, 2007). There are two modes for the electrical stimulation: bipolar and unipolar 
stimulation. The unipolar mode tends to stimulate a wider region while the bipolar mode is 
effective in producing localized current flows (NATHAN, 1993). Moreover, electrode-tissue 
impedance varies over the time and a voltage controlled stimulator cannot stimulate the brain 
tissue with a fix current. Therefore, current controlled stimulation is always preferable because of 
Ohm’s law and safety purpose. The current stimulator can deliver the desired quantity of charges 
into the brain tissue by keeping the current amplitude constant. Furthermore, charge-balanced 
asymmetric current biphasic stimulation (Figure 3-3(a)) can avoid damaging electrochemical 
 
Figure 3-2: Time-frequency (FSZ) and time-amplitude (VMA) analysis of icEEG recording (Vin) in 
(a) normal signal, (b) BES, and (c) electroclinical seizure. 
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Figure 3-3: Biphasic stimulation parameters: (a) stimulation waveform profile; and (b) 
limitation of maximum pulse width with injected current of biphasic stimulation. 
 
processes of the brain because the anodic pulse (ISTIM1) of the biphasic stimulation (Figure 3-3(a)) 
activates the neurons and the cathodic pulse (ISTIM2=ISTIM1/4) removes the delivered charges of 
ISTIM1. However, two subsequent opposite pulses could prevent the generation of an action 
potential. Thus, a short time delay (T4) between the pulses is required to propagate the action 
potential away from the stimulation site before removing the injected charge. It is generally agreed 
that limiting the maximum charge density (σMAX) to 60 µC/cm2 per phase can avoid tissue damage 
(SKARPAAS, 2009). Figure 3-3(b) illustrates the electrical brain stimulation safe region using 
standard subdural electrodes (diameter: 5mm and interelectrode spacing: 10 mm). The safety 
region is defined by Eq. (3.1). 
4T
A
I MAXSTIM
σ
=                                                               (3.1) 
where T4 is pulse width, A is area of the electrode and ISTIM is injected current to brain tissue. 
During the biphasic stimulation using bipolar subdural electrodes, there is significant shunting of 
current through the cerebrospinal fluid (CSF) because of higher (approximately four times) current 
density in CSF than the gray matter (NATHAN, 1993). Therefore, the proposed CLNS has a wide 
range of output current ISTIM.  
The proper stimulation parameters need to be individualized during the presurgical icEEG 
study for maximum efficacy prior to the implantation of a stimulation device. The stimulation is 
delivered at close proximity to the seizure onset, directly to (i) EZ by subdural electrodes, which is 
suitable for patients with one or two discrete EZ (SKARPAAS, 2009; OSORIO, 2005); or (ii) the 
anterior thalamic nucleus (ATN) by way of depth electrodes, which may be suitable for patients 
with large or more than two EZ  (FISHER, 2010). Further details are described below. 
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Figure 3-4: Block diagram of the proposed CLNS. 
 
3.4 LOW POWER SYSTEM DESIGN METHODOLOGY 
Figure 3-4 illustrates the architecture of the CLNS. The proposed CLNS features advance 
icEEG monitoring and neurostimulation technology. We achieve low-power design goal in the 
closed-loop system by using power gating strategy. In the CLNS, SD provides continuous long-
term monitoring of icEEG and ES delivers electrical stimulation in response to seizure detection. 
Thus, long-term energy dissipation in CLNS is dominated by SD. The field programmable gate 
array (FPGA) embedded ES stays in sleep mode and shuts down output stage, unless SD triggers it 
to active mode. The SD comprises two main blocks: detection core and controller of SD. Details 
of the CLNS are described below. 
3.4.1  Seizure detector 
A new seizure detector chip was introduced and measurements of the chip have been reported 
in our previous work (SALAM, 2010(f)). However, in this paper, the detector chip was integrated 
in a closed-loop system that monitor continuous long-term icEEG recording, adjust detection and 
stimulation parameters wirelessly, and able to trigger electrical stimulation on seizure detection. 
The detection core is responsible for icEEG acquisition front-end and epileptic seizure detection, 
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Figure 3-5: Schematic diagram of the detection core: (a) detection core based on the classic chopper 
preamplifier and (b) low-power detection core. 
 
while the controller adjusts tuneable parameters of the detection core in order to optimize the 
sensitivity of detection (Figure 3-4). As mentioned before, the epileptic seizure detection criteria 
may vary from patient to patient and detection criteria for a patient may change from time to time. 
Thus, the controller is introduced in SD so that a clinician can always modify the criteria through 
wireless communication.   
3.4.1.1 Low-power detection core design 
The classical chopper preamplifier (GOSSELIN, 2004) is widely used for icEEG acquisition 
front-end. Figure 3-5(a) illustrates schematic diagram of a traditional detection core based on the 
classic preamplifier. The traditional system consumed 24.06µW. To improve power management 
technique, a new chopper preamplification method was integrated with the detection system 
(Figure 3-2(b)). The demodulator and low-pass filter of a classical chopper preamplifier (Figure 3-
2(a)) were replaced by a rectifier and a digital demodulator (Figure 3-2(b)) to reduce addition 
noise (e.g. ripple noise) by demodulator and extra power consumption by a low-pass filter with 
sharp cutoff frequency. Moreover, the traditional design required four amplitude detectors (ADs) 
(positive and negative comparators) and four frequency detectors (FDs) to determine progressively 
increase low voltage fast activity in icEEG (figure 3-5(a)). But amplitude modulation in the low-
power design converts the negative amplitude signal information into positive amplitudes. 
Therefore, two ADs (only positive comparators) and two FDs are required to determine an 
upcoming seizure (figure 3-5(b)).  
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Table 3.2: Comparison on simulated power consumption (PC) of traditional and low-power 
detection cores 
Block 
Power consumption (W) 
Traditional Low-power  
Acquisition front-end 24 µ 6.70 µ 
Amplitude detector 22.8n 11.4n 
Frequency detector 25.2n 12.6n 
Digital demodulator 0 12.6n 
Seizure decision 10.96n 5.48n 
Total system 24.06µ 6.74 µ 
 
Table 3.2 show the comparison between a traditional and low-power detection core. Overall, 
the new preamplifier (Figure 3-5(b)) has lower power consumption (6.70 µW) and improved 
input-referred noise (6 µVrms) in 17 kHz (2 kHz to 19 kHz) bandwidth. The amplified modulated 
signal rectified the negative side of signal and passed through two ADs with variable threshold 
voltages ViHET1,2. The digital demodulator translated the signal back to baseband and later, the FDs 
detected seizure frequency by measuring fast activities in time frame Tf_i. The Tf_i and ViHET1,2 can 
be tuned to the specific seizure onset frequency of a patient so that no false alarms occur during 
signal monitoring.  
3.4.1.2 Controller of detector 
The detection core has several tuneable parameters that are personalized in a specific manner to 
prevent false seizure detections. The controller of detector (Figure 3-4) provides digitally-
controlled high precision signal to adjust SD. The controller comprises digital-to-analog converter 
(DACD,i), buffers (BFD,i), and oscillator (OLT1). Figure 3-4 shows that the controller receives 48 
bits serial input Data_SD to adjust 6 tuneable parameters (6 x 8 bit) of the detection core.  
3.4.2 Electrical stimulator 
The ES has two operating modes: sleep and active mode. During the icEEG monitoring period, 
the ES stays in sleep mode to improve power management techniques. The detection signal of SD 
(VSOD) interrupts control unit to active mode and generates predefined stimulation waveforms 
(Figure 3-6). Figure 4 shows that the entire ES is partitioned into several parts. Control unit of the 
ES reduces the switching on clock networks and saves power consumption. Optimization of the 
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Figure 3-6: Flow chart of electrical stimulator 
 
clock routing power allows to enable those portions of the clock network that are required to feed 
downstream registers. Furthermore, power is reduced by gating clocks when they are not needed. 
Moreover, discrete components of the output stage have shutdown mode that reduce further 
power dissipation. The output stage maintains constant current amplitude and delivers a burst of 
electrical stimulations to the brain tissue. A miniaturized ES with wireless system was introduced 
in our previous work for dysfunctions of the lower urinary tract (MOUNAIM, 2007). In this paper, 
internal structure of the ES has been modified to adapt in the CLNS and the ranges of stimulation 
parameters of ES were changed to Table 3.1 for the treatment of epilepsy. Further details of the 
control unit and output stage are described below. 
3.4.2.1 Control unit 
The control unit of the CLNS is based on a commercially available FPGA and the achieved 
prototype of ES has been made using one of latest FPGA (Ex256).  The miniaturized FPGA 
facilitates low-power multi-function features. Moreover, external controller provides energy and 
transmits data to the implanted CLNS by means of inductive coupling of spiral antennas. The 
power recovery module rectifies and filters the carrier signal to provide different regulated power 
supplies for the implant. The receiver demodulates and sends the Manchester-coded data to the 
control unit. Details of the power recovery and receiver are described in our previous works 
(FAYCAL, 2009). The flow chart of the control unit (Figure 3-6) shows that the control unit 
remains idle unless the data entry or seizure detection signal interrupts it. The control unit is 
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Figure 3-7: Timing process of electrical stimulation waveform using variable parameters 
responsible for receiving input parameter values for seizure detections (Data_SD) and electrical 
stimulations (Data_SD and SWs). The control unit stores the parameters in memory and loads into 
the detector and stimulator. There are five variable parameters in ES: stimulation duration (T1), 
relax time (T2), stimulation frequency (FES = 1/ T3), pulse width (T4), and stimulation current 
(ISTIM). Figure 3-7 shows the time process of electrical stimulation with variable parameters. The 
stimulation duration is defined with the number of stimulation pulses NT and T1 = NT x T3, where 
T3 ≥ 6 T4.   
3.4.2.2 Output stage 
The output stage retrieves stimulation parameters from the FPGA (stored in Data_ES and 
SWs), generates biphasic stimulation waveform, and injects to the EZ through the subdural 
electrodes or to the anterior thalamic nucleus (ATN) by way of depth electrodes. The output stage 
includes a digital-to-analog converter (DACS) and a current amplifier (CAM) and three sets of 
synchronous CMOS analog switches to direct the stimuli (Figure 3-8(a)). At first, the VSOD signal 
interrupts the FPGA to send the amplitude code stored in Data_ES to DACS. The output voltage of 
DACS is converted into a proportional current (ISTIM) by the CAM and R1 resistance. The injected 
current ISTIM is limited by the R1. Figure 3-8(b) shows that the analog switches manipulate constant 
current (ISTIM1 = ISTIM and ISTIM2 = ISTIM/4) and generate biphasic stimulation waveform ISTIM 
across the two electrodes. Switches SW1 and SW2 set the stimulation current direction and SW3 
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Figure 3-8: Output stage of the CLNS: (a) block diagram of output stage and (b) control 
signals sequence of switches to generate biphasic stimulation waveform. 
 
bypasses high transient current (glitch) of the biphasic stimulation. Moreover, SW3 switch shunts 
the CAM output with its negative input before SW1 and SW2 activation and confirms the 
appearance of appropriate stimulation parameter on both electrodes before releasing the SW3 
switch. 
3.5 EXPERIMENTAL AND CLINICAL RESULTS  
The CLNS is assembled into two PCBs (Figures 3-9(a) and (b)). The ES is designed in two 
20mm diameter circular shape blocks in a PCB. The top part of the ES PCB (Figure 3-9(a)) 
contains a spiral antenna, the power and data recovery stages described in (MOUNAIM, 2007). 
The bottom part of the ES PCB shows the output stage and its opposite side is the control unit of 
the ES. On the other hand, the SD is designed in 60mm diameter PCB. The controller of detection 
is shown in Figure 3-9(b) and the zoom inset shows the detection core, located on the opposite 
side of Figure 3-9(b). The detection core was fabricated in a CMOS 0.18-µm process and 
occupied 2 mm2 of silicon area. Figure 3-9(c) shows photographs of the fabricated chip assembled 
in a package and zoom inset of the figure shows the fabricated detection core. Details of the 
measurement and validations are described below.    
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Figure 3-9: The proposed CLNS device: (a) is ES PCB and zoom inset shows opposite side; (b) 
is SD PCB; and (c) is detection core attached in opposite side of (b); and zoom inset of (c) shows 
photograph of detection core chip. 
3.5.1 Circuit Measured Performance 
Measurements on each block of the CLNS were done separately. The detection core of the SD 
was tested on ten samples of the fabricated chip and provided consistent results. Figure 3-10 
shows measured digitally controlled waveforms of Tf_i, FS, and ViHET1,2. Figure 3-10(a) illustrates 
the variation of FS from 985 Hz to 5.12 kHz and the corresponding generation of Tf_i from 1.6 sec 
to 16.63 sec. Figure 3-10(b) shows that the value of ViHET1,2 can be controlled from 18 mV to 588 
mV. On the other hand, in the ES, stimulation current was delivered to a 1 kΩ load and Figure 3-
10(c) demonstrates the range of ISTIM (17 µA to 42 mA) with 164 µA resolution. The detailed 
measured power consumption of the CLNS is shown in Table 3.3. Table 3.4 presents 
measurements of widely variable stimulation parameters (ISTIM, T1, T2, T3, and T4).  
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Table 3.3:Measured power consumption (PC) of CLNS 
System Blocks PS
a 
(V) 
     Component  PC 
(mW) Name Commercial 
name 
 
SDb 
Detector 
core 
1.8 
Preamplifier  
0.05 Seizure activity detector High frequency detector 
Others  
Controller 3.3 
DACD,i DAC0845  
BFD,i LM324 1.5 
OLT1 LTC6900 
 
 
ESc 
Control 
unit  FPGA Ex 256  
(S
le
ep
) 
(A
ct
iv
e) 
Output 
stage 
3.3 
DACS MAX550 
 
 
 
2 
 
20 SW 
MAX4678 
OLT2 LTC6900 
  CAM LT1806   
CLNSd 
IcEEG monitoring (sleep) mode  4 
Stimulation (active) mode  22 
aPS: Power supply, bSD: Seizure detector, cES: Electrical 
stimulator, and dCLNS: Closed-loop neurostimulator. 
 
 
Figure 3-10: Digitally controlled measured results: (a) time frame Tf_i generation using sampling 
frequency FS; (b) threshold voltage Vi,HET1,2; and (c) output stimulation current ISTIM. 
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Table 3.4: Measured stimulation parameters of the electrical stimulator. 
Parameter Variable Variable 
size (bit) 
       Values 
Min Max 
Number of stimulation N T 10 1 1023 
Duration of stimulation T1 - 1 ms 1min 54 sec 
Relax time T2 18 1 s 4.36 min 
Stimulation Frequency T3 4 1ms 15 ms 
Pulse width T4 10 12 µs 12 ms 
Stimulation current ISTIM 8 7 µA 42 mA 
 
3.5.2 Method of case studies and validation 
This study was conducted at Notre-Dame Hospital, Centre Hospitalier de l'Université de 
Montréal (CHUM) with approval from the CHUM ethical committee and research ethics 
committee of Ecole Polytechnique. This study included seven patients (age: 15 to 49) with 
refractory epilepsy who underwent an intracranial study to better delineate the EZ. Through a 
craniotomy window, a combination of depth and subdural (strip and/or grid) electrodes were 
implanted over suspected areas of epileptogenicity. Following the implantation of intracranial 
electrodes, the patients underwent long-term (~3 weeks) video-icEEG monitoring (using Stellate’s 
EEG system) in the epilepsy monitoring unit waiting for spontaneous seizures to occur. A post-
implantation MRI was used to reconstruct a 3-D representation of electrode positions (using 
Stellate’s gridview software) (Figures 3-11(a)-(c)). Recorded seizures were carefully analyzed to 
delineate the EZ. For each seizure, onset was marked by an epileptologist (DKN) (yellow marker 
shown in Figure 3-11(d)).  The recordings from the contacts (Figure 3-11(c)) showing earliest ictal 
changes were fed into the CLNS. Figure 3-11(e) shows the validation procedure. The icEEG 
recordings from the two contacts positioned over the EZ (Figure 3-11(c)) were selected, 
transferred to the signal conditioner and then to the CLNS for detection and triggering of a 
predefined electrical stimulation.   
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Figure 3-11: Case study and validation method: (a) - (b) 3-D reconstruct images of implanted 
electrodes using Stellate’s gridview software; (c) identify epileptogenic zones; (d)  icEEG 
recordings from the zone; and (e) the icEEG recording from the epileptogenic zone of patients 
were used to test the proposed seizure detector and the triggering of predefined electrical 
stimulation was validated. 
Table 3.5: Seizure detection performance on seven patients and  
average seizure detection delay (TDET) 
Case 
No. 
Age 
/Gender Epileptogenic zone 
Average 
TDET (sec) 
1 36/M Left lateral temporal 15 
2 44/M Left premotor cortex 15 
3 41/M Right amygdala/ hippocampus  21 
4 49/F Left hippocampus 12 
5 32/M Left hippocampus 12 
6 15/M Right lingual gyrus 20 
7 24/M Right hippocampus 6 
 
3.5.3 Validation of the closed-loop neurostimulator 
For each patient, the icEEG recording was fed into the CLNS. Input signals were sampled and 
modulated at FS, amplified, filtered and analyzed in time-frequency and time-amplitude domain 
in order to detect seizure. The CLNS was tested on an average of six seizures per patient and 
results are shown in Table 3.5. The CLNS detected the electroclinical seizures of the seven 
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Figure 3-12: Measured electrical stimulation process triggered by seizure onset detection, where 
Vin is icEEG of seizure from epileptogenic zone, VSOD is seizure onset detection, VST is electrical 
stimulation period (offline), zoom inset shows stimulation waveforms, and VNS is no stimulation 
period. 
patients an average of 14.4 sec after seizure onset, well before visible clinical manifestation. 
Figure 3- 12 shows the seizure detection on icEEG recordings (Vin) from a patient (cases 1 in 
Table 3.5) and the seizure detection delay TDET = 6.4 sec on VSOD, well before clinical 
manifestation onset. In this study, the CLNS was set to ignore the many BES as the clinician 
judged them to be too short and frequent, and not always leading to clinical manifestations. In 
response to the early detection of seizure development VSOD, a burst (T1 = 1.3 sec) of 198.4 Hz 
bipolar biphasic stimulation was administered and no stimulation period VNS began right after the 
stimulation period (Figure 3-12). However, the proper stimulation parameters need to be 
individualized during the presurgical icEEG study for maximum efficacy prior to the implantation 
of a stimulation device. Power consumption of the CLNS was dominated by the stimulation 
current and waveforms; however 4 mW power was continuously dissipated by the CLNS in sleep 
mode. Power dissipation densities (δP) of the seizure detector and electrical stimulator were under 
maximum safety level (δPmax = 6mW/cm2 that may cause enough heat to damage surrounding 
tissue) (HARRISON, 2008). Figure 3-13 (a) – (b) illustrate devices operation modes in icEEG 
recording and corresponding average δP. 
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Figure 3-13: Demonstration of power dissipation of proposed CLNS: (a) Electrographic seizure in 
icEEG recording and (b) Power dissipation densities δP of the devices. 
 3.5.4 Performance analysis of the proposed CLNS 
Detection performance of the proposed detector based on seven patients with refractory 
epilepsy and all the detection performed before clinical manifestation. This performance was 
evaluated in terms of power consumption and sensitivity of the detector. This detector has 
performed better than feature extraction process (FEP) (VERMA, 2010), dual-path detector (DPD) 
(SAFI-HARB, 2011), event-based seizure detector (ESD) (RAGHUNATHAN, 2009), cascaded 
two-stage seizure detector (CSD) (RAGHUNATHAN, 2011), and linear discriminant analysis 
classifier (LDA) (PATEL, 2009). Figure 3-14 illustrates the comparative analysis and it shows that 
the power consumption of the proposed detector is lower and sensitivity of the detector is higher 
than (VERMA, 2010; SAFI-HARB, 2011; RAGHUNATHAN, 2009; RAGHUNATHAN, 2011; 
PATEL, 2009). Moreover, the proposed detector demonstrates the use of different effective 
detection parameters for creating several decision boundaries and reduces the number of false 
detections for the patient’s specific seizure onset pattern while enhanced the sensitivity. The 
detector can categorize different electrographic icEEG patterns (e.g. normal neural activity, low-
voltage fast activity, slow spike wave, brief electrical seizure, artifact, and progressive amplitude 
increase signal) and identify the specific electrographic pattern at the seizure onset without 
having false detection.  
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Figure 3-14: A comparative analysis of the proposed results (based on 7 patients) from different 
detectors. 
There has been very few electrical stimulator reported for suppressing upcoming seizure. The 
pilot study (KOSSOFF, 2004; OSORIO, 2005) was done using a large constant current stimulator 
(S-12; Grass Instruments). Neuropace Inc. (Mountain View, California, US) has a responsive 
neurostimulator (RNS) system and investigation on the device is evaluated in clinical trials 
(SKARPAAS, 2009). The detection algorithm of RNS system is based on data reduction (line 
length function and area under the curve) and feature extraction (half wave analysis). However, 
the proposed seizure detection is based on noise reduction (modulation), feature extraction 
(progressively increasing low-voltage fast activity), and data reduction (digitally demodulation). 
The detection criteria of RNS system are based on high frequency tracking of amplitude variations 
in icEEG recording, but the proposed algorithm detects progressively increase signal amplitude as 
well as high-frequency signal in icEEG. Furthermore, Neuropace Inc. has not yet to publish the 
hardware description, detection performances and power consumption of their RNS system. A 
microcontroller based stimulator (NIRO, 2007) has been proposed for brain stimulation, but its 
power consumption is also unknown. Power consumption of the proposed ES is dominated by the 
stimulation parameters and would vary from patient to patient.  
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3.6 CONCLUSION 
In this paper, we present an implantable low-power closed-loop neurostimulator for the 
treatment of epilepsy. This device records icEEG activity, analyzes the signal in time-frequency 
and time-amplitude domains, and triggers a predefined seizure suppression biphasic electrical 
stimulation. The proposed CLNS uses low-power management technique. The neural signal 
amplifier and seizure detector consumes 6.74 µW, while power consumption of ES mainly 
depends on electrical stimulation parameters. The tuneable patient-specific parameters of SD and 
ES can be adjusted wirelessly. The performance of the CLNS was tested in seven patients with 
refractory epilepsy and the early detection of seizure was able to trigger subsequent responsive 
electrical stimulation.     
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CHAPTER 4  IMPLANTABLE CLOSED-LOOP EPILEPSY 
PROSTHESIS 
We presented a responsive neurostimulator for the treatment of epilepsy in chapter 3 and this 
chapter concerns another neurostimulator which has lower power consumption, wider range of 
features, better precision, and larger memory.  This chapter also demonstrates effect of focal 
bipolar electrical stimulation and corresponding spatial voltage distribution in an in vitro 
morphologic electrical model. The experimental results show the optimum stimulation parameters 
for efficiently affecting the suspected epileptic focus. This work will be appeared in “ACM 
Journal on Emerging Technologies in Computing Systems” as reproduced in the following papers. 
 
 
4.1 IMPLANTABLE CLOSED-LOOP EPILEPSY PROSTHESIS: 
MODELING, IMPLEMENTATION AND VALIDATION 
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2Notre-Dame Hospital, Centre Hospitalier de l'Université de Montréal (CHUM), Québec, Canada 
 
Publication to appear in: ACM Journal on Emerging Technologies in Computing Systems, Special 
Issue on Implantable Electronics, Vol. 8, No 1, February 2012 
 
Abstract - In this paper, we present an implantable closed-loop epilepsy prosthesis, which is 
dedicated to automatically detect seizure onsets based on intracerebral electroencephalographic 
(icEEG) recordings from intracranial electrode contacts and provide an electrical stimulation 
feedback to the same contacts in order to disrupt these seizures.  A novel epileptic seizure 
detector and a dedicated electrical stimulator were assembled together with common recording 
electrodes to complete the proposed prosthesis. The seizure detector was implemented in CMOS 
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0.18-µm by incorporating a new seizure detection algorithm that models time-amplitude and -
frequency relationship in icEEG. The detector was validated offline on ten patients with 
refractory epilepsy and showed excellent performance for early detection of seizures. The 
electrical stimulator, used for suppressing the developing seizure, is composed of two biphasic 
channels and was assembled with embedded FPGA in a miniature PCB. The stimulator efficiency 
was evaluated on cadaveric animal brain tissue in an in vitro morphologic electrical model. 
Spatial characteristics of the voltage distribution in cortex were assessed in an attempt to identify 
optimal stimulation parameters required to affect the suspected epileptic focus. The experimental 
results suggest that lower frequency stimulation parameters cause significant amount of shunting 
of current through the cerebrospinal fluid; however higher frequency stimulation parameters 
produce effective spatial voltage distribution with lower stimulation charge.    
 
4.2 INTRODUCTION 
Over the last 20 years, there have been many advances in the treatment of epilepsy. 
Antiepileptic drugs remain the first line of treatment albeit with side effects in a significant 
number of patients. Furthermore, approximately a third of ‘refractory’ patients fail to be controlled 
despite several antiepileptic drug trials. These patients with pharmacoresistant epilepsy can 
sometimes be helped by resective epilepsy surgery. Unfortunately, not all are good candidates for 
epilepsy surgery such as patients with a poorly delineated epileptogenic zone, multiple epileptic 
foci or an epileptogenic zone overlying eloquent areas (language, motor, visual) which cannot be 
removed (JEROME, 2009; SPENCER, 2009).   
Recently, there has been a growing interest to fill the gap between antiepileptic drug therapy 
and epilepsy surgery. Several research groups have explored treating conventionally untreatable 
epilepsies with non-resective therapeutic alternatives (e.g. vagus or trigeminal nerve stimulation 
(RYCHLICKI, 2006; SETHI, 2008; REESE, 2009); focal cooling (GUERRA, 2005), focal drug 
delivery (STEIN, 2000) or electrical stimulation (FISHER, 2010)). Recent studies have shown that 
electrical stimulation is effective in reducing seizure frequency (FISHER, 2010; OSORIO, 2005; 
SKARPAAS, 2009; NIRO, 2007; KOSSOFF, 2004). There are two main approaches to brain 
stimulation: open loop (FISHER, 2010; SETHI, 2008; REESE, 2009; RYCHLICKI, 2006) and 
closed-loop neurostimulation (OSORIO, 2009; SKARPAAS, 2009; NIRO, 2007). The open loop 
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system consists in scheduled delivery of stimulation. Whereas in a closed-loop system, 
stimulation is only triggered upon detection of a seizure. Closed-loop stimulation has several 
potential advantages over the open-loop method such as lower number of stimulations, higher 
efficiency because of rapid access, and ability to review intracerebral electroencephalographic 
(icEEG) recordings to monitor seizure frequency (OSORIO, 2009; SKARPAAS, 2009; 
SCHACHTER, 2009; SUN, 2008). A closed-loop system requires an efficient seizure detector to 
identify seizures at their onset and trigger an abortive stimulation before clinical manifestations 
occur. Although many seizure detection algorithms have so far been proposed (ZANDI, 2009; 
NANDAN, 2009; POLYCHRONAKI, 2010), these have mainly been developed for high-speed 
desktop computers and short-term applications which cannot be employed in a low-power 
implantable microchip (SALAM, 2010(a)). Further development in epileptic prosthetic devices 
would benefit from an epileptic seizure detection algorithm for low-power integrated circuits that 
could provide high-detection accuracy and reduce instrumentational low-frequency noises 
(SALAM, 2009(a); RAGHUNATHAN, 2009; PATEL, 2009; SALAM, 2010(b); VERMA, 2010).  
In addition to the seizure detection performance of such a closed-loop system, the safety of 
focal electrical stimulation and choice of electrical stimulation parameters are also important 
issues. Proof-of-concept experiments conducted in animals and humans have demonstrated that 
limiting the maximum charge density to 60 µC/cm2 per phase can avoid tissue damage 
(SKARPAAS, 2009; GORDON, 1990). It remains unclear however how selected parameters at 
specific anatomical locations affect the electric field strength and modulate pathological neural 
activity. Traditionally, stimulation parameters have been determined empirically: tune the 
parameters (i.e. current, pulse width and frequency) in order to achieve best possible seizure 
suppression parameters (SUN, 2008; OSORIO, 2009; FISHER, 2010). But these parameters vary 
from patient to patient possibly due to the variability of the epileptogenic zone localization: depth 
of sulcus, superficial cortex, deep hippocampal focus etc. In other words, the optimal parameters 
may depend on the location of epileptogenic zone being stimulated (SRAMKA, 1990). Electric 
field distribution is difficult to predict (i.e. which area is directly affected by the stimulation). 
Several simulation models of cerebral cortex and subcortical structures (thalamus and 
subthalamic nucleus) have been proposed to estimate the charge density (CHRISTOPHER, 2008; 
NATHAN, 1993; AGARWAL, 1994; RAYPORT, 1969; BUTSON, 2008) and voltage 
distribution (MIOCINOVIC, 2009; CAMERON, 2004; RAYPORT, 1969). The subcortical 
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structure model for the treatment of Parkinson’s disease is well established and validated in vitro 
and in vivo (LESTER, 2009; BLAD, 2007; BUTSONA, 2006; KUNCEL, 2006; MCINTYRE, 
2004). However, a cerebral cortex structure model for the treatment of epilepsy is not well 
established. Lack of model validation is a drawback for choosing effective seizure suppression 
stimulation parameters. Moreover, several others aspect need to be addressed, such as stimulation 
mode, current distribution, shunting of injected current, and impedance of cerebral tissue.  
In this paper, we present an implantable epilepsy prosthesis that identifies electrographic 
seizure onsets and triggers focal electrical stimulation to disrupt seizure progression. We also 
demonstrate spatial characteristics of voltage distribution in cerebral cortex generated by the 
electrical stimulation. The proposed device includes intracranial electrodes, a data acquisition 
system, a digital signal processor for real-time seizure detection, and a programmable electrical 
stimulator. The integrated seizure detection algorithm has high detection sensitivity for patients’ 
specific seizure patterns, and low false detections. The seizure detector was validated on different 
platforms (Matlab, Cadence post-layout CMOS 0.18-µm circuit simulation and fabricated chip).  
The electrical stimulator was built around an FPGA platform and allows tuning all parameters of 
the employed biphasic stimulus. The proposed device was validated using recorded icEEG from 
ten patients with refractory partial epilepsy. Furthermore, the electrical stimulator was tested on 
cadaveric animal brain tissue in an in vitro morphologic electrical model. The experimental data 
showed that high frequency stimulation parameters provided optimal spatial voltage distribution in 
gray matter.   
The remaining of this paper includes Methods and Materials in section 2. Results are reported 
in section 3, and Conclusions are the subject of section 4. 
4.3 METHODS AND MATERIALS 
4.3.1 Patient selection and device validation method 
More than half of epilepsy patients suffer from partial (focal) seizures and a non-negligible 
percentage of them are drug resistant. In a partial seizure, the ictal discharge originates from a 
seizure onset zone which frequently will not lead to any overt clinical manifestations unless it 
builds up to involve a larger area (the symptomatic zone). Further propagation ipsilaterally and 
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controlaterally may lead to the most commonly known and most bothersome ictal manifestation: 
tonic-clonic convulsions. 
Patients with intractable non-lesional partial epilepsy who are candidate for epilepsy surgery 
may sometimes require an intracranial study to better delineate their epileptogenic zone. Through 
a craniotomy window, a combination of depth and subdural (strip and/or grid) electrodes are 
implanted over suspected areas of epileptogenicity. Following the implantation of intracranial 
electrodes, patients are then transferred to the epilepsy monitoring unit for long-term (~2-3 weeks) 
video-icEEG recording of spontaneous seizures. Once the epileptogenic zone is adequately 
delineated, the patient returns to the operating room for the removal of electrodes and resection of 
the identified epileptogenic zone. During this evaluation with intracranial electrodes, 128 channel- 
icEEG recordings are performed using amplifiers (PRO-36 amplifiers, Stellate Harmonie System) 
at 200 Hz and 2000 Hz sampling frequency.   
The icEEG seizure recordings used for the validation of the proposed closed-loop epilepsy 
prosthesis came from such patients undergoing an invasive EEG study. Offline recordings from 
two contacts positioned over the epileptogenic zone are selected, uploaded onto a signal 
conditioner (arbitrary signal waveform generator) for reproducing icEEG recording and fed into 
the closed-loop epilepsy prosthesis for detection by the seizure detector which is supposed to 
trigger a burst of electrical stimulation on a cadaveric animal brain tissue in vitro model (Figure 4-
1). During the stimulation, voltage recording is performed in the vicinity of the active subdural 
electrodes implanted on the cerebral cortex. 
 
 
Figure 4-1: The closed-loop epilepsy prosthesis: icEEG recorded from patients with medically 
refractory epilepsy were used to test our seizure detection algorithm and the triggering of an 
electrical stimulation to cadaveric animal brain tissue.   
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4.3.2 Proposed closed-loop Epilepsy prosthesis 
 The proposed implantable closed-loop epilepsy prosthesis provides continuous long-term 
monitoring from epileptogenic zone. Figure 4-2 illustrates the implant configuration. The device is 
intended to be implanted within the skull and interface directly with the recording/stimulation 
sites. This device is composed of two main parts: 1) a seizure detector, and 2) an electrical 
stimulator. 
 
Figure 4-2: Illustration of the proposed implantable closed-loop epilepsy prosthesis. 
4.3.2.1 The Seizure Detector 
The seizure detector is based on a detection algorithm first validated in Matlab, followed by 
circuit validation using CMOS 0.18-µm technology under Cadence environment and chip 
fabrication by TSMC through CMC Microsystems. Features of the device are described below. 
The implemented algorithm detects seizure onsets before first clinical manifestations. 
Electrographically, several patterns can be seen at seizure onset such as low-voltage fast-activity, 
high-voltage fast-activity or rhythmic spiking (SPENCER, 2009). The proposed epileptic seizure 
detection algorithm is designed to detect partial seizures characterized by a progressive increase of 
low-voltage fast-activity on icEEG recordings. This detection algorithm is illustrated in Figure 4-
3. At first, the recorded icEEG is modulated into high frequency (Fs = 1/Ts) and the discrete 
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modulated signal (Vmod) is confined to a time frame (Tf). Later, Vmod passes through several voltage 
level detectors (VLD) to detect the progressive increases of signal amplitude. The threshold 
voltages of VLD (ViHET1,2) are adjusted to the amplitude levels of interest for each individual 
patient. The outputs of VLD (VSDi) are demodulated to the original frequency band and analyzed 
in frequency domain. The real-time signal frequencies fsi in different amplitude level are compared 
to the specific seizure onset frequency (fSZ) of a patient to declare the start of a seizure.  The 
sensitivity and specificity of the algorithm is dependent on the optimal values of ViHET1,2 and Tf 
(SALAM, 2009(b)).  
 
Figure 4-3: Flowchart of the proposed epileptic seizure detection algorithm, tuneable parameters, 
and block diagram of the proposed detection system. 
 
The functional block diagram of the implemented detector is shown in Figure 4-3 (detection 
system). This detector consists of a modulator, a seizure activity detector, and a high frequency 
detector. Several variable parameters (Ts, ViHET1,2 and Tf) are introduced to facilitate high accuracy 
in real-time seizure onset detection (SALAM, 2009(b)). 
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For the modulator, four synchronous switches modulate the icEEG signal and translate the 
signal into high frequency (Fs). Therefore, signal processing of icEEG in circuits is not effected by 
flicker noise, thermal noise and DC offset.  
The seizure activity detector contains a preamplifier, comparators, and logic gates. The 
preamplifier consists of a low-power low-noise amplifier and a high-pass filter. The preamplifier 
has a 80 dB midband gain and 17 kHz (2 kHz to 19 kHz) bandwidth with 6µVrms input-referred 
noise. Moreover, the gain of the preamplifier is variable and a certain amplitude range of the input 
signal can be amplified. Two comparator and logic gates are used to construct a voltage level 
detector (VLD) that detects the progressive increase of signal amplitude.  
The high frequency detector (HFD) consists of a demodulator, counters and logic gates. The 
demodulator comprises RC circuits and a VLD that digitally demodulate the signal to the original 
frequency band. The frequency detector is composed of counters and logic gates that could declare 
the start of a seizure by detecting the high frequency signal on icEEG. 
4.3.2.2 The Electrical Stimulator 
Several versions of a dedicated electrical stimulator were introduced in our laboratory for the 
treatment of epilepsy (SALAM, 2010(c); SALAM, 2011(d)). The closed-loop stimulator 
(SALAM, 2010(a)) was simulated on CMOS 0.18µm and only simulation results were reported. A 
FPGA based stimulator was implemented in an Actel EX256 embedded system (SALAM, 
2011(d)), which was replaced by a low-power FPGA device, the Actel igloo AGL125. In addition 
to small dimensions and low-power consumption, the Igloo devices have larger memory and 
higher number of logic gates. Therefore, the stimulator integrated in the proposed device has a 
wide range of parameters, higher precision and more flexibility in data manipulation.  
Concerning the stimulation parameters, different cortical electrical stimulation strategies 
employing several types of stimuli have been shown feasible, safe, tolerable, and efficient 
(FISHER, 2010; OSORIO, 2005; SKARPAAS, 2009; NIRO, 2007; KOSSOFF, 2004). The 
proposed stimulator generates charge-balanced asymmetric biphasic stimulation through bipolar 
platinum electrodes; thus it reduces electrochemical processes and avoids damaging brain tissues 
(MERRILL, 2005; OSORIO, 2005). Moreover, the bipolar stimulation can effectively produce 
localized current flows (NATHAN, 1993) in specific region. Table 4-1 shows main parameters 
and their values for the proposed stimulator. 
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Table 4.1: Available parameters in the proposed electrical stimulator 
Parameter Variable Value Parameter Variable Value Min Max Min Max 
Number of 
stimulation 
N 1 1023 Duration of 
stimulation 
T1 2 
msec 
10 sec 
Off time T2 1 min 4.26 min Stimulation 
Frequency 
T3 2 
msec 
10 msec 
Pulse 
width 
T4 10 µsec 12 msec Current ISTIM 10 µA 40 mA 
Figures 4-4 (a) – 4(d) demonstrate the timing process of the stimulator in the response to 
seizure detections VSOD. The duration of current stimulation (ISTIM) is T1; if the stimulation does 
not terminate the seizure another stimulation is triggered by the detector after T2. Repetition of 
stimulation is subject to a safety constraint of no more than five stimulations per detection 
(OSORIO, 2005; SKARPAAS, 2009). Figure 4-4(d) shows that the cathodic pulse (IS1) of the 
biphasic stimulation activates the neural cells and the anodic stimulus (IS2=IS1/4) removes the 
delivered charges of IS1. However, two subsequent opposite stimuli could prevent the generation 
of an action potential. Thus, a short time delay (T4) in between the pulses is required to propagate 
the action potential away from the stimulation site before removing the injected charge 
(RUBINSTEIN, 2001; CONSTANDINOU, 2008).  
 
Figure 4-4: Proposed electrical stimulator: (a) seizure detections VSOD (b) two subsequent bursts 
of biphasic stimulations, (c) the biphasic stimulation, (d) the stimulation waveform profile, and (e) 
block diagram of the stimulator. 
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The stimulator also includes a stimuli generator, which is composed of a memory, a waveform 
generator, a frequency controller, and a digital multiplexor (MUX) (Figure 4-4(e)). The memory is 
used to store all parameters for the seizure detector and electrical stimulator. The waveform 
generator controls the stimulation duration (T1), rest time (T2), stimulation frequency (T3), pulse 
width (T4), and stimulation current (Istim). The stimuli generator remains in standby mode unless 
data entry or a seizure detection signal interrupts it. The memory receives the input data by serial 
protocol interface.  
Finally, the output stage includes a digital-to-analog converter (DAC), a current source, and 
several switches. The DAC receives 8-bit data of Istim from the stimuli generator and outputs the 
stimulation current (Is1 or Is2). The switches generate biphasic simulation waveforms across the 
bipolar electrodes. Moreover, the stimuli generator controls the stimulation duration (T1) and the 
rest time (T2). 
4.3.2.3 Circuits and devices implementation 
The detection algorithm was tested in Matlab tools and post-layout circuit simulation (PLCS). 
Then, the seizure detector was fabricated in a CMOS 0.18-µm process, occupying a 2 mm x 1 mm 
silicon area. The electrical stimulator was assembled on 20-mm diameter circular printed circuit 
board (PCB). Photographs of the chip layout, the fabricated chip and electrical stimulator are 
shown in Figures 4-5 (a), (b), and (c), respectively. 
 
Figure 4-5: Photographs of main parts of the system: (a) Layout of chip, (b) Fabricated chip, and 
(c) Electrical stimulator and zoom inset shows FPGA in the opposite side. 
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4.3.3 Seizure detection from icEEG recordings 
Ten patients (age: 15 to 49) with intractable nonlesional partial epilepsy candidate for epilepsy 
surgery underwent an intracranial study (Figures 4-6(a) – (b)) to better delineate the epileptogenic 
zone. A combination of depth, subdural grid and strip electrodes were implanted in various 
suspected areas of epileptogenicity. Following the implantation, patients underwent a magnetic 
resonance imaging (MRI) study to verify the location of implanted electrodes (Figures 4-6 (c) – 
(d)). All icEEG recordings were reviewed by an epileptologist (DKN) who marked the onset of 
electrical and electroclinical seizures (e.g. yellow mark ‘Seizure’ shown in Figure 4-6(e)). The 
recorded seizure was electrically characterized by a diffuse slow wave followed by 
desynchronization (Figure 4-6(e)) and regional low-voltage high-frequency activity over temporal 
neocortical contacts (Figure 4-6(d)). The electroclinical seizures could be preceded by low-
frequency preictal spiking, high-frequency preictal spiking or even a brief electrical seizure (BES). 
The recordings from the contacts showing the earliest ictal changes were fed into the proposed 
seizure detection algorithm (Matlab software) and seizure onset detector (CMOS 0.18 µm 
process). The detection performances of Matlab analysis, PLCS and fabricated chip measured 
results are presented.   
 
Figure 4-6: Method of case studies: (a)-(b) is an intracranial study for better delineate the 
epileptogenic zone, (c) is axial MRI image and (d) is 3-D reconstruction of implanted electrodes, 
and (e) electrical seizure onset was marked (‘Seizure’) on icEEG. 
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4.3.4 In Vitro Experiments 
The in vitro experiments were performed by suspending a subdural strip electrode (Ad-tech, 
Inc.) on a cadaveric animal brain tissue in saline solution (Figure 4-7(a)). The conductivity of 
saline solution is 17 mS/cm, which is similar to conductivity of cerebrospinal fluid (CSF) 
(MANOLA, 2005). The conductivity of the gray matter of the cadaveric animal brain tissue varies 
from 1.4 mS/cm to 4 mS/cm. Figure 4-7(a) shows the interface between brain tissue (i.e. gray 
matter) and the subdural electrodes (i.e. platinum electrode, medical grade Polydimethylsiloxane 
(PDMS) and stainless steel wire). The equivalent electrical equivalent circuit model for Figure 4-
7(a) is shown in Figure 4-7(b), where Rwi is wire resistance, Rpi is polarized resistance of 
electrolyte; Cpi is double layer capacitance, RCSF is resistance of saline solution, RGM is resistance 
of gray matter, and CGM is capacitance through gray matter. Resistance of CSF is 3 to 12 times 
lower than the gray matter (NATHAN, 1993; AGARWAL, 1994; MANOLA, 2005). Thus a 
bipolar stimulation causes significant shunting of current through the CSF at low frequency 
stimulation. However, stimulation at high frequency reduces impedance (RGM || CGM) through the 
gray matter and decreases the shunting of current. 
 
Figure 4-7: in vitro voltage recordings using a cadaveric animal brain tissue in saline solution: (a) 
Experimental setup, (b) Equivalent electrical circuit model of (a), and (c) spatial voltage 
distribution were recorded in 1 mm (VG1), 2 mm (VG2) and 3 mm (VG3) distance. 
 
Biphasic constant-current pulse trains were applied through the subdural electrodes and 
voltages generated in gray matter of brain were recorded with commercial microelectrodes (FHC 
Company). The microelectrodes were positioned at 1 mm, 2 mm and 3 mm outer radius of the 
stimulating electrodes and similarly underneath, 1 mm distance interval up to 3 mm (Figure 4-
76 
 
7(c)). During the stimulation with different parameters, voltage distribution at 1 mm (VG1), 2 mm 
(VG2) and 3 mm (VG3) were recorded to characterize the stimulations effect on different areas. 
 
4.4 RESULTS 
4.4.1 Power dissipation of the proposed device 
Measured power consumption of the proposed system is shown in Table 4-2. Power 
measurements in simulation platform were undertaken separately on each block. The core seizure 
detector consumed 6.71 µW in PLCS, whereas fabricated detector chip assembled in the closed-
loop device consumed 51 µW due to the loading of electrical stimulator, adjustable circuits of the 
detection parameters and parasitic effects. The detection core was always in active mode due to 
the continuous icEEG monitoring (Table 4-2). The achieved prototype of stimulator has been 
made using one of the latest FPGA (AGL125). Power consumption of the stimulator was 
dominated by the stimulation current; however 2 mW power was continuously dissipated by the 
FPGA in standby mode. Power dissipation densities (δP) of the seizure detector and electrical 
stimulator were under maximum safety level (δPmax = 6mW/cm2 that may cause enough heat to 
damage surrounding tissue) (HARRISON, 2008). Figures 4-8 (a) – (b) illustrate devices operation 
modes in icEEG recording and corresponding average δP.  
 
Table 4.2: Measured power consumption of proposed closed-loop epilepsy prosthesis 
System Block Power 
supply 
Power  consumption (W) 
Standby mode Active mode 
Seizure detector 
Preamplifier 
1.8 V 
50 µ 50 µ 
Detector 45.8 n 45.8 n 
Electrical stimulation 
Stimuli generator 3.3 V 2 m 10 m 
Output stage 5 V 10 n 5 m 
Total power consumption of the proposed system ~2 m ~16 m 
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Figure 4-8: Demonstration of power dissipation of proposed system: (a) Electrographic 
seizure in icEEG recording and (b) Power dissipation densities δP of the devices. 
 
4.4.2 Validation of seizure detection  
The achieved validation was performed on three incremental steps: 1) Algorithm under Matlab 
simulation, 2) Post-layout circuit simulation (PLCS) under Cadence environment, and 3) 
Measurement through the fabricated chip.  The details of these results are the following: 
The signal recorded from two contacts located in the epileptogenic zone during a normal state 
(Figure 4-9(a)), a BES (Figure 4-9(b)), and an electroclinical seizure (Figure 4-9(c)) were fed into 
Matlab to test the seizure detection algorithm. Figure 4-9(a) shows that there was no abnormalities 
detected in VLDs (VD1,2 in Figure 4-9(a)) and no false alarms (VSOD) during the normal state. The 
algorithm ignored the BES (VSOD in Figure 4-9(b)) in this example (as specified by the clinician 
because in this particular patient, BES signals were very frequent and did frequently lead to an 
electroclinical seizure). However, it would have been possible to modify detection parameters so 
that these BES be detected. The algorithm detected the electroclinical seizure onset after 8 sec 
(VSOD in Figure 4-9(c)). 
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Figure 4-9: The seizure detection algorithm is validated in (a) normal signal, (b) a BES, and (c) 
an electroclinical seizure: Vin is icEEG recording from the two contacts positioned over 
epileptogenic zone, VD1 – VD2 are abnormalities detection in VLD, and VSOD is seizure detection. 
 
Following the testing of the algorithm in Matlab, the detection circuits were constructed in 
Cadence software (CMOS 0.18-µm technology) and tested using the seizure recordings containing 
an electrical seizure quickly followed by an electroclinical seizure. Similarly, the PLCS ignored 
the BES (as specified by the clinician) and detected the electrographic seizure onset after 7 sec 
(VSOD in Figure 4-10(a)). 
After the testing of the seizure detection in PLCS, the detection circuits were fabricated in a 
microchip and tested using the same seizure recordings (Figure 4-10(b)). For this particular 
seizure, the microchip detected the electroclinical seizure onset after 15 sec (VSOD in Figure 4-
10(b)). Overt clinical manifestations for this seizure occurred approximately 30 sec after the 
electrographic seizure onset. Table 4-3 shows operating frequency Fs of the detector is 5 kHz to 
reduce the lower-frequency noises. The tunable detection parameters values and the seizure 
detection delays of the seizure detector are shown in Table 4-3. The seizure detection 
performances in Matlab, PLCS and fabricated chip differed due to the various surrounding 
environment. The Matlab and PLCS provide idle environment without noises effect. However, 
real-time test in fabricated chip includes other sources of noise (e.g. 60 Hz noise). Therefore, the 
threshold voltages of VLDs of a chip were always kept higher in real-time test compared to the 
simulation platform (Table 4-3). Moreover, PLCS and fabricated chip had 100mV dc offset in the 
amplified icEEG recording, thus the threshold voltages of VLDs were different from Matlab 
simulation.  
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The detectors were validated on ten more patients: no false alarm and 100% sensitivity were 
obtained. Overall for all patients, the device detected the electroclinical seizures after a mean delay 
of ~16 sec after seizure onset and before onset of overt clinical manifestations.  
 
Figure 4-10: The seizure detection performance: (a) post-layout circuit simulation results and (b) 
fabricated chip measured results. 
 
Table 4.3: Average tuneable parameters and detection delay (TSOD) of seizure detector 
Method Fs (kHz) V1HET1,2 (mV) V2HET1,2 (mV) Tf (sec) TSOD (sec) 
Matlab 5 80, 100 100,130 3 10 
PLCS* 5 197, 233 233, 270 2 9 
Chip 5 210, 240 270, 300 2.5 16 
*PLCS: Post-layout circuit simulation 
 
The detection performances are compared with published different types of seizure detectors 
based on wavelet artificial neural network (WANN) (AZIZ, 2006), events (ESD) 
(RAGHUNATHAN, 2009), nonlinear Energy (NED) (PATEL, 2009), and spectral energy (SED) 
(VERMA, 2010) in Table 4-4. Results presented in ESD and NED are based on circuits 
simulation, but WANN and SED were fully integrated and results were based on animals, human 
and scalp EEG. The proposed detector is a fully integrated device and the experimental results 
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were based on icEEG recordings from different locations in the human brain. The proposed 
detector has maximum sensitivity and lower power consumption, and higher average detection 
delay, but well before overt clinical manifestations in all patients. Moreover, proposed detector 
shows promising improvement in hardware cost. Table 4-4 shows comparison of normalized 
hardware cost of the competitive detectors. The normalized hardware cost is defined by Eq. (4.1). 
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where, PCD and PCmax are power consumption of a detector and maximum consumption of the 
compared detector, respectively. AD and Amax are area on a detector and maximum area on the 
compared detector, respectively. The algorithm ESD, NED and SED had lower sensitivity 
because the algorithms often detected brief high frequency bursts as seizures, but did not detect 
the seizure onset characterized by progressively increases low-voltage fast activity. Moreover, if 
the detection parameters of ESD, NED and SED methods were adjusted to low-voltage fast 
activity seizure onset, the methods detected low amplitude physiological rhythms and other 
similar activity. These algorithms do not have specific boundaries to distinguish an electrographic 
seizure onset from brief electrical seizures or other physiological rhythms. Therefore, the proposed 
algorithm were introduced several effective detection parameters that create several decision 
boundaries and reduce the number of false detections for the patient’s specific seizure onset 
pattern while enhanced the sensitivity. Figures 4-11 (a) – (c) show time-amplitude (VMA) and time-
frequency (fSi) analysis of a train data Vin that extract patient’s specific detection parameters 
(ViHET1,2 and fSZ) and draw several detection boundaries (Figure 4-11(d)) such as normal neural 
activity, low-voltage fast activity, slow spike wave, brief electrical seizure, artifact, and 
progressive amplitude increase. Later, continuous icEEG recording with other five seizures was 
fed into the detector and Figure 4-11(d) shows that all seizure onsets were located inside the 
detection boundaries without having false detection. Therefore, the proposed algorithm has high 
detection sensitivity and avoids false detections of interictal spikes and polyspikes, movement 
artifacts, physiological rhythms (e.g. sleep spindles), and brief asymptomatic high frequency 
voltage activities or very brief electrical seizures. 
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Table 4.4: A competitive comparison of different types of seizure detectors 
Reference AZIZ, 
2007 
RAGHUNATHAN, 
2009 
PATEL, 
2009 
VERMA, 
2010 
This work 
# of subject 1(animal) 6 (animal) 13 (Human) 16 (Human) 10 (Human) 
Sensitivity N/A 95% (sima) 94% (sima) 93% (sima) 100% 
(meab) 
Detection delay N/A 8.5 sec N/A 8.2 sec 16 sec 
Chip area (cm2) 351µ N/A N/A 62.5m 20m 
Power 
consumption 
23 µW 350nW 2.7 µW 63 µW 44.8 nW 
Normalized 
Hardware Cost 0.18 N/A N/A 1 0.16 
Process 0.35-µm 180-nm  0.13-µm 0.18-µm 0.18-µm 
asim: Simulation results and bmea: Measured results 
 
 
Figure 4-11: Illustration of proposed seizure detection performance: (a) – (c): Analysis on 
training data Vin and detection parameters (ViHET1,2 and fSZ) setting from patients’ specific seizure 
patterns, and (d) Decision boundaries formation using ViHET1,2 and fSZ and test detection 
performance using other 5 seizures, 3 brief electrical seizures and 5 normal activities. 
 
Neuropace Inc. has seizure detection in responsive neurostimulator (RNS) system. The 
detection algorithm of RNS system is based on data reduction (line length function and area under 
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the curve) and feature extraction (half wave analysis). However, the proposed seizure detection is 
based on noise reduction (modulation), feature extraction (amplitude levels detection), and data 
reduction (demodulation). The detection criteria of RNS system are based on high frequency 
tracking of amplitude variations in icEEG recording, but the proposed algorithm detects 
progressive increase of high-frequency signal in icEEG. In addition, hardware description, total 
power dissipation and detection performance of the RNS system are unknown. 
4.4.3 Validation of electrical stimulation 
The effective bipolar stimulation was administrated to cadaveric animal brain tissue in response 
to the early detection of seizure development. The stimulation parameters (ISTIM, T1, T2, T3, and T4) 
are widely programmable. Figure 4-12(a) shows that the range of stimulation current in spice 
simulation platform and experiment. Figure 4-12(b) shows self-triggering of a burst of biphasic 
stimulation in response to the detection of a seizure and illustrates the corresponding 
individualized parameters.  
 
 
Figure 4-12: Measured and simulation results of electrical stimulator: (a) Output current of the 
stimulator for binary encoded amplitude and (b) Measured electrical stimulation triggered by 
seizure detector. 
4.4.4 In vitro voltage distribution 
The goal of this study was to quantify the electric field in the surrounding tissue during 
biphasic current stimulation using different parameters. In vitro experiments, the seizure detector 
triggered bipolar stimulation on brain tissue that generated spatial voltage distribution around the 
subdural electrodes. The maximum voltages were recorded under the active electrode (VElect) and 
the voltage distributions decayed non-linearly as a function of distance from the active electrode. 
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Figure 4-13 demonstrates a substantial voltage drop across the electrode–brain interface due to 
the double-layer phenomenon. The VElect was increased with the stimulation current and the 
voltages generated in the surrounding medium varied as function stimulation parameters. 
 
Figure 4-13: Current-controlled stimulus waveforms (1 – 12 mA, 100 – 500 Hz, and 100-500 
µsec pulse width) were applied on the brain tissue and individual voltage recordings plotted 
against the distance from the microelectrode tips around the active subdural strip electrodes: (a) – 
(d) Spatial maps of the voltage distribution in brain when stimulated by 1 – 12 mA 
 
The spatial voltage distribution, as a function of different stimulation parameter settings (i.e. 
frequency, pulse width and current amplitude), was recorded from the cortical surface and 
underneath. Figures 4-14 (a)-(c) show the spatial maps as a function of stimulation pulse width 
and frequency. The spatial voltage distributions remained constant for low amplitude current 
stimulation (Figure 4-14(a)), but the distributions were inversely proportional to pulse width for 
high amplitude current stimulation (Figure 4-14(b)). However, the distributions at high amplitude 
stimulation increased progressively with frequency (Figure 4-14(c)) while the distributions 
resulting from low current stimulation remained almost constant (not shown in this figure). 
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Figure 4-14: Voltage distribution resulting from biphasic current stimulation: (a) Low-amplitude 
current (1mA) at 100 – 500 µsec pulse width, and high-amplitude current (12mA) at 10 – 100 
µsec pulse width (b) and 100 – 500 Hz frequency (c). 
 
Constant-current stimulation generated various voltage distributions as a function of the 
stimulation parameters. Thus, an electric field can be predicted to desynchronize a group of 
neurons process at variable distance. Figure 4-15(a) shows variation VG3 with different 
stimulation parameters. The VG3 increased slowly resulting from low frequency stimulation 
parameters (high pulse width and low frequency). However, VG3 increased linearly with 
stimulation current at high-frequency stimulation parameters (low-pulse width and high 
frequency). The bipolar stimulation at low frequency parameters increased impedance of gray 
matter (RGM and CGM in Figure 4-7(b)) that causes significant shunting of current through the CSF 
and voltage distribution (VG3 did not increase linearly with stimulation current). On the other 
hand, high-frequency stimulation parameters decreased impedance of gray matter and reduced 
shunting of current through the CSF. Therefore, VG3 increased linearly with stimulation current at 
high frequency. Figure 4-15(b) illustrates applied stimulating charge density (δC = Istim × T4 / Area 
of electrode) per phase due to the stimulation parameters used in Figure 4- 15(a). The high-
frequency stimulation parameters required a lower stimulating charge compared to low-frequency 
stimulation parameters (Figure 4-15(b)). At the higher frequency stimulation, most of the applied 
charge went through the gray mater and only a small amount of the charge was shunted through 
the CSF. Thus, the higher frequency stimulation parameters generated higher voltage distribution 
with lower applied charges. Intuitively, the high frequency stimulation parameters appear more 
suitable for affecting an epileptogenic zone at least in a radius of 3 mm. 
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Figure 4-15: 3D plot of voltage distribution at 3 mm distance and charge density per phase 
resulting from current-controlled bipolar stimulation settings. 
 
4.5 CONCLUSION 
In this article, we describe a close-loop seizure detector and neurostimulation device, which 
records signal from cortical regions, modulates recorded icEEG, amplifies the signal till the 
desired amplitude level, extracts abnormal activity information using voltage level detectors, 
demodulates the signal to the original frequency, detects seizure frequency by dedicated circuits 
and administrates individualized electrical stimulations. Most of signal processing is done in the 
digital domain, while analog signal processing is accomplished by imposing the signal in high 
frequency in order to isolate the instrumentational low-frequency noise. Analysis and comparison 
of the seizure detection performances in different platforms were presented. The overall test 
performance using seizure icEEG recording from ten patients with refractory epilepsy showed 
early detection of electroclinical seizure onsets. Efficiency of the stimulator has demonstrated on 
cadaveric animal brain tissue, and spatial voltage distribution was depicted as a function of 
electrical stimulation parameters.  
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CHAPTER 5  IMPLANTABLE DRUG DELIVERY SYSTEM 
Following the discussion on the closed-loop electrical stimulator in chapters 3 and 4, this 
chapter presents another alternative promising implantable device therapy: direct drug injection. 
A new power saving strategy is employed to design a direct drug delivery device. This chapter 
presents a new preamplifier, an asynchronous seizure onset detector, a drug delivery system, and 
hybrid subdural electrodes. The experimental results demonstrate the efficiency of the device and 
wide range of drug dosing capabilities at seizure onset. The content of this chapter is an 
manuscript that will appear in the “IEEE Transactions on Neural Systems and Rehabilitation 
Engineering” and it is reproduced in following pages. 
 
5.1 AN IMPLANTABLE CLOSED-LOOP ASYNCHRONOUS 
DRUG DELIVERY SYSTEM FOR THE TREATMENT OF 
REFRACTORY EPILEPSY 
 
Muhammad Tariqus Salam1, Marjan Mirzaei1, My Sandra Ly1, Dang Khoa Nguyen2, and 
Mohamad Sawan1 
1Polystim Neurotechnologies Laboratory, École Polytechnique de Montréal, Québec, Canada 
2Notre-Dame Hospital, Centre Hospitalier de l'Université de Montréal (CHUM), Québec, Canada 
 
Publication to appear in: IEEE Transactions on Neural Systems and Rehabilitation 
Engineering, special issue on closing the loop via advanced neurotechnologies.  
 
Abstract – In this paper, we present an implantable device for intra-cerebral 
electroencephalography (icEEG) data acquisition and real-time epileptic seizure detection with 
simultaneous focal antiepileptic drug injection feedback. This implantable device includes a 
neural signal amplifier, an asynchronous seizure detector, a drug delivery system (DDS) 
including a micropump, and a hybrid subdural electrode (HSE). The asynchronous detection 
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algorithm is based on data-dependent analysis and validated with Matlab tools. The detector and 
DDS have a power saving mode. The HSE contacts are made of Platinum (Pt) encapsulated with 
polydimethylsiloxane (PDMS). Given the heterogeneity of electrographic seizure signals and 
seizure suppression threshold, the implantable device provides tunable parameters facility 
through an external transmitter to adapt to each individual’s neurophysiology prior to clinical 
deployment. The proposed detector and DDS were assembled in Ø 50 mm and Ø 30 mm circular 
printed circuit boards, respectively. The detector was validated using icEEG recordings of 7 
patients who had previously undergone an intracranial investigation for epilepsy surgery. The 
triggering of the DDS was tested and a predefined seizure suppression dose was delivered ~16 
sec after electrographical seizure onsets. The device’s power consumption was reduced by 12% 
in active mode and 49% in power saving mode compared to similar seizure detection algorithms 
implemented with synchronous architecture. 
Index terms – Epilepsy, seizure detection, focal drug delivery.  
5.2 INTRODUCTION  
Interest has grown recently in emerging prosthetic therapies for conventionally-untreatable 
neurological conditions, such as epilepsy (TERRY, 2009), Parkinson’s disease (SARMA, 2010), 
depression (PENESCU, 2005), and motor impairments (CELIK, 2010). Researchers are 
exploring the brain-machine interface to translate physiological activity and neuromodulation 
into machine language for therapeutic purposes. Brain signal monitoring, clinical state analysis 
and low-power dissipation in prosthetic devices for long-term treatment are key challenges for 
emerging prosthetic therapies. Epilepsy, which affects approximately 60 million people 
worldwide, is the second most common chronic neurological condition. It is characterized by a 
predisposition to unprovoked recurrent seizures. Despite the existence of a number of 
anticonvulsants, ~30% of patients continue to have disabling seizures. Half of them may benefit 
from epilepsy surgery if the epileptogenic zone (EZ) can be identified and resected without harm. 
Others, however, are not good surgical candidates. Due to the limited spatial or temporal 
resolution of currently available non-invasive localization techniques, accurate delineation of the 
EZ may sometimes be arduous, particularly in patients with non-lesional refractory epilepsy 
(JEROME, 2009; SPENCER, 2009). Moreover, many patients have an extensive area of 
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epileptogenicity, multifocal epileptic foci, or an EZ overlying eloquent areas (language, primary 
motor or visual regions) that cannot be resected without permanent sequelae (SPENCER, 2009). 
Hence, there is a need for alternative treatment modalities.  
Proof-of-principle experiments conducted in animals and humans with epilepsy have 
demonstrated the safety of successful chronic electrical stimulation (RYCHLICKI, 2006; 
THEODORE, 2004; BOON, 2009), focal pharmacological manipulations (GOOD, 2004; STEIN, 
2000), and thermal cooling (GUERRA, 2005) for the treatment of epilepsy. Much progress has 
been made with focal electrical stimulation therapy methods. Neuropace Inc. has developed a 
closed-loop-responsive neurostimulator (RNS) that records intra-cerebral electroencephalographic 
(icEEG) signals, analyzes them and triggers electrical stimulation only upon seizure detection. 
Preliminary results of electrical stimulation therapy are acceptable, but many patients do not 
respond to the stimulation and continue have disabling seizures (SUN, 2008; SKARPAAS, 2009; 
SALAM, 2010(a)).  
Focal drug delivery has shown promising seizure suppression results (BOON, 2009; STEIN, 
2000). Direct drug injection onto the epileptogenic zone could enhance the efficacy of medication 
while limiting side effects to a minimum. Table 5-1 shows drugs and doses used in pilot trials. 
Maximum safe tolerated dose was 150 µL per 20 min for a rat (STEIN, 2000). Two main 
approaches have been described for focal drug delivery: open-loop and closed-loop. The open-
loop approach has been used to increase seizure threshold through continuous drug release while 
the closed-loop drug delivery system (DDS) is meant to release the drug only upon a seizure 
detection (STEIN, 2000). The advantages of closed-loop drug delivery over the open-loop 
method are (i) lower drug dose injection, (ii) potentially less adverse effects, and (iii) rapid focal 
drug injection. However, several issues of closed-loop systems remain to be addressed, such as 
Table 5.1: Pilot studies on focal drug delivery therapy 
Drug Therapy Dose Result 
Diazepam (STEIN, 2000) Closed-loop 35-50 µL Seizure supression 
pH-balenced vehicle (STEIN, 
2000) 
Closed-loop 35-50 µL Seizure number reduction 
Adenosian (ANSCHEL, 2004) Open-loop 750 µL Seizure prevention 
Lidocaine (SMITH, 1993) Open-loop 5 µL Seizure severity reduction 
Gabapentine (OOMMEN, 2007) Open-loop N/A Seizure threshold 
increment 
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the sensitivity and specificity of seizure detection and device power consumption.  
Good quality icEEG recording and effective automated seizure detection are obviously 
necessary for any closed-loop system. Over the past few decades, several seizure detection 
mathematical models have been developed, with support vectors (MEIER, 2008), artificial neural 
networks (GHOSH-DASTIDAR, 2008), wavelet transformation (ZANDI, 2010), wavelet 
decomposition (SAAB, 2005), nonlinear time series analysis (LEHNERTZ, 1995), and mean 
nonlinear decision function (TITO, 2009). These complex mathematical models are meant to be 
run on high-speed desktop computers for off-line, long-term data processing to help clinicians find 
seizures but can hardly be employed in low-power implantable devices. Later, several implantable 
seizure detectors have been described in the literature on closed-loop epilepsy prostheses 
(SALAM, 2009(a); RAGHUNATHAN, 2009; SALAM, 2009(b); PATEL, 2009; SALAM, 2010 
(b); VERMA, 2010; SALAM, 2010(c); SALAM; 2011(c)). Power management is an important 
issue for these detectors. Power consumption is mainly dependent on signal transitions in a 
device, such as charging and discharging of parasitic capacitances in transistors and short-circuit 
currents during switching (NIELSEN, 1999). Thus, power consumption can be reduced by 
avoiding unnecessary signal transitions (NIELSEN, 1999). With synchronous designs (SALAM, 
2009(a); RAGHUNATHAN, 2009; SALAM, 2009(b); PATEL, 2009; SALAM, 2010 (b); 
VERMA, 2010; SALAM, 2010(c); SALAM; 2011(c)), all components share a common clock 
signal distributed throughout the circuit, and unnecessary signal transitions arise from clock 
gating. Because of these limitations in conventional synchronous circuit design, the asynchronous 
design technique is likely to become more popular. An asynchronous device is fundamentally 
different, and device transistors do not change their transient state unless an event happens. This 
device does not use or share a common clock; thus, it has no clock skew and no clock tree.  
In the following parts, we will describe methods and materials in Section II and results in 
Section III. Conclusions are summarized in the last section of this paper.  
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5.3 METHODS AND MATERIALS 
5.3.1 Proposed closed-loop epilepsy prosthesis 
The proposed closed-loop epilepsy prosthesis would benefit the patients with focal epilepsy 
with or without secondary generalization who are not controlled and report significant side 
effects with oral antiepileptic drugs, especially those whose epileptic focus cannot be removed 
because it overlies an important functional area (motor, sensory, visual, language areas). This 
epilepsy prosthesis requires low-power, continuous, long-term icEEG monitoring to identify 
seizures online before the appearance of disabling clinical manifestations (e.g. altered 
consciousness, tonic or clonic movements). An asynchronous device has inherent properties that 
work locally and activate all modules, if needed. Therefore, an asynchronous design holds 
significant promise in icEEG recording extraction applications, where complex analyses are 
 
Figure 5-1: Proposed closed-loop drug delivery system: (a) Flow chart, (b) Block diagram, and 
(c) Implant configuration. 
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Figure 5-2: Block diagram of closed-loop asynchronous drug delivery system. 
 
needed for a short period (e.g. seizure onset). Therefore, power management pleads in favor of an 
asynchronous design. In this paper, an asynchronous device is designed and implemented to 
improve data-dependent computation and power management.  
Figure 5-1 illustrates flowchart, block diagram, and implant configuration of the proposed 
closed-loop drug delivery system. The refilling port is made of a microtube (Ø 1.93 mm) coated 
with PDMS and sealed the entry port with PDMS so that a syringe easily goes through the PDMS 
to fill the reservoir without having a bacteria entry point. The functional block diagram in Figure 
5-2 presents the architecture of the closed-loop DDS that includes total 11 modules, such as 1 
amplifier, 4 voltage level detectors, 4 asynchronous frequency analyzers, 1 receiver- controller, 
and 1 DDS. First, the icEEG recording Vin is amplified and decomposed by seizure detectors. The 
extracted activities define an upcoming seizure. The responsive DDS must be adjusted by setting 
voltages (VT,i,a/b), time windows (Tf), and dose (drug injection period TPM and micropump control 
voltage VDP) labeled as corresponding to seizures and non-seizures. Optimum parameters are 
measured from time-amplitude and time-frequency analysis of 1 seizure from the EZ and normal 
signal activity. Clinical studies have shown that several electrographic patterns (e.g. low-voltage 
and high-voltage fast activities or rhythmic spiking) can be seen in EZ at seizure onset, depending 
on such factors as etiology, location, position of intracerebral electrodes (SPENCER, 2009; 
SALAM, 2010(a)).  Generally, same patient-specific pattern and seizure frequency can also be 
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Table 5.2: Comparison of synchronous and asynchronous epileptic seizure detection algorithms 
Synchronous (SALAM, 2010(b)) Asynchronous (this work) 
Modulates input signals before analysis Directly analyzes input signals without modulation 
Window detection in positive amplitude Window detection in positive and negative 
amplitude 
Signal analysis in high frequency band Signal analysis in original frequency band 
Demodulates to original frequency band No demodulation 
Frequency divider generates time frames Externala device generates time frames 
Clock controls frequency analysis External device controls frequency analysis 
aExternal: On top of the skin  
seen in EZ which lead to a clinical seizure (SALAM, 2010(a); SALAM, 2010(b), SALAM, 
2010(c), SALAM, 2011(a)).  
5.3.1.1 Front-end seizure detector  
Synchronous epileptic seizure detection algorithms have been suggested in our previous works 
(SALAM, 2010(b), SALAM, 2009(b), SALAM, 2010(c)). In this paper, an asynchronous seizure 
detection algorithm is proposed for better power management. Table 5-2 compares the 
synchronous and asynchronous algorithms. Details of asynchronous front-end seizure detector are 
described below. 
5.3.1.2 Asynchronous epileptic seizure detection algorithm 
Amplified input signal (Vamp) passes through voltage window detectors (VWDs), and outputs 
Vw,i define the strength of neural signal activities in different amplitude windows (Eq. 5.1). 


 >>
=
otherwise
VVV
for
for
V biTampaiTwi ,,,,
,'0'
,'1'
            (5.1) 
where i = 1, 2, 3…N. VT,i,a-b are the threshold voltage of VWDs.   
Frequency analyzers extract Vw,i and measure the signal frequency (FS,i), as shown in Eq. (5.2).  
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Figure 5-3: Asynchronous seizure detection performance analysis using optimum parameters of 
different VWDs based on 5 seizures and long normal icEEG of the test patient. 
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If FS,i is greater than a specific seizure onset frequency (FSZ), the output of each channel VD,i is 
considered fast activity (Eq. 5.3). 
    


 ≥
=
otherwise
FF
for
for
nV SZiSiD
,
,
,'0'
,'1')(             (5.3) 
Seizure detection logic analyzes VD,i and quantifies specific features characterized by a 
progressive increase in amplitude and signal frequency. Thus, a seizure onset is declared on the 
basis of the following conditions (Eq. 5.4). 


 =
=
otherwise
VVVV
for
for
V NDDDDSD
1.....
,'0'
,'1'
,3,2,1,
     
(5.4) 
VT,i,a-b and Tf are tuned to the patient’s specific FSZ to minimize false alarms. The parameters 
can optimize the decision boundary and enhance sensitivity and specificity. Figure 5-3 shows 
maximum detection performance using 4 VWDs (2 VWDs monitor basal activities and the other 2 
VWDs detect epileptic activities).  
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5.3.1.3 Asynchronous front-end detector 
Figure 6-2 shows block diagram of the asynchronous front-end detector (AFED). The detector 
contains a neural signal amplifier, an asynchronous seizure detector, a controller and a receiver. 
Details are described below.  
5.3.1.3.1 Amplifier  
The icEEG recording is generally characterized by low-amplitude signal (microvolts) and low-
frequency bandwidth. Moreover, the instrumentation amplifier has relatively poor noise 
performance for amplifying the low spectral microvolt-level signal due to the flicker and thermal 
noise. Thus, icEEG signal must be amplified very carefully before further analysis (e.g. detection, 
digitization). The proposed neural signal amplifier has 3 stages for amplification and noise 
reduction (Figure 5-4(a)) (SALAM, 2011(a)). A feedback noise reduction circuit reduces DC 
offset VOS (Figure 5-4(b)).  Furthermore, flicker noise VnF and thermal noise VnT are reduced by 
high- and low-pass filters (Figure 5-4(b)). The amplifier features high-amplification gain: 60 dB 
and 48 Hz (3 Hz to 51 Hz) bandwidth (Figure 5-4(c)) with 6 µVrms input-referred voltage noise. 
Figure 5-4(d) shows measured input-referred noise voltage spectral densities of the proposed and 
commercial amplifier.   
 
5.3.1.3.2 Asynchronous seizure detector 
The detector comprises 4 VWDs and 4 asynchronous frequency analyzers. The VWDs have 8 
tunable parameters to adjust their threshold voltages (VT,i,a-b). Asynchronous frequency analyzers 
detect high-frequency events by analyzing neural activities in Tf, which can be tuned externally 
and configured to the specific seizure onset frequency (FSZ) of a patient to reduce false alarms 
during icEEG monitoring. 
5.3.1.3.3 Controller 
The proposed seizure detector allows to tune several parameters that are personalized in a 
specific manner to prevent false seizure detection. The controller includes 8 digital-to-analog 
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Figure 5-4: Neural signal amplifier: (a) Schematic diagram of amplifier, (b) Noise reduction 
method and corresponding frequency analysis of signals in different nodes, (c) Frequency response, 
and (d) Measured input-referred noise voltage spectral densities of the proposed and commercial 
amplifier.  
 converters, and 8 buffers. This controller can provide digitally-controlled, high-precision voltage 
VT,i,a/b and VDP.  
5.3.1.3.4 Receiver 
The receiver is responsible for power and data (e.g. Tf) recovery. The power recovery circuit 
was introduced in our previous work [35] and Figure 5-5(a) shows a schematic diagram of the 
data recovery. The external transmitter generates and transmits predefined Tf with inductive 
communication. A parallel LC network of the internal device receives Tf and controls the seizure 
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Figure 5-6: Proposed drug delivery system: (a) Seizure detections VSD (b) Drug injection period TPM, 
(c) Focal treatment duration TON, (d) Two subsequent drug injections, and (e) – (h): Operation of 
micropump. 
 
Figure 5-5: Time frame generation: (a) Schematic diagram of receiver, (b) Transmitted signal 
pattern VER from external coil, and (c) Recovered time frame VRST. 
 
detector. Graphic representation of the time-frame generation in Figures 5-5 (b)-(c) shows 
transmitted signal pattern VER and Tf recovered from VRST.  
5.3.1.4 Drug delivery system 
Figures 5-6(a)–(d) illustrate the operation of the DDS and demonstrate its timing process in 
response to seizure detections VSD. The duration of drug delivery (VPM) is TPM; if the injection 
does not terminate the seizure another dose is triggered by the detector after TON. VPM generates 
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Figure 5-7: Hybrid subdural electrodes fabrication process: (a) Dimension of mould; (b) 
Electrode, wire and fluidic channel assembly on mould; (c) Pour PDMS; (d) Cover up and 
heating with 110oC; (e) Side view of the released subdural electrodes; and (f) Top view of the 
electrodes. 
VP push-pull signal in the micropump (13 x 13 x 5 mm3) (Microbase technology Corporation) to 
drive the drug. 
5.3.1.5 Hybrid subdural electrodes 
The electrodes fabrication process includes mould fabrication, electrodes assembly, and 
biomedical grade polydimethylsiloxane (PDMS) encapsulation. The mould was fabricated on an 
Aluminum substrate (Figure 5-7(a)) using a computer numerically controlled machine. Electrodes 
(Platinum), wires (Platinum) and fluidic channel (Micro-tube: Ø 0.5 mm) were assembled on the 
mould (Figure 5-7(b)). PDMS is poured (Figure 5-7(c)) and the covered mould was heated to 
110oC for 20 minutes (Figure 5-7(d)). Once subdural electrode arrays become encapsulated with a 
thin PDMS substrate, they are released from the mould (Figures 5-7 (e) – (f)). 
5.3.2 Circuits and devices implementation 
The closed-loop DDS was assembled with discrete commercial components on circular shape 
printed circuit boards (PCB). Figures 5-8 (a) – (c) show photographs of the asynchronous front-
end detector. Photographs of the drug delivery system and hybrid subdural electrodes are 
presented in Figures 5-8 (d) – (f). 
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Figure 5-8: Proposed closed-loop drug delivery system: (a) – b) Top and bottom views of 
asynchronous front-end detector, (c) External transmitter, (d)–(e) Top and bottom views of drug 
delivery system, and (f) hybrid subdural electrodes. 
 
5.3.3 Patients description  
This study was conducted at Notre-Dame Hospital, Centre Hospitalier de l'Université de 
Montréal (CHUM). Seven patients with refractory focal epilepsy (age 15 to 49 years) were 
qualified for these studies based on electrographic seizure onset. The selected patients had 
previously undergone a comprehensive noninvasive assessment of brain. These complementary 
non-invasive studies failed to adequately localize the epileptogenic zone and invasive intracranial 
electrode studies were required to delineate with more precision the EZ. The seizure signals of 
cases 1, 4, 5, 6 and 7 were recorded using depth electrodes and the signals of cases 2 and 3 were 
recorded using subdural strip electrodes. These patients had seizure onsets characterized by 
progressive increase of low-voltage fast-activity in icEEG recordings. These patients also had 
frequent electrical seizures on the EZ. There is no consensus on what constitutes an appropriate 
definition of electrical seizure apart from the fact that they do not generate any clinical 
manifestations (BABB, 1984; GOTMAN, 1985). Some electrical seizures are simply very brief (a 
few seconds), focal (without spread) high-frequency discharges which do not evolve significantly 
in time or frequency, and are hence clinically silent. Others are longer (several seconds) with some 
evolution.  
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5.3.4 Device validation method 
The proposed implantable device was tested offline using icEEG recordings obtained from the 
7 patients. The experimental procedure was approved by the University of Montreal’s Hospital 
Center (CHUM) and Polytechnique Montreal research ethics committees. Figure 5-9 shows the 
proposed device validation procedure. These icEEG studies consist in implanting electrodes into 
or on the surface of the brain through a craniotomy or burr holes under general anaesthesia. After 
intracranial electrode implantation, patients are transferred to the Epilepsy Monitoring Unit for 
continuous video-EEG telemetry to record seizures. 128 channel icEEG recordings were 
performed using amplifiers (PRO-36 amplifiers, Stellate Harmonie System) at 200 Hz and 2000 
Hz sampling frequency.  
Post-implantation MRI served to reconstruct 3-D representation of electrode positioning (via 
Stellate’s Gridview software) (Figure 5-10). During the invasive study, several brief electrical 
seizures and electroclinical seizures were recorded and marked by an epileptologist (DKN).  All 
the seizures were found to originate from the red circle-marked electrodes in Figure 5-10 with 
subsequent rapid spread to square-marked electrodes and then propagation to triangle-marked 
electrodes. Figure 5-9 illustrates that the icEEG recordings from the two contacts positioned over 
the epileptogenic zone (Figure 5-10) were selected, transferred to the signal conditioner (arbitrary 
signal waveform generator) for reproducing icEEG recording and fed into the closed-loop epilepsy 
prosthesis. The reproduced microvolt-level icEEG recordings were amplified by the amplifier of 
 
Figure 5-9: The closed-loop epilepsy prosthesis: icEEG recorded from patients with medically 
refractory epilepsy were used to test the proposed seizure detector and the triggering of predefined 
drug dose was validated. 
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Figure 5-11: The icEEG recordings from the epileptogenic zone as well as adjacent functional 
regions and the corresponding behavioural relation with the electro-graphical signals. 
 
the AFED and processed for the seizure detection. The AFED detected seizure onset and 
triggered the DDS to deliver a predefined drug dose through the hybrid subdural electrodes. 
During the drug injection, the delivered drug was measured to validate the seizure suppression 
doses (Table 5-1). 
In order to justify the effectiveness of the proposed responsive device, all the seizures were 
observed during the experiments and analyzed all channels to determine seizure progression and 
propagation. Figure 5-11 shows typical electrographic seizures as recorded from the electrode 
contacts in the epileptogenic zone as well as nearest adjacent functional regions. Based on video-
EEG analysis of this seizure, the epileptiform discharges propagated slowly to the nearest 
functional region (22 sec) and patient reported feeling an aura 33 sec after the electrographic 
seizure onset. Altered consciousness occurred a few seconds later. This propagation time varied 
from patient to patient. In this experiment, the minimum propagation time is 22 sec in case 1 
 
Figure 5-10: Invasive study: 3-D images of implanted electrodes reconstructed with Stellate’s 
Gridview software and identification of epileptogenic zones. 
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(worst case scenario) and the maximum time is 110 sec in case 7 (worst case scenario). 
Furthermore, the pilot studies have shown epileptiform activities suppression within 5 sec due to 
the 35-50 µL Diazepam drug injection on epileptogenic zone during an electrographic seizure 
(STEIN, 2000). Therefore, the key challenges for an automated drug delivery system are to detect 
seizure onset and deliver drug on epileptogenic zone before the epileptiform discharges 
propagating to others adjacent functional areas. 
5.3.5 Prosthesis pre-implantation procedure 
A prosthesis pre-implantation procedure was introduced to observe patients’ specific 
neurophysiology properties and configure the AFED and DDS. Ictal discharges from patients 
generally contained high-frequency activities, but not all high frequency discharges were seizures 
(i.e. some were physiological rhythms). Moreover, patients presented frequent, brief, low-voltage, 
high-frequency discharges without clinical manifestations (reminiscent of very Brief electrical 
seizures - BES) which our clinician choose to ignore. As these discharges did not frequently 
evolve into longer electro-clinical seizure, they were overlooked to prevent the triggering of non-
clinically useful responsive drug deliveries that could rapidly deplete battery life and drug reserve. 
Hence, it was decided to configure the AFED to ignore these brief discharges. For proper AFED 
configuration, a normal signal, 2 BESs and an electro-clinical seizure from a patient were 
analyzed in the time-amplitude VMA (root mean square) and time-frequency FS domain. The 
obtained detection parameters from these training signals were used to adjust the AFED and 
consequently it detected the other seizures of the patient.  
Figure 5-12 depicts the analysis of 30 minutes of icEEG recording to demonstrate optimum 
selection of the seizure detection parameters (i.e. FSZ in Figure 5-12(b) and VT,i,a/b in Figure 5-
12(c)). Signal analysis of normal icEEG recordings Vin revealed no abnormalities in FS and VMA 
which define basal activity (|VT,2/3,a|).  Brief high-frequency discharges or BES had high 
frequency contents in FS with limited amplitude increase (|VT.2/3,b|) in VMA. Analysis of an electro-
clinical seizure onset demonstrated a sudden increment in FS with a progressive amplitude rise 
(|VT,1/4,a/b|) in VMA leading to clinical manifestations. Clinicians could set these parameters by 
visual inspection, but the pre-implantation procedure optimizes the tradeoff between detection 
delay and performance (i.e. sensitivity and specificity). 
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Figure 5-12: Prosthesis pre-implantation settings: (a) Training data Vin and (b) – (c): adjustment 
detection parameters FSZ and VT,i,a/b from time-frequency (FS) and time-amplitude (VMA) analysis 
of Vin. 
 
5.4 EXPERIMENTAL AND CLINICAL RESULTS 
Measurements were undertaken separately on each block of the proposed asynchronous device 
and were compared with the synchronous system (SALAM, 2010(c)) assembled with discrete 
commercial components. Table 5-3 shows power dissipation of these devices in both active and 
power saving modes. These prototyped devices have been made using latest low-power discrete 
components. However, recently developed FPGA operated in freeze standby mode, discrete 
components or custom integrated circuits could reduce the power consumption to microwatts. 
These prototyped devices have demonstrated smart operation to reduce power dissipation.  
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Table 5.3: Measured power consumption of synchronous and asynchronous prototyped 
devices at 3.3 V power supply  
Block Compa 
Synch Deviceb Asynch Devicec 
Qtd PC
e (mW) Qtd PC
 e
 (mW) 
AMf PSMg AMf PSMg 
Amplifier IAh 1 2 2 1 2 2 
Detector VWDi 3 13.1 13.1 4 17.4 8.0 
DFFj 3 6 6 0 0 0 
FDk 3 19.3 19.3 4 25.7 12.1 
Clock Oscl 1 1.5 1.5 0 0 0 
Modulator & 
Demodulator 
SWsm 4 0.1 0.1 0 0 0 
CPn 3 5 5 0 0 0 
VWDi 3 13.1 13.1 0 0 0 
TFGo FDk 3 19.3 19.3 0 0 0 
Receiver  0 0 0 1 6 6 
DDSp  1 0 5 1 10 5 
Total power consumptionq 70.1 65.1  61.2 33.1 
aComp: Component, bSynch Dev: Synchronous device, cAsynch Dev: 
Asynchronous device, dQt: Quantity, ePC: Power consumption, fAM: Active 
mode, gPSM: Power saving Mode, hIA: Instrumentational amplifier, iVWD: 
Voltage window detector, jDFF: Mater-salve D flip-flop, kFD: Frequency divider, 
lOsc: Oscillator, mSWs: Switches, nCP: charge pump, oTFG: Time frame 
generator, and pDDS: drug delivery system, and qpower dissipated by prototyped 
device based discrete components. 
The asynchronous prototyped device turned OFF 6 modules during the icEEG monitoring 
period and turned ON all 11 modules at seizure onset. With the synchronous device, the clock 
would have kept all modules running during the monitoring period. As a result, measured power 
consumption in the asynchronous detector was reduced by 49% in icEEG monitoring period 
(power saving mode) and 12% in active mode compared to the synchronous detector. The power 
dissipation densities were under maximum safety level (δPmax = 6mW/cm2 which may cause 
enough heat to damage surrounding tissue) (HARRISON, 2008). Figures 5-13 illustrate devices’ 
operation modes and their corresponding average power dissipation (PT) and power consumption 
densities (δp). 
Impedances of the proposed hybrid electrodes were electrically characterized in vitro using 
electrochemical impedance spectroscopy (Impedance analyzer HIOKI 3522 LCR) in standard 
physiological saline solution (0.9% NaCl). Figures 5-14(a) shows scanning electron microscope 
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Figure 5-13: Demonstration of power dissipation of proposed system: (a) Electrographic seizure 
in icEEG recording and (b) Average power dissipation PT and densities δP of the devices, where 
PT_A and PT_S are power dissipation in asynchronous and synchronous devices, and δP_A and δP_s
are power consumption densities, respectively. 
 
 
Figure 5-14: Electrical properties of the hybrid electrode: (a) SEM image of the proposed 
electrode contact and (b) Measured impedance sweep of the commercial and proposed 
electrodes. 
(SEM) images of the Pt electrodes and Figures 5-14(b) illustrates comparative studies on 
impedance magnitude of commercial electrode (AdTech Medical Instruments, WI, USA) and the 
proposed electrode. The proposed electrodes have significantly lower impedance and better 
recording performances (SALAM, 2011(b)). 
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Figure 5-15: Validation of proposed algorithm: (a) icEEG recordings Vin, (b) seizure onset 
activity is characterized by progressive amplitude increase, (c) rapid fast-activity, and (d) 
seizure onset detections. 
 
5.4.1 Validation of asynchronous front-end detector 
IcEEG recordings from two electrode contacts (Figure 5-10) located in the EZ from 7 patients 
were fed into the proposed algorithm and device. The AFED was tested on an average of 6 
electro-clinical seizures, 15 brief electrical seizures and 10 long normal signals (30 min randomly 
chosen) per patient. Figure 5-15 shows validation of the proposed detection algorithm using 
Matlab tools. The recorded icEEG Vin from case 1 was uploaded in Matlab simulation platform, 
and analyzed in time-amplitude and time-frequency domain, and detected seizure onset. Figure 5-
16 illustrates measured seizure detection of the proposed device on icEEG recordings (Vin) from 
case 1 and the seizure detection delay TDET of VSD. The simulation and experimental results of 
synchronous and asynchronous detectors are presented in Table 5.4. The AFED detected the 
electro-clinical seizures of all 7 patients in an average of 16 sec after seizure onset. Sensitivity of 
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Figure 5-16: Measured seizure onset detection by AFED, where Vamp is icEEG of seizure from 
the epileptogenic zone, and VSD is seizure onset detection of case 1. 
Table 5.4: Average seizure detection delay (TDET) of synchronous and asynchronous detectors.  
Case 
no. 
Age 
/Gender Epileptogenic zone 
Average TDET (s) 
Syncha Asynchb 
Simc Expd Simc Expd 
1 24/M Right hippocampus 7 6 7 9 
2 36/M Left lateral temporal neocortex 12 15 10 16 
3 44/M Left pre-motor cortex 7 15 7 18 
4 41/M Right amygdala/ hippocampus  10 21 12 22 
5 49/F Left hippocampus 24 12 18 15 
6 32/M Left hippocampus 12 12 11 13 
7 15/M Right lingual gyrus 25 20 19 22 
aSynch: Synchronous, bAsynch: Asynchronous,  cSim: Simulation results with Matlab, and dExp: 
Experimental results . 
 
the detectors has been defined according to (PANG, 2003) and both patient-specific seizure 
detectors had 100% sensitivity. The mean seizure detection delay was slightly longer than the one 
of the synchronous detector which took on average of 13 sec to detect seizures due to a lower 
noise effect in the device. 
5.4.2 Validation of drug delivery system 
The predefined drug dose was administrated in response to the early detection of seizure 
development. Figure 5-17 shows 3 self-triggered drug injections in response to the seizure 
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detection by the proposed system and illustrates the corresponding individualized dose. The doses 
are widely programmable by TPM and micropump control voltage VDP. Figure 5-18 shows range of 
drug dose for different variables. The desired seizure suppression dose (Table 5-1) was obtained 
by regulation TPM (Figure 5-18(a)), however, more precise was achieved with different 
combinations of VDP and TPM (Figure 5-18(b)).  
5.5 DISCUSSION 
The proposed closed-loop epilepsy prosthesis offers promises of lower power dissipation, 
better data-dependent computation and higher detection performances compared to a synchronous 
design. Current commercially-implantable epilepsy devices (SUN, 2008) and seizure detectors  
(SALAM, 2009(a); RAGHUNATHAN, 2009; SALAM, 2009(b); PATEL, 2009; SALAM, 2010 
(b); VERMA, 2010; SALAM, 2010(c); SALAM; 2011(c))  are based on a traditional synchronous 
design. Thus, these devices continuously dissipate battery power for clock gating which ultimately 
shortens the interval for battery replacement or recharging. Open loop devices, such as the VNS or 
anterior thalamic stimulators, stimulate in a periodic manner with a built-in clock which defines 
the periodic action (TERRY, 2009; SALAM, 2010(a); RYCHLICKI; 2006). These devices do not 
 
Figure 5-17: Monitored drug delivery process triggered by seizure detector, where Vin is neural 
signal, Vamp is amplified neural signal, VSD is seizure detection, VPM is drug injection period TPM, 
and VON is focal treatment duration TON. 
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Figure 5-18: Controlled widely programmable measured drug dose by: (a) injection period TPM
and (b) micropump needed voltage VDP with different TPM. 
 
require a change from traditional synchronous technology owing to the isolation of clock gating 
from the rest of the device in sleep mode. However, the RNS system (SUN, 2008) requires 
continuous long-term icEEG monitoring. Therefore, this system should replace traditional 
technology with asynchronous technology and improve data-dependent computation. Furthermore, 
the sensitivity of the proposed AFED are maximized 100% to prevent unwarranted drug delivery; 
however, sensitivity of (VERMA, 2010; RAGHUNATH, 2009; PATEL, 2009) are 94.35%, 
95.3%, and 93%, respectively.  Although the average detection of the proposed AFED is 8 sec 
(max) higher than the other detectors described in (VERMA, 2010; RAGHUNATH, 2009; 
PATEL, 2009); but the proposed device have showed well capability to detect seizure onset and 
deliver the antiepileptic drug well before the onset of clinical manifestations. For example, Figure 
5-11 shows minimum seizure progression time (~22 sec) for case 1 and subsequent aura reported 
at 33 sec; however, the proposed system detected this seizure at 8 sec (2nd row, 3rd column of 
Figure 5-16) and delivered sufficient amount of drug in a short duration (Figure 5-18), and 
consequently seizure may suppress within 5 sec (STEIN, 2000). The average detection delay of 
the detector is 16 sec, thus all the detections have sufficient time to inject drugs and block seizure 
progression. The direct drug delivery experiments for the seizure suppression in Table 5- 1 were 
demonstrated using external prototypes (e.g. desktop computer and syringe pump); however, the 
proposed prototyped device is implemented on two PCB boards and expected to be reliable in an 
implantable device without risking false detections. 
5.6 CONCLUSION 
We have described the design and implementation of an asynchronous closed-loop drug 
delivery system that paves the way for improved power management of currently-available 
technologies. The proposed asynchronous seizure detector was validated using icEEG recordings 
of 7 patients, and detection performance was as accurate as that obtained with synchronous 
devices, but reduced power consumption by 49% in power saving mode. Data-dependent analysis 
of this asynchronous design kept 6 modules (out of 11) OFF in icEEG monitoring mode unless 
abnormal activity interrupted it. The AFED integrates a multiple feature-based algorithm for the 
detection of epileptic seizures. Due to the heterogeneity of seizure onset patterns, an 
individualized method is the best solution among general feature-based approaches. Furthermore, 
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this method reduced device complexity. A computerized prosthesis pre-implantation procedure 
optimized individualized settings for adequate detection performance. Focusing on low-power 
dissipation, the proposed asynchronous detector is designed for progressively increasing low-
voltage, fast-activity, seizure-onset patterns. Experimental results have demonstrated the 
feasibility of asynchronous design in a low-power, reliable, implantable device. Further validation 
in an animal model of epilepsy is warranted.  
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CHAPTER 6  NOVEL INTRACRANIAL RECORDING SYSTEM 
Performance of the closed-loop brain stimulator (chapters 3, 4 and 5) is dependent on high 
quality icEEG recording. In this chapter, we present new electrodes for better quality icEEG 
recording. Also, we propose a new intracerebral recording system for epilepsy presurgical 
evaluation. The new subdural mini grid electrode has a new shape and several attributes to 
overcome currently encountered drawbacks with current intracranial electrodes. We present in 
the design of novel electrodes, the method of their fabrication, the architecture of a wireless EEG 
recording system, and in vitro and in vivo experimental results. This work was submitted for 
publication in the “IEEE Transactions on Biomedical Circuits and Systems” and it is reproduced 
in the following pages. 
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Abstract –In this paper, we present novel subdural electrodes in an attempt to improve 
localization of the epileptogenic zone with less morbidity. The new subdural mini grid electrode 
has a new shape and several attributes to address some of the problems encountered with 
currently used subdural electrodes. We demonstrate here the design of the novel electrodes, 
method of fabrication, in vitro and in vivo results. The mini grid electrodes contains 4 × 4 
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platinum/gold electrodes arrays on a thin polydimethylsiloxane (PDMS) substrate which is 
engineered to improve molding to the brain surface for better electrode tissue contact. Several 
mini grid electrodes are electrically connected as required to form a larger grid electrode. All 
the cables are routed internally and connected to the wireless recording device that is meant to 
be implanted on the skull under the skin. Up to 32-channel intracranial electroencephalo-graphic 
(icEEG) signals are recorded through intracerebral electrodes and transmitted wirelessly to a 
remote base station. The wireless system operates in the Medical Implant Communication 
Service (MICS) 400 MHz band. Results of in vitro experiment have shown minimum impedances 
for optimum choice of pure gold materials for electrodes and wire. The in vivo icEEG recordings 
in adult Sprague Dawley rats were performed for three weeks for basal activities and ~40 min for 
seizure activities recordings. The wirelessly icEEG recording system demonstrated on average a 
2% normalized root mean square deviation. The results of in vivo recordings demonstrated 
signal stability, 50% noise reduction and up to 6 dB SNR improvement to the commercial 
electrodes. Following the long-term icEEG recording, brain histological results showed no 
abnormal tissue reaction in underlying cortex. 
6.2 INTRODUCTION  
 Patients with refractory focal epilepsy may benefit from epilepsy surgery. Successful surgical 
treatment is highly dependent on adequate localization of the epileptogenic zone (EZ). Non-
invasive localization techniques such as scalp EEG, Positron emission tomography (PET), 
Magnetic resonance imaging (MRI), ictal single-photon emission computed tomography 
(SPECT), magnetoencephalography (MEG) and EEG-functional MRI (EEG-fMRI) can help in 
the identification of this EZ, sometimes allowing some patients to directly go onto resective 
surgery (SPENCER, 2009). When non-invasive techniques fail to adequately localize the EZ, an 
invasive EEG study is generally required. These invasive EEG studies consist in the implantation 
of intracerebral electrodes to allow direct recording from the brain. A wide verity of intracranial 
electrodes is available for such invasive studies: subdural strip or grid, depth, epidural, and 
foramen ovale electrodes (SPENCER, 2009; GOLDRING, 1984, WYLLIE 1987; WIESER, 
1985, DUBEAU 2007). They differ in method of insertion, accuracy, risks and limitations 
(TALAIRACH, 1958; BANCAUD, 1973, TALAIRACH, 1974, CRANDALL 1966). The choice 
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of electrodes depends on the suspected areas which need to be sampled. Figure 6-1(a) shows the 
traditional way of performing an invasive EEG study. 
The intracranial electrodes are more sensitive to the brain activities than extracranial 
electrodes because they are closer to the EZ. Whereas the extracranial electrodes record signal 
generated from a large cortical surface, intracranial electrodes record synchronous firing of many 
neurons throughout a few millimeters of cortex across the diameter of an electrode contact. 
However, uses of intracranial electrodes have disadvantages, such as a small risk of infection, 
edema and hemorrhage. Thus it is best to limit the number of electrodes implantation to delineate 
the EZ for safety purposes (Fountas, 2007; Benbadis, 2006). Restriction on the number of 
electrodes however may cause insufficient coverage to allow identification of the EZ. Erroneous 
identification of the EZ obviously translates into a poor epilepsy surgery outcome. 
 Intracerebral electrodes have been in use since the 1950s but no significant development has 
been made since except for the development of microelectrodes to record high-frequency 
oscillations mainly for research purposes (DODGE, 1963; PENFIELD, 1954). Due to their 
smaller electrode-tissue interface, these microelectrodes have different electrical characteristics 
compared to the subdural electrodes. Commercial companies (i.e. Ad-Tech Medical Instrument 
Corporation, WI or PMT Corporation, MN) use common manufacturing methods for developing 
intracerebral subdural electrodes (diameter 4/5 mm). These commercial electrodes are based on 
silicone rubber (Polydimethylsiloxane-PDMS) as insulation and substrate material, platinum or 
 
Figure 6-1:  Schematic representation of intracerebral EEG recording systems: the traditional 
procedure using currently available commercial electrodes and the new procedure using the 
proposed novel subdural electrodes. 
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stainless steel as electrode material, and stainless steel for wiring (HENLE, 2011). Gold (Au) has 
been used in subdural electrodes (REN, 2010) but no significant improvement on icEEG 
recording has been reported.  
Work presented here was motivated by the fact that currently used electrodes have several 
limitations. For one, mechanical resistance of electrode-wire generates noise that degrades the 
icEEG recording (REN, 2010). Higher chemical reactions at electrode-tissue interface produces 
toxic ions to the tissue (Merrill, 2005).  Moreover, many materials (i.e. stainless steel, tungsten, 
and titanium) need corrosion protection (i.e. passive film) (MERRILL, 2005), but this protection 
often dissolves due to faradic reaction in the passive film (Norlin, 2002). Other unresolved issues 
include wiring material, poor connection at electrode-wire interface, and visualization of 
implanted electrodes on post-implantation scans or MRIs. Finally, current intracerebral EEG 
recordings use many wired connections which limit the patient’s liberty to move and increase the 
risk of brain infections. 
The icEEG recording is generally characterized by low-amplitude signals (microvolt range) and 
low-frequency bandwidth. The available instruments have relatively poor noise performance for 
the low-spectral neural signal amplification (SALAM, 2009(a)). Moreover, other low-spectral 
noises generated from electrodes and electrode-tissue interface combine with instrument noise to 
modulate the neural signal and degrade the signal-to-noise ratio (SNR). We have previously 
demonstrated several front-end preamplifiers for noise reduction (SALAM, 2009(a); SALAM, 
2011(a)). However, optimum SNR value can also be obtained by improving intracranial electrode 
contacts (SALAM, 2011(b)).  
In this paper, we propose a novel subdural electrode based recording system (Figure 6-1(b)) 
featuring attributes which could potentially facilitate larger sampling with lower morbidity:  mini-
grids connected as needed, single exit cable, wireless transmission, grid notches and holes, edge 
markers and numbering system, low-impedance electrodes and wiring, and wireless recording 
system. 
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Figure 6-2: Illustration of the proposed novel subdural mini-grid electrodes: (a) new attributes 
and dimensions, (b) cross section of the mini grid, (c) placement, and (d) connection of the grid 
electrodes. 
6.3 PROPOSED NOVEL INTRACRANIAL RECORDING 
SYSTEM 
The proposed subdural mini grid and/or strip electrodes are meant to be implanted 
independently over suspected areas of epileptogenicity through a craniotomy (Figure 6-2). One or 
two main grid electrode(s) hold(s) all the electrodes and connect(s) to the implantable wireless 
icEEG recorder (Figure 6-1(b)). Following the implantation of intracranial electrodes, the patient 
can undergo an MRI study to verify the positioning of implanted electrodes and finally long-term 
video-EEG recording for localization of the EZ. The shapes and attributes of the new subdural 
electrodes, and recording system are described below. 
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(i) Smaller grids 
The mini subdural grid electrode is a 4 × 4 matrix (height 40 mm; width 40 mm; thickness 0.6 
mm thick). The dimensions of grid electrodes are smaller to fit curved regions of brain.  
(ii) Holes 
Commercial subdural grid electrodes may cause brain swelling (LEE, 2000). In an attempt to 
minimize risk of brain swelling, each mini-grid has six holes to allow CSF circulation. 
(iii) Notches 
The mini grid electrode is designed to fit on human brain cortical surface. Each mini grid has 4 
notches for better flexibility to allow a better fit with the curved cortical surface.  
(iv) Markers  
Edge and numbering markers are included in the grid electrodes to facilitate their identification 
on the post-implantation MRI. All materials used in the electrodes are MRI compatible and take 
into account the MR-susceptibility artifacts generated by metal contacts. 
(v) Connectors 
The mini grids are connected to each other using custom made contactors that enhance 
electrical and mechanical connection. The connectors provide internal routing of electrical wiring. 
Shorter wire length also reduces resistance in the electrical paths. Moreover, the connector 
provides stronger mechanical strength so that the mini-grids do not move and overlap. This mini 
grid electrode system can hopefully better adapt to the anatomy and different curvatures of various 
brain regions.  
(vi) One exit cable 
All the electrical paths are internally routed, thus all the cables are merged in one exit cable 
coated with Teflon that connects to the implantable device for wireless icEEG recording or to 
come out through the skin for wired recording. A single exit cable or wireless transmission should 
reduce risk of infections. 
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(vii) Electrode and wiring materials 
Quality of icEEG recordings is dependent on the choice of electrode material. We have 
previously shown that pure platinum (Pt) or pure gold (Au) electrodes provided higher 
conductivity than the commercial electrodes (SALAM, 2011(b)). In accordance, contacts of the 
mini grid electrodes are made of pure Pt or Au material, and wire connections between the 
electrodes (thickness 0.05 mm) and amplifiers are made the using same materials used for the 
electrodes with 0.1 mm diameter wires. 
(viii) Electrode-wire junction manipulation 
Electrode impedance can potentially be further improved by manipulating the electrode-wire 
junction. Two types of junction are used for the in vitro impedance analysis experiments: 
electrode-wire touch junction and manipulation of electrode-wire junction by high conductive 
Silver epoxy (SE). 
(ix) Wireless recording system 
The wireless recording system contains preamplifiers and a wireless data transceiver. The 
preamplifier has tuneable gain with an input referred RMS noise of ~1 µV and an accurate ADC 
converter with 24-bits resolution. The wireless chip has a SPI interface and a MAC layer module. 
The low-power wireless system uses a custom FSK transceiver (402-405 MHz) for icEEG 
recordings transmission. The MICS transceiver offers high throughput up to 800 kbps and 
automatic error handling and flow control with BER below 10-10. 
6.4 METHODS AND MATERIALS 
6.4.1 Fabrication of the mini grid electrodes 
Figure 6-3 illustrates the subdural mini grid electrodes fabrication process. This process has 
three steps: mould construction, electrode-wire junction manipulation, and assembly and 
packaging. 
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Figure 6-3: Flow chart of the subdural mini-grid electrode fabrication process. 
 (i) Mould design 
The moulds were designed using CATIA software and fabricated using high speed precision 3-
axis computer numerical controlled (CNC) vertical machining (Huron speed machine). The design 
and dimensions of the moulds are shown in Figures 6-4(a)-(b).  
 
(ii) Electrodes-wires connection 
Two types of electrode-wire connection were used to reduce impedance and improve icEEG 
recording performance. These connection types were electrode-wire touch connections and 
electrode-silver epoxy-wire connections. 
(iii) Assembly and packaging 
Electrodes and wires were assembled on the mould (Figure 6-4(c)) and PDMS was poured 
(Figure 6-4(d)). After 20 minutes of 110oC heating (Figure 6-4(e)), subdural electrode arrays were 
encapsulated with a thin PDMS substrate and were released from the mould (Figures 6-4 (f)-(g)). 
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Figure 6-4: Fabrication process: (a)-(b) Design of mini-grid electrodes mould structures of top 
(a) and bottom (b) parts using CATIA software and (c)-(g) Assembling and packaging process: 
assembling of electrodes and markers (c), pouring of silicone on the mould (d), attachment of 
both parts (e) and cross section of assembly (f), and cross section of fabricated mini-grid 
electrodes (g). 
6.4.1.1 Electron-probe microanalysis 
Compositional analyses of the electrode contacts were performed using Scanning electron 
microscope (SEM) images and electron-probe microanalysis with energy dispersive spectrometry 
quantitative technique (Oxford Instrumentation Company). 
6.4.1.2 Electrical impedance spectroscopy 
Impedances of the proposed electrodes were electrically characterized in vitro using 
electrochemical impedance spectroscopy (Impedance analyzer HIOKI 3522 LCR) in standard 
physiological saline solution (0.9% NaCl). Conductivity of the solution (Rs) was measured using 
a conductivity meter (Cole-Parmer, model 1481-40). The impedances of the new electrodes and 
commercial electrodes were measured as bipolar configuration. Figure 6-7(a) shows the 
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experimental set up. The corresponding equivalent circuit is shown in Figure 6-7(b). The total 
equivalent impedance is 
)||()||( 222111 ppwsppwT RCRRRCRZ ++++=                                    (6.1) 
where, Rw1,2 is the wire resistance, Cp1,2 is the double layer capacitance, Rp1,2 the charge 
transfer resistance, and Rs the resistance of the solution. Thus the impedance of an electrode (Zi) 
is the combination of Rw1/2, Cp1/2 and Rp1/2.  
6.4.2 IcEEG recording performance of proposed subdural contacts and 
comparison with commercially available subdural contacts 
These studies were conducted at the CHUM –Notre-Dame hospital and CHU-Ste-Justine 
hospital.  All procedures for the use and care of animals for these experiments were conformed to 
the policy and guidelines of the Canadian Council for Animal Care (CCAC). Experimental 
protocols were approved by the Comité Institutionnel des Bonnes Pratiques Animales en 
Recherche (CIBPAR) at the CHU Ste-Justine Research Center, Université de Montréal.  The 
recordings obtained with the proposed subdural contacts were compared with recordings made in 
human epileptics with commercial electrodes as part of their usual clinical care at the CHUM -
Notre-Dame Hospital. Use of these recordings was approved by the CHUM’s ethics committee. 
6.4.2.1 Animals and surgical electrode implantation procedure  
Two groups of male Sprague Dawley rats (P80, ~450-580g) underwent craniotomies (see 
below) with general anesthesia (i.e. induction: 4% isoflurane in 1 l/min of O2 and 0.05 mg/kg 
Buprenorphin, maintenance: 2% isoflurane in 0.5 l/min of O2 as shown in Figure 6-5(a). Twenty 
minutes before surgery the animals were pre-treated with atropine 0.1% (s.c. to minimize airways 
secretions), lactate ringer USP (2ml s.c. for hydration and electrolytes) and lidocaine 2.5% (s.c. 
for local anaesthesia). After that, a small slit (1cm) was done in the skin overlying the head to 
expose the skull.  
First, three holes were drilled on skull to place two anchor screws and one reference screw 
(1.25 mm in diameter) on top of the cerebellum as shown in Figure 6-5(b). Second, craniotomy 
windows were drilled out starting at the level of the Bregma coronal suture on the skull and the 
dura was carefully opened using a 30 ½ G seringe needle tip.  After that, the electrode implants 
120 
 
 
 
Figure 6-5: Surgical electrode implantation procedure in rats: (a) animal attached to stereotaxic 
instrument, (b) craniotomy windows, (c)-(d) electrode implantation in group 1 rats, and (e)-(f) 
implantation and coverage with dental cement on group 2 rats. 
 
were placed directly on top of cortex using a stereotaxic micro manipulator apparatus with steady 
forceps arms (Stoelting Co. Germany) and left there for 2 minutes while the brain was hydrated. 
Meanwhile, a piece of gelfoam (<1mm in thickness), covering the craniotomy windows space, 
was placed on top of the implant to keep the site moist, to stabilize the electrode, to minimize 
vibrations and, to protect the brain from the extrinsic milieu. Finally, the entire surgical site 
surface, remaining skull, anchors, canula sides and reference screws were covered/sealed with 
dental cement leaving to be seeing only the tip of the injection site (canula silicon entry), 
recording sites and reference outputs (Plastics-1 Inc., Roanoke, VA, USA).  
Following these implantations, the animals received post-operative care for three consecutive 
days (i.e. Enrofloxacine 10mg/kg, s.c. and Buprenorphin 0,05mg/kg, s.c.). After a 10-day post-
operative recovery period, the freely-moving animals were placed in a Plexiglas cylinder cage 
surrounded by a Faraday tent to undergo video-EEG recording. EEGs and animal behaviour were 
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recorded simultaneously with a Stellate Harmonie system linked to a 32-channel Lamont 
amplifying unit and an infrared video camera positioned 1.5 meter in front of the cages (Stellate 
Systems v 6.2e, Victoria, Montreal, Qc, CAN). Three separate observers blinded to the treatment 
groups, reviewed the video-EEGs to detect spontaneous recurrent seizures and clinically 
associated behaviours. 
6.4.2.2 IcEEG recordings and performance evaluation method 
Recording performance of the proposed subdural contacts was first tested in two different rat 
experimental groups and compared with icEEG recordings of human patients group using 
commercial electrodes. Quality of the recording is evaluated in terms of SNR of icEEG recording 
and the SNR is measured using Eq. (6.2). 
∑ ∑
∑
= =
=
+
=
N
i
N
i
nn
N
i
in
NiViV
NiV
dBSNR
1 1
2
2,
2
1,
1
2
10
/))()((
/)(
log20)(                                          (6.2) 
where, i = 1,2,3, ... N, Vin is icEEG recording, Vn,1 is noise1 and Vn,2 is noise2. SNR of icEEG 
recording improves with the signal strength in the icEEG frequency band while reducing noise1 
and noise2.  
6.4.2.2.1 Group-1: Basal activity recordings for three weeks with one subdural electrode 
contact on each side of the rat brain  
The rat in group-1 underwent two rectangular craniotomies (4 x 6 mm) on top of both 
hemispheres (Figure 6-5(c)). The proposed subdural pure Au contact was positioned over left 
hemisphere and the pure Pt electrode contact over the other through craniotomy windows (Figure 
6-5(d)). Basal icEEG activities and animal behaviours were monitored 12 hours per day (6 hours 
during the daytime, from 12 PM to 6 PM, and 6 hours at night, from 12 AM to 6 AM). Here, only 
basal activity was recorded to evaluate better SNR in recordings and electrode tissue reaction. 
6.4.2.2.2 Group-2: Induction of cortical seizures in vivo in rats using 4-aminopyridine (4-AP) 
For seizure induction and detection experiments, rats from group-2 were implanted with a 
subdural contact with a PDMS coated micro-cannula  (1.5 mm diameter and 10 mm length) using 
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drilling of a wider rectangular craniotomy (4 x 9 mm) only on the right side of the skull (Figures 
6-5(e)-(f) and zoom inset of Figure 6-6).  To induce focal seizures of different duration in these 
rats, animals were injected with 4-aminopyridine (4-AP: a selective blocker of the Kv1 family of 
voltage-activated K,+ channels) at doses of 30, 100 and 200 nmol respectively (all diluted in 2ul 
of sterile 0.9% saline plus sonicated for two minutes to have uniform suspension and adequate 
dilution of the drug). This injection was done using a 10 µL reservoir of 4-AP solution in a 
Hamilton syringe (26G) that was positioned using a stereotaxic apparatus and injected through the 
PDMS micro-canula orifice into the adjunct region of the anterior part of the subdural electrode. 
The syringe needle orifice was stereotaxically positioned at 11 mm downward from the top of 
canula for intracortically (≈ 0.5-1mm deep below the pial surface of the sensorimotor cortex) 4-
AP solution injection (2µL, over a 10 minutes period, at 0.2µL/min). In this second group of rats, 
similarly to group 1, 12 hours of basal activities were recorded but only over 24 hours; the 
following day, the rats were anesthetized with isoflurane and injected with 4-AP before being put 
back into a recording chamber to recover while being monitored for seizures for 40 minutes. 
These experiments were done to prove better SNR in seizure activity recordings and in order to 
evaluate seizure signal recording performance using the proposed electrodes with commercially 
available subdural electrodes. 
6.4.2.2.3 Group-3: comparative studies with human patients 
For comparative studies, we also obtained recordings from two human patients (24 and 36 
year-old male) with intractable partial epilepsy candidate for epilepsy surgery who had previously 
undergone an icEEG invasive study prior to epilepsy surgery. The signal analyzed in patient 1 
came from commercially-available subdural electrode (AdTech Medical Instruments, WI, USA) 
positioned over the right fronto-temporal region and in patient 2 from the electrode contact 
positioned over the left orbitofrontal region. The icEEG signal was recorded for 2 to 3 weeks. The 
SNR in the recordings were compared with icEEG recordings performed in rats using the 
proposed electrodes.  
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Figure 6-6: Method of icEEG recording using wired connections and the wireless system. Zoom 
inset illustrates implantation procedure and 4-AP drug injection into the brain for seizure 
induction. 
 
6.4.2.3 Magnetic resonance visualization of subdural mini-grids 
MRI appearance of the new electrodes was tested by placing them into a gel solution (0.9% 
NaCl with 14gm gelatin) and scanning them using a 1.5 T Phillips MR scanner. 
6.4.2.4 Validation of wireless transmission of icEEG recordings 
The icEEG was recorded in vivo from rats’ cortex using Stellate Inc.’s video-EEG wired 
recording system and the wireless recording device was tested in vitro using the wired recordings 
by evaluating the distortion between the original wired and the wirelessly re-recorded EEG. Figure 
6-6 shows the functional block diagram of the both recording system. Moreover, this wireless 
device is able to record 32 channels at 2 kHz sampling with 24-bit resolution.  
6.4.2.5 Histological analysis 
After long-term icEEG recordings using our proposed pure Pt and pure Au electrode contacts, 
histological examinations were carried out in the rats. The animals were first perfused through the 
heart using phosphate-buffered saline and 4% paraformaldehyde. The brains were blocked then 
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Figure 6-7: Fabrication of the mini grid-electrodes: (a)-(b) fabricated mould, (c)-(d) fabricated 
Au (c) and Pt (d) grid electrodes, (e) – (f) microanalysis of Au and Pt electrodes: X-ray 
fluorescence spectra recorded from Au (e) and Pt (f) electrode, and (g) wireless icEEG 
recording device.  
sterotaxically within the skull, removed, post-fixed for two hours at 4°C in a 4% 
paraformaldehyde phosphate-buffered solution (PB) and cryoprotected in graded sucrose in 0.1 
M phosphate buffer (pH 7.4) for 48 hours and frozen until processed. The blocks were cut in 
series of 50 µm thick sections in the coronal plane, sections stained with cresyl violet for nissl 
substance and histological examinations were performed. 
6.5 RESULTS 
Figures 6-7 (a)-(b) show the fabricated moulds of the new subdural electrodes. Two types of 
subdural grid electrodes were fabricated, one with pure Au contacts (Figure 6-7(c)) and the other 
with pure Pt contacts (Figure 6-7(d)). These electrodes were scanned using SEM imaging and 
their material composition analyzed using energy dispersive spectrometry quantitative technique. 
The SEM images and compositional analyses of the electrode contacts showed 99.90% purity for 
both electrodes (Figures 6-7 (e) and (f)). Figure 6-7(g) shows a photograph of the 4 × 5.5 cm 
wireless icEEG recording device. Details of experimental results are described below.     
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Figure 6-8: Impedance spectroscopy in vitro: (a) Bipolar impedance analysis configuration, (b) 
Equivalent electrical circuit of electrolyte-electrode interface, (c) Frequency analysis of icEEG 
recording with other noises, and (d) – (f) Measured impedance sweep of different electrodes, 
where Pt-Pt is Pt-electrode-Pt-wire, Au-Au is Au-electrode-Au-wire, Pt-SE-SS is Pt-electrode- 
Silver Epoxy (SE)-Stainless steel (SS)-wire, Pt-SE-Pt is Pt-electrode- Silver Epoxy (SE)-Pt-wire, 
Au-Pt is Au-electrode-Pt-wire, Au-SE-Pt is Au-electrode-Silver Epoxy-Pt-wire, and Au-SE-Au is 
Au-electrode-Silver Epoxy-Au-wire. 
 
6.5.1 Impedance measurement 
The in vivo icEEG recording at 200 Hz sampling frequency is generally located in the low-
frequency bandwidth (3 to 40 Hz). Flicker noise is predominant in lower frequency (<3Hz) and 
higher frequency noise is mainly located at >40Hz due to the sampling frequency limitation and 
thermal noise. Therefore, recorded signals are divided into three main frequency bands (i.e. 
noise1, icEEG and noise2 as shown in Figure 6-8(d)). Figures. 6-8 (d)-(f) show comparative 
studies on impedance magnitude of commercial subdural electrodes (AdTech Medical 
Instruments) and the proposed subdural electrodes. Figure 6-8(d) shows significantly lower 
impedance of the proposed pure Au and pure Pt electrodes compared to commercial electrodes. 
Moreover, Figure 6-8(e) shows that further impedance of Pt electrodes is reduced by attaching 
wire with Silver epoxy (SE). However, Au-electrode-Silver-Epoxy-Au-wire increases impedance 
compared to Au-electrode-Au-wire (Figure 6-8(f)).  
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Figure 6-9: In vivo IcEEG recordings using: (a) Commercial subdural electrodes; (b) 
Proposed Pt subdural electrodes; (c) Proposed Au electrodes; and (d) Average power spectral 
density of the icEEG recordings (a)-(c). 
6.5.2 IcEEG recording performance 
6.5.2.1 Basal activities recordings  
Figure 6-9 shows five second samples of in vivo icEEG recordings using commercial subdural 
electrodes, proposed Pt and Au electrode contacts. The icEEG recording using commercial 
subdural electrodes (Figure 6-9(a)) has severe low- and high-spectral noise effect due to higher 
electrode impedance. The recordings using proposed pure Pt and pure Au electrode contacts 
(Figures 6-9(b)-(c)) had lower noises while recording neural activities efficiently. Moreover, 
higher conductivity of the proposed electrodes allows translating more neural activities into 
icEEG recordings. Power spectral densities (PSD) of Figures 6-9 (a)-(c) demonstrate recording 
127 
 
 
Table 6.1: 4-AP induced seizure behavior in terms of modified racine’s scale (RACINE, 1972) 
Racine’s 
scale Convulsive behaviour 
0 Behavioral arrest (motionless), hair raising, excitement and rapid breathing  
1 Mouth movement of lips and tongue, vibrissae movements and salivation 
2 Head clonus and eye clonus 
3 Forelimb clonus, “wet dog shakes” 
4 Clonic rearing 
5 Clonic rearing with loss of postural control and uncontrollable jumping 
 
efficacy in 3 to 40 Hz bandwidth while suppressing the noises in lower and higher frequencies. 
Figure 6-9(d) illustrates that PSD of the recording using commercial subdural electrodes had 
highest noise effect in lower and higher frequency bands; whereas, recordings using the proposed 
Pt and Au electrode contacts had lowest noise effect.  
6.5.2.2   4-AP drug administration and seizure activities recording 
Following the 4-AP injection, the rats were plugged to the video-EEG recording system and 
various seizure signals were recorded for ~40 minutes. The epileptiform activity induced was 
characterized by an initial hypersynchronous brain wave activity followed by trains of poly-spikes, 
with low-amplitude and low-frequency spike-wave complexes that increased after the first few 
minutes. The corresponding convulsive behaviors (e.g. myoclonus and tonico-clonic) were ranked 
at modified Racine’s scale 0 to 5 (Table 6.1) in Figure 6-10 (RACINE, 1972). 
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Figure 6-11: Electrographic seizure recording and corresponding frequency analysis using (a) – (b) 
commercially available subdural electrodes, (c) – (d) proposed Pt subdural electrodes, and (e) – (f) 
proposed Au subdural electrodes.   
 
Figure 6-10: Histogram of seizure events induced by 200 nmol 4-AP injections: Durations of 34 
seizure events with different intensity (Racine’s scale) recorded in a rat. 
 
In order to evaluate recording performance, electrographic seizure signals recorded from 
human group using commercial subdural electrodes (Figure 6-11(a)) were compared with 4-AP 
induced seizure signals recorded using the proposed pure Pt (Figure 6-11(c)) and pure Au (Figure 
6-11(e)) electrode contacts. The corresponding frequency analysis of the recordings showed 
continuous degradation of lower-spectral noise in Figure 6-11(b) and reduced noise in Figures 6-
11(d)-(f). Further noise reduction evidence is illustrated in Figure 6-12. The PSD of seizure 
activities in Figure 6-11(a) recorded using the commercial electrodes had highest noise effect in 
129 
 
 
lower and higher frequency bands. However, the recordings using the proposed Pt and Au 
electrode contacts (Figure 6-11 (c) and (e)) had lowest noise effect. The impact of average noises 
and the SNR of the recordings are shown numerically in Table 6-2.  The icEEG recording using 
commercial subdural electrodes has the worst SNR (-4.84 dB) at seizure onset due to higher RMS 
noise 47.49 µV in the low frequency band (LFB) and 1.61 µV in the high frequency band (HFB). 
The proposed Pt and Au electrode contacts reduced significant amount of noises and achieved 
higher SNRs. The highest SNR (6.67dB) was recorded at seizure onset using Au electrode 
contacts. 
 
 
 
 
 
 
 
 
Figure 6-12: Power spectral density of the electrographic seizure recordings (same seizure 
as in Figure 6-11) using commercial subdural electrodes; proposed Pt subdural electrodes; 
and proposed Au electrodes. 
 
Table 6.2: Comparative study on average icEEG recordings in vivo 
 
                                      Basal                   Electrographic seizure 
                          Day                           Night Seizure onset    Seizure 
Electrode 
aRMS Noise 
(µV) dSNR 
(dB) 
aRMS Noise 
(µV) dSNR 
(dB) 
aRMS Noise 
(µV) dSNR 
(dB) 
aRMS Noise 
(µV) 
dSNR 
(dB) 
bLFB cHFB bLFB cHFB bLFB cHFB bLFB cHFB 
Commercial SDE 47.49 1.618 -4.84 54.25 7.07 -3.06 60.23 3.38 -2.92 47.44 5.12 5.35 
Proposed Pt 
electrodes 
39.81 6.53 0.22 35.18 9.91 0.16 32.58 14.38 3.12 57.20 12.73 2.37 
Proposed Au 
electrodes 
22.12 4.23 1.85 21.46 4.44 3.69 55.91 15.81 6.67 75.75 15.78 3.74 
aRMS: Root mean square, bLFB: Low frequency band, cHFB: High frequency band, and dSNR: Signal to noise ratio. 
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Figure 6-13: MRI image sequences of the new mini-grid Pt electrodes: Images (a) – (b) were 
taken by placing the electrodes into a gel solution (0.9% NaCl with 14gm gelatin) and scanning 
them using a 1.5 T Phillips MR scanner. 
 
6.5.3 Magnetic resonance visualization of subdural mini-grids 
All Au and Pt plates in the fabricated grid electrodes were clearly visualized in MRI images. 
Figure 6-13 shows MRI images of the proposed mini-grid electrodes, where electrodes, edge 
markers, and numbering markers were individually identified.  
6.5.4 Validation of wireless transmission of icEEG recordings 
The wireless icEEG recording system was implemented on printed circuit board and validated 
using the wired recorded icEEG from rats. Figures 6-14 (a)-(b) show icEEG recording from the 
wired Stellate Harmonie System and from the new wireless system. The icEEGs were recorded 
wirelessly at 250 Hz sampling frequency without degradation of signal quality. Normalized root-
mean-square deviation in between the original and wirelessly recorded signal was average 2%. 
The total power consumption of wireless recording system was 15mW.  
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Figure 6-15: Representative micrographs illustrating the effect of the proposed subdural 
electrodes on the morphological appearance of cortex, 7 days after the 3 weeks in vivo recording 
experiment in group 1: (a) Somatosensory cortices (exposed to the electrodes) and (b) Visual 
cortices (unexposed). 
 
Figure 6-14: IcEEG recordings using: (a) Stellate Harmonie System (wired setup) and (b) 
Wireless system. 
 
6.5.5 Post icEEG brain histology 
Histology results showed nissl substance and labeled cells on the cerebral cortex. The cyto-
architectures of the somatosensory cortices was similar between both brain hemispheres 
underneath the pure Pt (right) and pure Au (left) subdural electrode contacts in group 1 rats 
(Figure 6-15). The exposed regions were also compared to other sensory regions (not exposed to 
electrode contacts) such as the visual cortex. Clear cytoarchitectonic borders could still be 
defined between the primary and secondary sensory cortices. Neocortical laminar organization 
and cellular densities (e.g. neurons and glial cells) did not appear to be altered by the implants. 
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The rest of exposed tissues by the electrodes were found normal compared to (PAXINOS, 2009). 
6.6 CONCLUSION  
In this paper, we present early work on a new intracerebral recording system to improve 
localization of the EZ with less morbidity. The proposed novel subdural mini grid electrodes 
have a new shape and several attributes to address problems with the currently available 
electrodes: notches, holes, connectors, single exit cable, and wireless transmission. The new 
subdural electrodes were fabricated using moulding process and the pure Pt/Au electrode contacts 
were encapsulated with PDMS. The electrical characteristics of the pure Pt/Au electrodes were 
analyzed in vitro and their impedances were significantly lower than commercial electrodes.  The 
Au contact had better Electrical impedance spectroscopy properties in icEEG recording 
frequency band than the Pt contact. These electrodes were successfully implanted on rats and 
series of in vivo recording experiments were performed. The experimental results demonstrated 
50% less flicker and thermal noises than commercial electrodes, excellent signal stability, 
improved SNR by up to 6 dB, and no evidence of tissue damage. The next step will be to test the 
entire system in larger animals.  
6.7 ACKNOWLEDGMENTS  
The authors are grateful for support from the NSERC, the Canada Research Chair in Smart 
Medical Devices, the Microsystems Strategic Alliance of Québec (ReSMiQ), SAVOY 
Foundation, Epilepsy Canada, the CHU Sainte-Justine Foundation of the CHU Sainte-Justine, 
and the Foundation of Stars. 
 
133 
GENERAL DISCUSSION 
In this thesis, we have presented neural signal acquisition systems, automatic signal processors 
and responsive stimulators for the construction of new prosthetic devices to treat epilepsy. Also, 
we have proposed new subdural porous and notched mini grid electrodes during epilepsy 
presurgical evaluation. The contributions were made at circuit-level, system-level and 
fabrication-level. 
Implantable responsive device therapies offer a promising alternative treatment options 
outside of conventional medicine including the possibility of treating refractory epileptic patients 
who are not candidate for (or have failed) epilepsy surgery. The first step of constructing the 
therapeutic device is to design an electrographic seizure onset detector. However, 
electrophysiological seizure-onset patterns vary from patient to patient and a generic detector has 
higher level of complexity in circuit design and dissipates more power. The most frequently 
encountered ones are the low-voltage fast-activity, high-voltage fast-activity and rhythmic 
spiking patterns. The proposed seizure onset detection algorithm detects the most frequently 
seizure onset pattern (low-voltage fast-activity) in icEEG recordings. This algorithm includes a 
modified chopper stabilized preamplification and a real-time seizure onset detection method. 
Using this algorithm, we designed and implemented a integrated on chip detector that modulates 
icEEG recordings, amplifies the desired amplitude level of signal, extracts fast activity 
information using voltage window detectors, demodulates processed signal to the original 
frequency of acquisition using RC circuit, and detects seizure frequency by analyzing fast 
activities. Advantages of the proposed seizure detector are (i) reduction of the instrumentation and 
external noises, and enhancement of the sensitivity and specificity in seizure detection; (ii) 
increase of detection accuracy due to both high frequency and high amplitude detection criteria; 
(iii) decrease of false alarms due to seizure-unrelated physiological rhythmic activity and baseline 
activity variations; (iv) reduction of detection delay; and (v) the low-power consumption of the 
device. This detector was validated using icEEG recording from seven refractory epilepsy 
patients. The detection performance showed 100% sensitivity and specificity, and early detection 
of the abnormalities at electroclinical seizure onset demonstrates the capability of intervening 
quickly in the hope of disrupting before the seizure propagates to adjacent regions. 
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Responsive electrical stimulators composed of a seizure detector and a biphasic electrical 
stimulator. We proposed two prototypes of the responsive electrical stimulators. The first 
prototype combines the seizure detector and a FPGA based embedded stimulator. This device 
records icEEG continuously from the epileptogenic zone, monitors the recording, and triggers a 
burst of electrical stimulation on epileptic seizure onset detection. The second prototype of the 
responsive electrical stimulator which has lower power consumption, wider range of parameter 
variation, better precision, and larger memory. These responsive stimulators were validated 
offline using icEEG recording from ten refractory epilepsy patients and the early triggering of a 
burst of electrical stimulation is able to disrupt an upcoming seizure. Also, the second prototype 
stimulator was tested on cadaveric animal brain tissue in an in vitro morphologic electrical 
model. Spatial characteristics of the voltage distribution in cortex due to the stimulation were 
demonstrated and the experimental results suggested that lower frequency stimulation parameters 
caused significant amount of shunting of current through the cerebrospinal fluid; however higher 
frequency stimulation parameters produced effective spatial voltage distribution with lower 
stimulation charge. 
Another interesting alternative focal treatment of epilepsy is responsive direct drug delivery. 
In this thesis, we proposed an implantable device which contains a new asynchronous seizure 
detector and a drug delivery system. The proposed device offers promises of low power 
dissipation, better data-dependent computation and higher detection performances compared to 
the previously proposed synchronous design. The synchronous devices continuously dissipate 
battery power for clock gating which ultimately shortens the interval for battery replacement or 
recharging. The asynchronous system is validated using icEEG recordings from seven patients, 
and detection performance is as accurate as that obtained with synchronous devices, but reduces 
power consumption by 49% in power saving mode. Sensitivity of the device is maximized to 
prevent unwarranted drug delivery; however, the average detection of the device is higher than 
the other the state-of-the-art detectors; but the proposed device has showed capability to detect 
seizure onset and deliver the antiepileptic drug well before the onset of clinical manifestations. 
All the detections have sufficient time to inject drugs and block seizure progression. The 
proposed device was mounted on two PCBs and proven to be reliable in an implantable device 
without risking false detections. 
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Efficacy of the responsive focal treatment depends on high quality icEEG recording. In 
chapter 5, we proposed high conductive intracranial electrodes for better icEEG recordings. Apart 
from their necessity for implantable responsive devices, intracranial electrodes are used in the 
epilepsy centers to delineate the EZ prior to epilepsy surgery in drug-refractory patients. Current 
clinical use of such electrodes is associated with some risk of complications, the most common 
being infection, hemorrhage and edema. Hence, it is important to limit the number of electrodes 
used without compromising the ability to localize the epileptogenic zone (EZ) adequately. As 
such, there is always a risk that an intracranial study may fail to identify the EZ from suboptimal 
coverage. We presented a new subdural electrode design which will hopefully allow large 
sampling of suspected areas of epileptogenicity at lower risk.  The new subdural electrodes has 
several new attributes: (i) smaller in size but connectable grids which are intended to provide 
better conductivity with tissues in curvature regions and reduce electrode displacement or 
overlap; (ii) notches to provide better flexibility; (iii) holes to potentially reduce the risk of edema 
and hemorrhage; (iv) a numbering system and edge markers to facilitate their identification on 
post-implantation magnetic resonance imaging, (v) only two exit cables or wireless icEEG 
recordings in order to reduce the risk of infections. Moreover, the electrode contact and inter-
connection wiring use pure Gold and Platinum material to obtain lower impedance (~116 kΩ) 
values compared to commercial contacts. The electrode contacts were tested for long-term in vivo 
neural recordings in rats. The recorded signal had excellent stability; moreover, noises were 
reduced and the signal-to-noise ratio was increased by ~6 dB. Following icEEG recordings using 
novel electrode contacts, histological examination of the rats’ cortex showed no tissue damage.   
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CONCLUSION AND FUTURE WORKS 
Herein, we conclude this thesis by a review of our contributions along with offering some 
suggestions for future works. 
CONTRIBUTIONS 
1. Design, implementation and validation of two seizure onset detectors with different level of 
complexity and power dissipation as broken into the following points: 
(i) Proposing new preamplification techniques: (a) a chopper stabilized preamplification 
methodology and (b) a three-stage preamplifier. 
(ii) Proposing seizure onset detection algorithms: (a) synchronous detection algorithm and 
(b) asynchronous detection algorithm. 
(iii) Implementing the preamplifiers and seizure detectors in PCBs with discrete 
components and 0.18µm CMOS process, and successfully testing using icEEG 
recordings from refractory epilepsy patients.  
2. Modeling, implementation and validation of three new implantable closed-loops focal brain 
treatment devices as detailed below: 
(i) Proposing two architectures for the closed-loop electrical stimulators. 
(ii) Demonstration of spatial voltage distribution model in gray matter of brain due to the 
bipolar biphasic electrical stimulation. 
(iii) Proposing optimum electrical stimulation parameters for the suspected epileptic focus. 
(iv) Proposing an implantable asynchronous direct drug delivery device. 
(v) Construction of new hybrid electrodes. 
(vi) Implementing the closed-loop brain stimulators with microchip (0.18µm CMOS 
technology), FPGA (e.g. Actel EX256 and Igloo AGL125) and discrete components in 
miniature PCBs, and successfully testing using icEEG recording from ten refractory 
epilepsy patients. 
3. Design and implementation of a new presurgical procedure to improve localization of the 
epileptogenic zone with less morbidity as detailed below: 
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(i) Design new attributes and shapes for novel subdural electrodes in order to provide 
better coverage of the suspected regions of epileptogenicity. 
(ii) Improvement of signal-to-noise ratio of icEEG recording and better electrode-tissue 
reaction using higher conductive subdural electrode contact. 
(iii) Construction of a new implantable wireless icEEG recording system to reduce 
bacterial infection and CSF leakage. 
RECOMMENDATIONS FOR FUTURE WORKS 
This thesis paves the way for several research topics. Moreover, the new microelectronic 
device therapies like focal electrical stimulation and direct drug delivery have obviously many 
important considerations from different aspect of this approach. Herein, we mention some of 
these issues based on our studies and experiments in this thesis. 
(i) Preamplification: Design a modified chopper-stabilized amplifier using a conventional 
folded-cascode amplifier because of better noise performance. This conventional 
architecture requires additional four CMOS modulation switches to chopper stabilize 
the amplifier. Moreover, the demodulator and low-pass filter of the chopper amplifier 
can be replaced by a charge pump in order to reconstruct the signal in digital domain. 
This modified chopper-stabilized amplifier would be useful in low-power seizure 
detection applications. 
(ii) Seizure detection: Investigate different types of electrographic seizure onset (e.g. high 
voltage fast activities and rhythmic patterns) for a generic seizure detection algorithm. 
Determine optimum seizure onset detection criteria, design a power efficient algorithm, 
and implement it using CMOS process.    
(iii) High Frequency Oscillation (HFO): Increasing evidence indicate that pathological 
HFOs are good markers of the EZ. Thus, it is important to analyze the HFOs and 
determine optimum detection criteria and find out antiepileptic affect due to 
neuromodulation at HFO detection. Also, sampling frequency is important for the 
better HFO recoding. It is recommended to use 2 kHz or more sampling frequency to 
record HFOs and subsequent analysis and detections.  
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(iv) Closed-loop focal brain treatment device: Performance of a closed-loop 
neurostimulator can be improved several ways. We believe the following issues should 
be taken into count in future works:  
• Design and implementation of a miniaturized low-power fully integrated closed-loop 
neurostimulator.  
• Improvement of further electrical conductivity in intracranial electrodes and 
electrical path for better icEEG recoding. 
• Implementation of a low-power electrical stimulator using freeze-mode FPGA. 
• Design and implementation of low-power micropump rather than commercial 
micropump which has been used in this thesis. 
• Model and implementation of responsive thermoelectric (Peltier) device for focal 
cooling therapy. 
(v) Presurgical evaluation: Design and fabrication of hybrid subdural grid electrodes 
incorporating focal cooling. The grid electrodes can be fabricated using moulding 
process and microtubing would be integrated in the grid for cold water circulation.  
 
139 
 
 
 
BIBLIOGRAPHIE 
Abdelhalim, K., Smolyakov, V. & Genov, R. (2011). Phase-Synchronization Early Epileptic 
Seizure Detector VLSI Architecture, IEEE TBIOCAS, vol. 5, No. 5. 
Agarwal, V.S., Thakor, N.V., Lesser, R.P., Gordon, B., & Nathan, S. (1994). Modeling 
electrical stimulation of the human cerebral cortex; Engineering Advances: New Opportunities 
for Biomedical Engineers. Proceedings of the 16th Annual International Conference of the IEEE, 
1, 185- 186. 
Agnew, W.F., McCreery, D.B, (1990). Neural prostheses: fundamental studies. Englewood 
Cliff, NJ: Prentice Hall. 
Aksenova, T. I., Volkovych, V. V., & Villa, A. E. P. (2007). Detection of spectral instability 
in EEG recordings during the preictal period, J. Neural Eng., 4, 173. 
Anschel, D. J., Ortega, E. L., Kraus, A. C., Fisher, R. S. (2004). Focally injected adenosine 
prevents seizures in the rat. Experimental Neurology, vol. 190(2), pp. 544-547. 
Anschel, D. J., Ortega, E. L., Kraus, A. C., & Fisher, R. S. (2004). Focally injected adenosine 
prevents seizures in the rat. Experimental Neurology, 190, 544-547. 
Arnhold, J., Grassberger, P., Lehnertz, K., & Elger, C. E. (1999). A robust method for 
detecting interdependences: application to intracranially recorded EEG.  Physica D: Nonlinear 
Phenomena, 134, 419-430. 
Aziz, J. N. Y., Karakiewicz, R., Genov, R., Bardakjian, B. L., Derchansky, M., & Carlen, P. L. 
(2006). Towards Real-Time In-Implant Epileptic Seizure Prediction. IEEE Engineering in 
Medicine and Biology Conference.  
Aziz, J. N. Y., Karakiewicz, R., Genov, R., Bardakjian, B. L., Derchansky, M., & Carlen, P. L. 
(2006). Real-time seizure monitoring and spectral analysis microsystem.  IEEE ISCAS, 2133–36. 
140 
 
 
Aziz, J. N. Y., Karakiewicz, R., Genov, R., Chiu, A. W. L., Bardakjian, B. L., Derchansky, 
M., & Carlen, P. L. (2007). In vitro epileptic seizure prediction microsystem.  IEEE ISCAS, 
3115-3118. 
Babb, T. L., Lieb, J. P., Brown, W. J., Pretorius, J., Crandall, P. H. (1984). Distribution of 
pyramidal cell density and hyperexcitability in the epileptic human hippocampal formation. 
Epilepsia, vol. 25, pp. 721-728. 
Bancaud, J. & Talairach, J. (1973). Methodology of stereo EEG exploration and surgical 
intervention in epilepsy," Rev Otoneuroophtalmol., vol. 45(4), pp.315-28. 
Berdakh, A., & Don, S. H. (2009). Epileptic seizures detection using continuous time wavelet 
based artificial neural networks. ITNG - Int. Conf. Inf. Technol.: New Gener, 1456-1461. 
Benbadis S., Wyllie, E. & Bingaman, W. (2006). Intracranial electroencephalography and 
localization studies”, In: Wyllie E, ed., ch:77, The treatment of epilepsy: principles and practice. 
Bhavaraju, N. C., Frei, M. G., & Osorio, I. (2006). Analog seizure detection and performance 
evaluation. IEEE transactions on bio-medical engineering, 53, 238-245. 
Blad, N.B.L. (2007). An Electrical Impedance Model for Deep Brain Stimulation of 
Parkinson’s Disease. In 13th International Conference on Electrical Bioimpedance and the 8th 
Conference on Electrical Impedance Tomography. 
Boon, P., Raedt, R., de Herdt, V., Wyckhuys, T., & Vonck, K. (2009). Electrical stimulation 
for the treatment of epilepsy. Neurotherapeutics, 6(2):218-27. 
Butson, C. R., & McIntyre, C. C. (2008). Current steering to control the volume of tissue 
activated during deep brain stimulation. 1, 1, 7-1. 
Butsona, C. R., Maksa C. B., & McIntyre, C. C. (2006). Sources and effects of electrode 
impedance during deep brain stimulation. Clinical Neurophysiology, 117, 2, 447-454. 
Celik, O., O'Malley, M. K., Boake C., et al. (2010). Normalized movement quality measures 
for therapeutic robots strongly correlate with clinical motor impairment measures. IEEE Trans. 
Neural. Syst. Rehabil. Eng., vol. 18, no. 4, pp. 433-44. 
141 
 
 
Chabardes, S., Kahane, P.,  Minotti, L., Koudsie, A., Hirsch, E., Benabid, A.L. (2002). Deep 
brain stimulation in epilepsy with particular reference to the subthalamic nucleus. Epileptic 
Disord., 4 (Suppl. 3), S83–S93. 
Chen, Y. C., Hsu, H. L., Lee, Y. T., et al. (2011). An active, flexible carbon nanotube 
microelectrode array for recording electrocorticograms. J. Neural Eng., vol. 8(3).  
Constandinou, T. G. Georgiou, J., & Toumazou, C. (2008). A Partial-Current-Steering 
Biphasic Stimulation Driver for Vestibular Prostheses. IEEE Trans.Biomed. Eng., 2, 2, 106-113. 
Coulombe, J., Sawan, M., & Gervais, J. F. (2007). A Highly Flexible System for 
Microstimulation of the Visual Cortex: Design and Implementation.  IEEE Trans. Biom. Circuits 
& Systems, 1, 258–269. 
Crandall, P.H., Brown, W.J. & Brinza, K. (1966). Stereotaxic accuracy in vivo of Talairach 
method in temporal lobes. Confin Neurol., vol. 27, pp.149–53. 
David, J. A., Ortega, E., & Robert S. F. (2004). Diazepam prophylaxis for bicuculline-induced 
seizures: a rat dose-response model. Neuroscience Letters, 356, 66-68. 
DodGe, H.W., Bailey, A.A., Bickford, R.G., Petersen, M.C., Sem-Jacobsen, C.W. & Miller, 
R.H. (1953). Neurosurgical and neurologic application of depth electrography," Proc Staff Meet 
Mayo Clin., Vol. 28(6), pp. 188-91. 
Dubeau, F. & McLachlan, R. S. (2000). Invasive electrographic recording techniques in 
temporal lobe epilepsy. Can J Neurol Sci., vol. 27 Suppl 1, pp. S29-34. 
Engel, J. J. (2009). Overview of surgical treatment for epilepsy (3e éd.). The Treatment of 
Epilepsy, Wiley-Blackwell, 60, 743-756. 
Fisher, R. S., & Ho J. (2002). Potential new methods for antiepileptic drug delivery. CNS 
drugs, 16(9), 579-593. 
Fisher, R., Salanova, V., Witt, T., Worth, R., Henry, T., Gross, R., Oommen, K., Osorio, I., et 
al. (2010). Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory 
epilepsy. Epilepsia, 51(5), 899–908. 
142 
 
 
Fountas, K. N. & Smith, J. R. (2007). Subdural Electrode-Associated Complications: A 20-
Year Experience. Stereotact Funct Neurosurg, vol. 85, pp. 264–272. 
Ghosh-Dastidar, S., Adeli, H., & Dadmehr, N. (2008). Principal component analysis-enhanced 
cosine radial basis function neural network for robust epilepsy and seizure detection. IEEE Trans. 
Biomed. Eng., vol. 55, no. 2, pp. 512-8. 
Goldring S. & Gregorie, E.M. (10984). Surgical management of epilepsy using epidural 
recordings to localize the seizure focus. Review of 100 cases. J Neurosurg., vol. 60(3), pp. 457-
66. 
Good, L. B., Sabesan, S., Iasemidis, L. D., Tsakalis, K., & Treiman, D. M. (2004). Brain 
dynamical disentrainment by anti-epileptic drugs in rat and human status epilepticus. Conf. Proc. 
IEEE Eng. Med. Biol. Soc., vol.1, pp. 176-9. 
Gordon, B., Lesser, R., Rance, N., et al. (1990). Parameters for direct cortical electrical 
stimulation in the human: histopathologic confirmation. Electroenchepalog and Clin 
Neurophysiol, 75, 371–377. 
Gosselin, B., Simard, V., Roy, J. F., Marrouche, W., Dumortier, C., & Sawan, M. (2004). 
Multichannel wireless cortical recording: Circuits, system design and assembly challenges. IEEE 
International Workshop on Biomedical Circuits and Systems, Singapore. 
Gosselin, B., Simard, V., & Sawan, M. (2004). Low-power implantable microsystem intended 
to multichannel cortical recording. IEEE International Symposium on Circuits and Systems, 
Vancouver, BC, Canada. 
Gosselin, B., Simard, V., & Sawan, M. (2004). An ultra low-power chopper stabilized front-
end for multichannel cortical signals recording. IEEE CCECE, 2259 – 2262. 
Gosselin, B., Robert, P. Y., & Sawan, M. (2007). A Scalable Design for Signal Conditioning 
and Digitization in Implantable Multi-Channel Neural Sensors. Computer Architecture for 
Machine Perception and Sensing, International Workshop, 73-74. 
143 
 
 
Gosselin, B., & Sawan, M. (2007). A low-power integrated neural interface with digital spike 
detection and isolation. 14th IEEE International Conference on Electronics, Circuits and 
Systems, Marrakech, Morocco. 
Gosselin, B., & Sawan, M., & Chapman, C. A. (2007). A low-power integrated bioamplifier 
with active low-frequency suppression. IEEE Trans. on BioCAS, 1(3), 184-192. 
Gosselin, B., & Sawan, M. (2008). An ultra low-power CMOS action potential detector. IEEE 
International Symposium on Circuits and Systems, Seattle, WA. 
Gosselin, B., & Sawan, M. (2009). An ultra low-power CMOS automatic action potential 
detector. IEEE Trans. on Neural Systems and Rehabilitation Engineering, 17(4), 346-353. 
Gosselin, B., Sawan, M., & Kerherv, E. (2010). Linear-phase delay filters for ultra-low-power 
signal processing in neural recording implants. IEEE Trans. on BioCAS, 4(3), 171-180. 
Gosselin, B., & Sawan, M. (2010). A low-power integrated neural interface with digital spike 
detection and extraction.  AICSP, vol. 64(1), 3-11. 
Gotman, J., (1985). Seizure recognition and analysis. In Long-term Monitoring in Epilepsy, 
Electroencephalography and Clinical Neurophysiology, Suppl 37, Amsterdam: Elsevier, pp. 133-
145. 
Gordon B., Lesser R., Rance N., et al. (1990). Parameters for direct cortical electrical 
stimulation in the human: histopathologic confirmation. Electroenchepalog and Clin 
Neurophysiol,  75, 371–377. 
Guerra, G. R., Davalos, R. V., Garcia P. A., et al. (2005). Heat transfer model to characterize 
the focal cooling necessary to suppress spontaneous epileptiform activity. Proceedings of SPIE: 
Progress in Biomedical Optics and Imaging, 240-246. 
Handforth, A., DeSalles, A.A.,  Krahl, S.E. (2006) Deep brain stimulation of the subthalamic 
nucleus as adjunct treatment for refractory epilepsy. Epilepsia, 47 (7), 1239–1241. 
Harrison, R. R. (2008). The design of integrated circuits to observe brain activity. Proceedings 
of the IEEE, 96, 1203-1216. 
144 
 
 
Henle, C., Raab, M., Cordeiro, J. G., Doostkam, S., Schulze-Bonhage, A., Stieglitz, T. & 
Ricker, J. (2011). First long term in vivo study on subdurally implanted Micro-ECoG electrodes, 
manufactured with a novel laser technology.  Biomed Microdevices, vol. 13, pp.59–6. 
Hodaie, M., Wennberg, R.A., Dostrovsky, J.O., and Lozano, A.M., (2002). Chronic anterior 
thalamus stimulation for intractable epilepsy. Epilepsia, 43 (6), 603–608. 
Iasemidis, L. D., Deng-Shan, S., Chaovalitwongse, W., Sackellares, J. C., Pardalos, P. M., 
Principe, J. C., Carney, P. R., Prasad, A., Veeramani, B. & Tsakalis, K. (2003). Adaptive 
epileptic seizure prediction system. IEEE Transactions on Biomedical Engineering, 50, 616-627. 
Iasemidis, L. D., Pardalos, P. M., Shiau, D.S., Chaowolitwongse, W., Narayanan, K., Kumar, 
S., Carney, P. R., & Sackellares, J.C. (2003). Prediction of human epileptic seizures based on 
optimization and phase changes of brain electrical activity. J. Optimization Methods and 
Software, 81-104. 
Jacobs, J., Zijlmans, M., Zelmann, R., Olivier, A., Hall, J., Gotman, J., & Dubeau, F. (2010). 
Value of electrical stimulation and high frequency oscillations (80-500 Hz) in identifying 
epileptogenic areas during intracranial EEG recordings. Epilepsia, Vol. 51(4), pp. 573-82. 
Jawed, S. A., Nielsen, J. H., Gottardi, M., Baschirotto, A., & Bruun, E. (2009). A 
multifunction low-power preamplifier for MEMS capacitive microphones. Proceedings of the 
35th European Solid-State Circuits Conference. ESSCIRC, pp. 292-5. 
Katz, B., & Miledi, R. (1965). The effect of temperature on the synaptic delay at the 
neuromuscular junction. J. Physiol, 181, 656–670. 
Kossoff, E. H., Ritzl, E. K., Politsky, J. M., Murro, A. M., Smith, J. R., Duckrow, R. B., 
Spencer, D. D. & Bergey, G. K. (2004). Effect of an external responsive neurostimulator on 
seizures and electrographic discharges during subdural electrode monitoring.  Epilepsia, 45, 
1560-1567. 
Kuncel, A.M., Cooper, S.E., Wolgamuth, B.R., Clyde, M.A., Snyder, S.A., Montgomery Jr, 
E.B., Rezai, A.R., & Grill, W.M. (2006).  Clinical response to varying the stimulus parameters 
in deep brain stimulation foressential tremor. Mov. Disord., 21, 11, 1920–1928. 
145 
 
 
Lee, W.S., Lee, J.K., Lee, S.A., Kang, J.K., & Ko, T.S. (2000) Complications and results of 
subdural grid electrode implantation in epilepsy surgery. Surg Neurol. Vol. 54(5), pp. 346-51. 
Lega, B. C., Halpern, C. H., Jaggi, J. L. and Baltuch,  G. H. (2009). Deep brain stimulation in the 
treatment of refractory epilepsy: update on current data and future directions. Neurobiol Dis., 
38(3):354-60. 
Lehnertz, A., & Elger, C. E. (1995). Spatio-temporal dynamics of the primary epileptogenic 
area in temporal lobe epilepsy characterized by neuronal complexity loss. Electroencephalogr. 
Clin. Neurophysiol., vol. 95, no. 2, pp. 108-17. 
Lester, D. B., Rogers, T. D., & Blaha, C. D. (2009). Neuronal pathways involved in deep brain 
stimulation of the subthalamic nucleus for treatment of Parkinson’s disease, IEEE EMBC, 3302-
5. 
Manola L., Roelofsen B. H., Holsheimer J., Marani E., & Geelen J. (2005). Modelling motor 
cortex stimulation for chronic pain control: Electrical potential field, activating functions and 
responses of simple nerve fibre models. 43, 3, 335-343. 
Masaya, Y., Akiyoshi, S., Keiichi, T., Nobuhiko, N. (2010). Multichannel biosensing and 
stimulation LSI chip using 0.18m complementary metal-oxide-semiconductor technology. 
Japanese Journal of Applied Physics, Vol. 49, No. 4 PART 2. 
McIntyre C. C., Mori S., Sherman, D. L., Thakor N. V., & Vitek J. L. (2004). Electric 
field and stimulating influence generated by deep brain stimulation of the subthalamic nucleus. 
115, 3, 589-595. 
McSharry, P. E., He, T., Smith, L. A. & Tarassenko, L. (2002). Linear and non-linear methods 
for automatic seizure detection in scalp electro-encephalogram recordings. Medical & biological 
engineering & computing, 40(4), 447-461. 
Meier, R., Dittrich, H., Schulze-Bonhage, A., et al. (2008). Detecting epileptic seizures in 
long-term human EEG: a new approach to automatic online and real-time detection and 
classification of polymorphic seizure patterns,” J. Clin. Neurophysiol., vol. 25, no. 3, pp. 119-
131. 
146 
 
 
Merrill, D. R., Biksonb, M., & Jefferysc, J.G.R. (2005). Electrical stimulation of excitable 
tissue: design of efficacious and safe protocols. Journal of Neuroscience Methods, 141, 171–198. 
Miocinovic, S., Lempka, S. F., Russo, G. S., Maks, C. B., Butson , C. R., Sakaie, K. E., Vitek, 
J. L., & McIntyre,  C. C. (2009).  Experimental and theoretical characterization of the voltage 
distribution generated by deep brain stimulation. Exp Neurol., 216, 1, 166-76. 
Mormann, F., Lehnertz, K., David, P., & Elger, C. E. (2000). Mean phase coherence as a 
measure for phase synchronization and its application to the EEG of epilepsy patients. Elsevier 
Science, 144, 358-369. 
Morrell, M. J. (2002). Brain stimulation for epilepsy: can scheduled or responsive 
neurostimulation stop seizures?.  Neurology, 164–168. 
Morrell, M. J. (2011). Responsive cortical stimulation for the treatment of medically 
intractable partial epilepsy, Neurology. 77, 13, 1295-304. 
Mounaim, F., Sawan, M., & Bedard, S. (2006). Implantable Neuro-Monito-Stimulation 
System Dedicated to Enhance the Bladder Functions.  IEEE Biomedical Circuits and Systems 
Conference - Healthcare Technology, 198–201. 
Mounaim, F., & Sawan, M. (2007). Miniature Implantable System Dedicated to Bi-Channel 
Selective Neurostimulation. IEEE ISCAS, 2072-2075. 
Mounaim, F., & Sawan, M. (2011). Integrated High-Voltage Inductive Power and Data 
Recovery Front-End Dedicated to Implantable. IEEE TBIOCAS, 5, 3, 283-291. 
Moxon, K., Kuzmick, V., Lafferty, J., Serfass, A., Szperka, D., Zale, B., Johnson, J. & 
Nagvajara, P. (2001).  Real-time seizure detection system using multiple single-neuron 
recordings. Conference Proceedings of the 23rd Annual International Conference of the IEEE 
Engineering in Medicine and Biology Society, 934-937. 
Nadeau, P., & Sawan, M. (2006).  A flexible high voltage biphasic current-controlled 
stimulator. Conference on Biomedical Circuits and Systems, 206–209. 
Nagaraj, S., Shah, A., Shah, P., Szeto, V., & Bergen, M. T. (2006). Ambulatory preseizure 
detection device. IEEE 32nd Annual Northeast Bioengineering Conference, 41-42. 
147 
 
 
Nandan, M., Sachin, S. S., Myers, S., Ditto, W. L., Khargonekar, P. P., & Carney, P, R. 
(2010). Support vector machines for seizure detection in an animal model of chronic epilepsy. J. 
Neural Eng., 7, 036001. 
Nathan, S. S., Sinha, S. R., Gordon, B., Lesser, R. P., & Thakor, N. V. (1993). Determination 
of current density distributions generated by electrical stimulation of the human cerebral cortex. 
Electroencephalography and Clinical Neurophysiology, 86, 3, 183-92. 
Nielsen, L. S. & Sparso, J. (1999). Designing asynchronous circuits for low power: an IFIR 
filter bank for a digital hearing aid. Proceedings of the IEEE, vol. 87, no. 2, pp. 268-81. 
Nguyen, D. K., & Spencer, S. S. (2004). Invasive EEG in presurgical evaluation of epilepsy 
(2e éd.). The Treatment of Epilepsy, Wiley-Blackwell, 53, 633-658. 
Niro, J., Manso, J., Ballina, F., Periolo, S., D'Atellis, C., Ponce, S., Barroso, M., Anessi, C., & 
Kochen, S. (2007). Development of a neurostimulator for studies of epileptic crisis. J. Phys. 
Conf. Ser., 90, 012032. 
Norlin, J. P. & Leygraf, C. (2002). Investigation of interfacial capacitance of Pt, Ti and TiN 
coated electrodes by electrochemical impedance spectroscopy, Biomol. Eng., vol. 19, no. 67. 
Oommena, J., Krausb, A. C., & Fisher, R. S. (2007). Intraventricular administration of 
gabapentin in the rat increases flurothyl seizure threshold.  Neuroscience Letters, 417, 308-311. 
Osorio, I., Frei, M.G., Manly, B.F., Sunderam, S., Bhavaraju, N.C., and Wilkinson, S.B. 
(2001).An introduction to contingent (closed-loop) brain electrical stimulation for seizure 
blockage, to ultra-short-term clinical trials, and to multidimensional statistical analysis of 
therapeutic efficacy. J Clin Neurophysiol, 18(6), 533-44. 
Osorio, I., Frei, M. G., Sunderam, S., Giftakis, J., Bhavaraju, N. C., Schaffner, S. F. & 
Wilkinson, S. B. (2005). Automated seizure abatement in humans using electrical stimulation. 
Annals of Neurology, 57(2), 258-68. 
Osorio, I., Frei, M. G., Sornette, D., & Milton, J. (2009). Pharmaco-resistant seizures: self-
triggering capacity, scale-free properties and predictability? European Journal of Neuroscience, 
30, 1554–1558. 
148 
 
 
Osorio, I., & Frei, M. G. (2009). Real-time detection, quantification, warning, and control of 
epileptic seizures: The foundations for a scientific epileptology. Epilepsy & Behavior, 16, 391–
396. 
Panescu, D. (2005). Vagus nerve stimulation for the treatment of depression. IEEE Eng. Med. 
Biol. Mag., vol. 24, no. 6, pp. 68-72. 
Patel, K., Chua, C. P., Faul, S., & Bleakley, C. J. (2009). Low power real-time seizure 
detection for ambulatory EEG. Int. Conf. on PCTHealth - Pervasive Health. 
Pang, C. C. C., Upton, A. R. M., Shine, G. & Kamath, M. V. 2003. A Comparison of 
Algorithms for Detection of Spikes in the Electroencephalogram", IEEE Trans. Biomed. Eng., 
vol. 50(4). 
Paxinos G. & Watson, C. (2009). The rat brain in stereotaxis coordinates, 6th edition: 
Academic Press Elsevier, London, Burlinton, San Diego. 
Penfield, W. & Jasper, H. (1954). Epilepsy and the Functional Anatomy of the Human Brain. 
Boston, Little, Brown and Co. 
Polychronaki, G. E., Ktonas, P. Y., Gatzonis, S., Siatouni, A., Asvestas, P. A., Tsekou, H., 
Sakas, D., & Nikita, K. S. (2010). Comparison of fractal dimension estimation algorithms for 
epileptic seizure onset detection. J. Neural Eng., 7, 046007. 
Racine, R. J. (1972). Modification of seizure activity by electrical stimulation. II. Motor 
seizure. Electroencephalography and Clinical Neurophysiology, vol. 32, pp. 281–94. 
Raghunathan, S., Gupta, S. K., Ward, M. P., Worth, R. M., Roy, K., & Irazoqui, P. P. (2009). 
The design and hardware implementation of a low-power real-time seizure detection algorithm. 
Journal of Neural Engineering, 6(5), 1-13. 
Raghunathan, S., Jaitli, A. & Irazoqui, P. P. (2011). Multistage seizure detection techniques 
optimized for low-power hardware platforms. Epilepsy & Behavior, vol. 22, pp. S61–S68. 
Raghunathan, S., Gupta, S. K., Markandeya, H. S., Irazoqui, P. P., & K. Roy. (2011) Ultra 
Low-Power Algorithm Design for Implantable Devices: Application to Epilepsy Prostheses. J. 
Low Power Electron. Appl. vol. 1, pp. 175-203.  
149 
 
 
Rayport, M., & Sandler, B. (1969). Six-electrode method for the measurement of the passive 
electrical properties of brain envelopes. Med Biol Eng., 7, 3, 321-4. 
Ren,  T. L., Yan, B., Lin, J. H., Wu, X. M., Wang, L. G., Yang, Y. & Liu, L. T. (2010).  A 
MEMS-Based Flexible Electrode Array Using Composite Substrate. IEEE Electron Devices and 
Solid-State Circuits. 
Reese, T. J. (2009). Vagus nerve stimulation: A proven therapy for treatment of epilepsy 
strives to improve efficacy and expand applications. IEEE EMBC., 4631-4634. 
Ren, T. L., Yan, B., Lin, J. H., Wu, X. M., Wang, L. G., Yang, Y., & Liu, L. T. (2010). A 
MEMS-Based Flexible Electrode Array Using Composite Substrate. IEEE EDSSC. 
Risinger, M. and Gumnit, R., (1995). Intracranial electrophysiologic studies. Neuroimaging 
and Clin N Am,.5, 559 –573. 
Rothman, S. M., Smyth, M. D., Yang, X. F., & Peterson, G. P. (2005). Focal cooling for 
epilepsy: an alternative therapy that might actually work.  Epilepsy Behav, 7, 214–221. 
Rubinstein, J. T., Miller, C. A., Mino, H., & Abbas, P. J. (2001). Analysis of monophasic and 
biphasic electrical stimulation of nerve. IEEE Trans. Biomed. Eng., 48, 10, 1065–1070. 
Rychlicki, F., Zamponi, N., Trignani, R., Ricciuti, R. A., Iacoangeli, M., & Scerrati M. (2006). 
Vagus nerve stimulation: clinical experience in drug-resistant pediatric epileptic patients, Seizure, 
15(7), 483-490. 
Saab, M. E., & Gotman, J. (2005). A system to detect the onset of epileptic seizures in scalp 
EEG. Clin Neurophysiol., vol. 116, no. 2, pp. 427-4. 
Safi-Harb, M., Salam, M. T., Nguyen, D. K., & Sawan, M. (2011). An Implantable Seizure-
Onset Detector Based on a Dual-Path Single-Window Count-Based Technique for Closed-Loop 
Applications, IEEE Journal on Emerging and Selected Topics in Circuits and Systems, (Accepted 
for publication). 
Safi-Harb, M., Salam, M. T., Sawan, M., Nguyen, D. K., & Mirabbasi, S. (2011) A High 
Sensitivity Low-Power CMOS Seizure-Onset Detector, IEEE EMBC, Boston, USA.  
150 
 
 
Salam, M. T., Sawan, M., Hamoui, A., & Nguyen D. K. (2009). Low-power CMOS-based 
epileptic seizure onset detector.  IEEE-NEWCAS, pp. 1-4. 
Salam, M. T., Sawan, M., & Nguyen, D. K., & Hamoui, A. A. (2009). Epileptic low-voltage 
fast-activity seizure-onset detector,” IEEE-BIOCAS, pp. 169-172. 
Salam, M. T., Sawan, M., & Nguyen, D. K. (2010). Low-power implantable device for onset 
detection and subsequent treatment of epileptic seizures: a review. Journal of Healthcare 
Engineering, 1(2), 169-184.  
Salam, M. T., Sawan, M., & Nguyen, D. K. (2010). Epileptic seizure onset detection 
prior to clinical manifestation.  IEEE EMBC 6210-3. 
Salam, M. T., Sawan, M., & Nguyen, D. K. (2010). A Low-power Implantable Device For 
Epileptic Seizure Detection and Neurostimulation, IEEE-BIOCAS, pp. 154 – 157. 
Salam, M. T., Sawan, M., & Nguyen, D. K. (2011). A Multichannel Intracerebral EEG 
Monitoring System For Epilepsy Presurgical Evaluation, IEEE Canadian Conference on 
Electrical and Computer Engineering: Biomedical and Health Informatics Symposium, Niagara, 
Canada. 
Salam, M. T., Desgent, S., Duss, S., Carmant, L., Nguyen, D. K., & Sawan, M. (2011). New 
Subdural Electrode Contacts for Intracerebral Electroencephalographic Recordings: Comparative 
Studies on Neural Signal Recording In Vivo, IEEE BioCAS, San Diego, USA. 
Salam, M. T., Sawan, M., & Nguyen, D. K. (2011). A Novel Low-Power Implantable 
Epileptic Seizure-Onset Detector, IEEE Transactions on Biomedical Circuits and Systems (online 
version available since 23 June 2011). 
Salam, M. T., Nguyen, D. K., & Sawan, M. (2012). Implantable Closed-loop Epilepsy 
Prosthesis: Modeling, Implementation and Validation, ACM Journal of Emerging Technologies 
in Computing, 2011 (To be appeared). 
Salam, M. T. , Mirzaei, M. Sawan, M., & Nguyen, D. K. (2012), A Implantable Asynchronous 
Responsive Drug Delivery System for Treatment of Epilepsy, IEEE Transactions on Neural 
Systems & Rehabilitation Engineering (To be appeared).   
151 
 
 
Salam, M. T., Mounaïm , F., Nguyen, D. K., & Sawan, M. (2012). Low-Power Circuit 
Techniques for Epileptic Seizures Detection and Subsequent Neurostimulation, Journal of Low 
Power Electronics - American Scientific Publishers: Special Issue on Emerging Technologies, 
Vol. 8, N°2 (To be appeared). 
Salam, M. T., Gelinas, S., Desgent, S., Duss, S., Turmel, F. B., Carmant, L., Sawan, M., and 
Nguyen D. K. (2012). Subdural Porous and Notched Mini Grid Electrodes for Wireless 
Intracranial EEG Recordings. IEEE Transactions on Biomedical Circuits and Systems, 
(Submitted for publication). 
Sarma, S. V., Eden, U. T., Cheng, M. L., et al. (2010). Using point process models to compare 
neural spiking activity in the subthalamic nucleus of Parkinson's patients and a healthy primate. 
IEEE Trans. Biomed. Eng., vol. 57, no. 6, pp. 1297-305. 
Sawan, M., Salam, M. T., Gelinas, S., Lesage, F., & Nguyen, D. K. (2012). Combined NIRS-
EEG Remote Recordings for Epilepsy and Stroke Real-Time Monitoring. IEEE ISCAS special 
session, Korea (Accepted). 
Sawan, M., Hu, Y., & Coulombe, J. (2005). Wireless Smart Implants Dedicated to 
Multichannel Monitoring and Microstimulation. Invited paper in IEEE Circuits and Systems 
Magazine, 5, 21-39. 
Sawan, M., Ba, A., Mounaim, F., Corcos, J., & Elhilali, M. M.  (2008). Biomedical Circuits 
and Systems Dedicated for Sensing and Neurostimulation: Case study on Urinary Bladder 
dysfunctions.  Turkish Journal of Electrical Engineering and Computer Science, 16,  3, 171-187. 
Schachter, S. C., Guttag, J., Schiff, S. J., Schomer, D. L., & Summit Contributors. (2009). 
Advances in the application of technology to epilepsy: the CIMIT/NIO epilepsy innovation 
summit. Epilepsy & Behavior, 16, 3–46. 
Sethi, N., Labar, D., Ponticello, L., Torgovnick, J., Sethi, P., & Arsura, E. (2008). Treatment 
of Medically Refractory Epilepsy: A Review Of Vagus Nerve Stimulator.  The Internet Journal 
of Neurology, 9(1). 
Shoeb, A., Edwards, H., Connolly, J., Bourgeois, B., Treves, T. & Guttag, J. (2004). Patient-
Specific Seizure Onset Detection, Engineering in Medicine and Biology Society,  5(4), 483-498. 
152 
 
 
Skarpaas, T. L., & Morrell, M. J. (2009).  Intracranial stimulation therapy for epilepsy. 
Neurotherapeutics, 6(2), 238-43. 
Smith, D. C., Krahl, S. E., Browning, R. A. & Barea, E. J. (1993). Rapid cessation of focally 
induced generalized seizures in rats through microinfusion of lidocaine hydrochloride into the 
focus. Epilepsia, vol. 34, pp. 43-53. 
Sramka M, Chkhenkeli S. A., (1990). Clinical experience in intraoperational determination of 
brain inhibitory structures and application of implanted neurostimulators in epilepsy. Stereotact 
Funct Neurosurg, 54 –55:56 –59. 
Stein, A. G., Eder, H. G., Blum, D. E., Drachev, A., & Fisher, R. S. (2000). An automated 
drug delivery system for focal epilepsy. Epilepsy research, 39, 103-114. 
Spencer, S. S., Nguyen, D. K., & Duckrow, R. B. (2009). Invasive EEG in presurgical 
evaluation of epilepsy (3e éd.). The Treatment of Epilepsy, 53, 767-798. 
Suffczynski, P., Da Silva, F. H. L., Parra, J., Velis, D. N., Bouwman, B. M., van Rijn, C. M., 
van Hese, P., Boon, P., Khosravani, H., Derchansky, M., Carlen, P. & Kalitzin, S. (2006). 
Dynamics of epileptic phenomena determined from statistics of ictal transitions. IEEE 
Transactions on Biomedical Engineering, 53(3), 524-532. 
Sukhi, G. & Jean, G. (2005). An automatic warning system for epileptic seizures recorded on 
intracerebral EEGs. Clinical neurophysiology, 116, 2460–2472.  
Sun, F. T., Morrell, M. J., & Wharen, R. E. Jr. (2008). Responsive cortical stimulation for the 
treatment of epilepsy. Neurotherapeutics, vol. 5, no. 1, pp. 68-74. 
Talairach, J. & Tournoux, P. (1958). Stereotaxic localization of central gray nuclei. 
Neurochirurgia (Stuttg), vol. 1, pp. 88–93. 
Talairach, J., Bancaud, J., Szikla, G., Bonis, A., Geier, S. & Vedrenne, C. (1974). [New 
approach to the neurosurgery of epilepsy. Stereotaxic methodology and therapeutic results. 1. 
Introduction and history]. Neurochirurgie, vol. 20 Suppl 1, pp.1-240. 
153 
 
 
Tanaka, N., Fujii, M., Imoto, H., Uchiyama, J., Nakano, K., Nomura, S., Fujisawa, H., 
Kunitsugu, I., Saito, T., & Suzuki, M. (2008).  Effective suppression of hippocampal seizures in 
rats by direct hippocampal cooling with a Peltier chip.  J Neurosurg, 108(4), 791-797. 
Tangel, A., & Choi, K. (2004). "The CMOS inverter" as a comparator in ADC designs.  
AICSP, 39, 147-55. 
Terry, R. (2009). Vagus nerve stimulation: a proven therapy for treatment of epilepsy strives 
to improve efficacy and expand applications. Conf. Proc. IEEE Eng. Med. Biol. Soc., pp. 4631-4. 
Tetzlaff, R., Niederhofer, C., & Fischer P. (2006). Automated detection of a preseizure state: 
nonlinear EEG analysis in epilepsy by cellular nonlinear networks and Volterra systems. 
International Journal of Circuit Theory and Applications, 34, 89-108. 
Tito, M., Cabrerizo, M., Ayala, M. et al. (2009). Seizure detection: an assessment of time- and 
frequency-based features in a unified two-dimensional decisional space using nonlinear decision 
functions. J. Clin. Neurophysiol., vol. 26, pp. 381-91. 
Theodore, W. H., & Fisher, R. S. (2004). Brain stimulation for epilepsy.  Neurology, 3(8), 
111-118. 
Thompson, S. M., Masukawa, L. M., & Prince, D. A. (1985). Temperature dependence of 
intrinsic membrane properties and synaptic potentials in hippocampal CA1 neurons in vitro.  J 
Neurosci, 817–824. 
Verma, N., Shoeb, A., Bohorquez, J., Dawson,  J., Guttag, J., & Chandrakasan, A. P. (2010). 
A micro-Power EEG acquisition SoC with integrated feature extraction processor for a chronic 
seizure detection system.  IEEE Journal of Solid-State Circuits, 45(4), 804-16. 
Volgushev, M., Vidyasagar, T. R., Chistiakova, M., Yousef, T., & Eysel, U. T. (2000).  
Membrane properties and spike generation in rat visual cortical cells during reversible cooling.  J 
Physiol, 522, 59–76. 
Wieser, H.G., Elger, C.E. & Stodieck, S.R. (1985). The 'foramen ovale electrode': a new 
recording method for the preoperative evaluation of patients suffering from mesio-basal temporal 
lobe epilepsy. Electroencephalogr Clin Neurophysiol., vol. 61(4), pp. 314-22. 
154 
 
 
Wyllie, E., Lüders, H., Morris, H.H., Lesser, R.P., Dinner, D.S., Hahn, J., Estes M.L., 
Rothner, A.D., Erenberg, G. & Cruse, R. (1987). Clinical outcome after complete or partial 
cortical resection for intractable epilepsy. Neurologym, vol. 37(10), pp.1634-41. 
Xiao-Feng, Y., Duffy, D. W., Morley, R. E., & Rothman, S. M. (2002). Neocortical seizure 
termination by focal cooling: Temperature dependence and automated seizure detection.  
Epilepsia, 43, 240-245. 
Yadav, R., Agarwal, R.  & Swamy, M. N. S. (2009). A new improved model-based seizure 
detection using statistically optimal null filter, IEEE-EMBC, 1318-22. 
Yadav, R., Agarwal, R., & Swamy, M. N. S. (2008). A novel dual-stage classifier for 
automatic detection of epileptic seizures. Engineering in Medicine and Biology Society, 30th 
Annual International Conference of the IEEE, 911-914. 
Zandi, A. S., Dumont, A. G., Javidan, M., & Tafreshi, R. (2009). An entropy-based approach 
to predict seizures in temporal lobe epilepsy using scalp EEG. Proc. Annu. Int. Conf. IEEE Eng. 
Med. Biol. Soc.: Eng. Future Biomed., EMBC, 228-231. 
Zandi, A. S., Javidan, M., Dumont, G. A. et al. (2010) Automated real-time epileptic seizure 
detection in scalp EEG recordings using an algorithm based on wavelet packet transform. IEEE 
Trans. Biomed. Eng., vol. 57, no. 7, pp. 1639-51. 
Zarifi, M. H., Frounchi, J., Farshchi, S. & Judy, J. W. (2008). A Low-Power, Low-Noise 
Neural-Signal Amplifier Circuit in 90-nm CMOS," IEEE EMBS Conference, Canada. 
Zhong, X. L., Yu J. T., Zhang, Q., Wang, N. D., Tan, L. (2011). Deep brain stimulation for 
epilepsy in clinical practice and in animal models. Brain Research Bulletin, 85(3-4), 81-8. 
 
  155 
 
APPENDICE A: Ethics approvals for in vitro and in vivo 
experiments 
All experiments in the thesis were conducted at the Polytechnique Montreal, Centre Hospitalier 
de l'Université de Montréal (CHUM) - Notre-Dame Hospital, and University Hospital Center 
(UHC) - Ste-Justine Hospital. Ethical issues in the experiments have been considered and 
approval for the research has been given by the research ethics committee of Polytechnique 
Montreal, CHUM ethical committee, and UHC Ste-Justine Research Center. 
Ethic approval # 10.173 (page # 149) and Ethic approval # CER-10/11-05 (page #151) have 
been given for the clinical experiments in chapters 2, 3, 4, and 5. The low-power devices were 
validated using the icEEG recordings from human epileptics during epilepsy presurgical 
evaluation at the CHUM – Notre-Dame Hospital. Use of these recordings and validation 
procedure were approved by the CHUM’s ethics committee and research ethics committee of 
Polytechnique Montreal. 
Ethic approval # 10.176 (page #152) and Ethic approval reference # 444 (page #154) have 
been given for the clinical experiments of chapter 6. Moreover, all procedures for the use and 
care of animals for these experiments were conformed to the policy and guidelines of the 
Canadian Council for Animal Care (CCAC). Experimental protocols were approved by the 
Comité Institutionnel des Bonnes Pratiques Animales en Recherche (CIBPAR).   
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